10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

Form 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from _____________ to _____________

Commission file number 001-36583

ENERGY FOCUS, INC.

(Exact name of registrant as specified in its charter)  

Delaware	94-3021850
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
32000 Aurora Road, Suite B Solon, OH
(Address of principal executive offices)
44139
(Zip Code)
(Registrant’s telephone number, including area code): (440) 715-1300
None
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.0001 per share	EFOI	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☑    No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☑    No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☑	Smaller reporting company	☑
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐    No ☑

The number of outstanding shares of the registrant’s common stock, $0.0001 par value, as of November 9, 2021 was 5,087,574.

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION
			Page
ITEM 1.	FINANCIAL STATEMENTS
	a.	Condensed Consolidated Balance Sheets as of September 30, 2021 (Unaudited) and December 31, 2020	4
	b.	Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020 (Unaudited)	6
	c.	Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2021 and 2020 (Unaudited)	7
	d.	Condensed Consolidated Statements of Changes in Stockholders' Equity for the three and nine months ended September 30, 2021 and 2020 (Unaudited)	8
	e.	Condensed Consolidated Statements of Cash Flows for the three and nine months ended September 30, 2021 and 2020 (Unaudited)	10
	f.	Notes to the Condensed Consolidated Financial Statements (Unaudited)	12
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS		32
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK		43
ITEM 4.	CONTROLS AND PROCEDURES		43
PART II - OTHER INFORMATION
ITEM 1.	LEGAL PROCEEDINGS		44
ITEM 1A.	RISK FACTORS		44
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS		44
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES		44
ITEM 4.	MINE SAFETY DISCLOSURES		44
ITEM 5.	OTHER INFORMATION		44
ITEM 6.	EXHIBITS		45
	SIGNATURES		46

1

PART I - FINANCIAL INFORMATION

Forward-looking statements

Unless the context otherwise requires, all references to “Energy Focus,” “we,” “us,” “our,” “our company,” or “the Company” refer to Energy Focus, Inc., a Delaware corporation, and its consolidated subsidiary for the applicable periods, considered as a single enterprise.

This Quarterly Report on Form 10-Q (this “Quarterly Report”) includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “feels,” “seeks,” “forecasts,” “projects,” “intends,” “plans,” “may,” “will,” “should,” “could” or “would” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this Quarterly Report and include statements regarding our intentions, beliefs, or current expectations concerning, among other things, our results of operations, financial condition, liquidity, prospects, growth, strategies, capital expenditures, and the industry in which we operate.

By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Although we base these forward-looking statements on assumptions that we believe are reasonable when made in light of information currently available to us, we caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and industry developments may differ materially from statements made in or suggested by the forward-looking statements contained in this Quarterly Report. In addition, even if our results of operations, financial condition and liquidity, and industry developments are consistent with the forward-looking statements contained in this Quarterly Report, those results or developments may not be indicative of results or developments in subsequent periods.

We believe that important factors that could cause our actual results to differ materially from forward-looking statements include, but are not limited to, the risks and uncertainties outlined under “Risk Factors” under Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020 and other matters described in this Quarterly Report and our other filings with the Securities and Exchange Commission generally. Some of these factors include:

•instability in the U.S. and global economies and business interruptions experienced by us, our customers and our suppliers as a result of the coronavirus (“COVID-19”) pandemic and related impacts on travel, trade and business operations;

•our ability to realize the expected novelty, disinfection effectiveness, affordability and estimated delivery timing of our ultraviolet light disinfection (“UVCD”) products and their appeal compared to other products;

•our ability to extend our product portfolio into commercial services and consumer products;

•market acceptance of our light-emitting diode (“LED”) lighting, control and UVCD technologies, services and products;

•our need for additional financing in the near term to continue our operations;

•our ability to refinance or extend maturing debt on acceptable terms or at all;

•our ability to continue as a going concern for a reasonable period of time;

•our ability to implement plans to increase sales and control expenses;

•our reliance on a limited number of customers for a significant portion of our revenue, and our ability to maintain or grow such sales levels;

•our ability to add new customers to reduce customer concentration;

•our reliance on a limited number of third-party suppliers and research and development partners, our ability to manage third-party product development and obtain critical components and finished products from such suppliers on acceptable terms and of acceptable quality despite ongoing global supply chain challenges, and the impact of our fluctuating demand on the stability of such suppliers;

•our ability to timely, efficiently and cost-effectively transport products from our third-party suppliers to our facility by ocean marine and other logistics channels despite global supply chain and logistics disruptions;

•our ability to increase demand in our targeted markets and to manage sales cycles that are difficult to predict and may span several quarters;

•the timing of large customer orders, significant expenses and fluctuations between demand and capacity as we invest in growth opportunities;

2

•our ability to compete effectively against companies with lower prices or cost structures, greater resources, or more rapid development capabilities, and new competitors in our target markets;

•our ability to successfully scale our network of sales representatives, agents, distributors and other channel partners to match the sales reach of larger, established competitors;

•our ability to attract, develop and retain qualified personnel, and to do so in a timely manner;

•the impact of any type of legal inquiry, claim or dispute;

•the inflationary or deflationary general economic conditions in the United States and in other markets in which we operate or secure products, which could affect our ability to obtain raw materials, component parts, freight, energy, labor, and sourced finished goods in a timely and cost-effective manner;

•our dependence on military maritime customers and on the levels and timing of government funding available to such customers, as well as the funding resources of our other customers in the public sector and commercial markets;

•business interruptions resulting from geopolitical actions, including war and terrorism, natural disasters, including earthquakes, typhoons, floods and fires, or from health epidemics, or pandemics or other contagious outbreaks;

•our ability to respond to new lighting technologies and market trends;

•our ability to fulfill our warranty obligations with safe and reliable products;

•any delays we may encounter in making new products available or fulfilling customer specifications;

•any flaws or defects in our products or in the manner in which they are used or installed;

•our ability to protect our intellectual property rights and other confidential information, and manage infringement claims made by others;

•our compliance with government contracting laws and regulations, through both direct and indirect sale channels, as well as other laws, such as those relating to the environment and health and safety;

•risks inherent in international markets, such as economic and political uncertainty, changing regulatory and tax requirements and currency fluctuations, including tariffs and other potential barriers to international trade;

•our ability to maintain effective internal controls and otherwise comply with our obligations as a public company; and

•our ability to maintain compliance with the continued listing standards of The Nasdaq Stock Market (“Nasdaq”).

In light of the foregoing, we caution you not to place undue reliance on our forward-looking statements. Any forward-looking statement that we make in this Quarterly Report speaks only as of the date of such statement, and we undertake no obligation to update any forward-looking statement or to publicly announce the results of any revision to any of those statements to reflect future events or developments, except as required by law. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless specifically expressed as such, and should only be viewed as historical data. Furthermore, new risks and uncertainties arise from time to time, and it is impossible for us to predict those events or how they may affect us.

Energy Focus®, Intellitube®, RedCap®, EnFocus™, nUVo™, abUV™, mUVe™, mUVe CrewTM, and SuncycleTM are our registered trademarks. We may also refer to trademarks of other corporations and organizations in this document.

3

ITEM 1. FINANCIAL STATEMENTS

ENERGY FOCUS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

	September 30, 2021		December 31, 2020
	(Unaudited)
ASSETS
Current assets:
Cash	$	381	$	1,836
Trade accounts receivable, less allowances of $18 and $8, respectively	1,628		2,021
Inventories, net	7,755		5,641
Short-term deposits	913		796
Prepaid and other current assets	1,421		782
Total current assets	12,098		11,076
Property and equipment, net	588		420
Operating lease, right-of-use asset	419		794
Restructured lease, right-of-use asset	—		107
Total assets	$	13,105	$	12,397
LIABILITIES
Current liabilities:
Accounts payable	$	2,606	$	2,477
Accrued liabilities	233		45
Accrued legal and professional fees	17		149
Accrued payroll and related benefits	691		885
Accrued sales commissions	40		95
Accrued restructuring	—		11
Accrued warranty reserve	240		227
Deferred revenue	2		72
Operating lease liabilities	475		598
Restructured lease liabilities	—		168
Finance lease liabilities	1		3
Streeterville note, net of discount and loan origination fees	1,602		—
PPP loan	—		529
Credit line borrowings, net of loan origination fees	2,666		2,298
Total current liabilities	8,573		7,557

(continued on the next page)

4

ENERGY FOCUS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

	September 30, 2021		December 31, 2020
	(Unaudited)
Operating lease liabilities, net of current portion	30		318
Finance lease liabilities, net of current portion	—		1
PPP loan, net of current maturities	—		266
Total liabilities	8,603		8,142
STOCKHOLDERS' EQUITY
Preferred stock, par value $0.0001 per share:
Authorized: 5,000,000 shares (3,300,000 designated as Series A Convertible Preferred Stock) at September 30, 2021 and December 31, 2020
Issued and outstanding: 876,447 at September 30, 2021 and 2,597,470 at December 31, 2020	—		—
Common stock, par value $0.0001 per share:
Authorized: 50,000,000 shares at September 30, 2021 and December 31, 2020
Issued and outstanding: 5,087,574 at September 30, 2021 and 3,525,374 at December 31, 2020	—		—
Additional paid-in capital	140,615		135,113
Accumulated other comprehensive loss	(3)		(3)
Accumulated deficit	(136,110)		(130,855)
Total stockholders' equity	4,502		4,255
Total liabilities and stockholders' equity	$	13,105	$	12,397

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

ENERGY FOCUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(Unaudited) 

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net sales	$	2,749	$	5,964	$	7,460	$	13,082
Cost of sales	2,186		4,588		5,951		9,331
Gross profit	563		1,376		1,509		3,751
Operating expenses:
Product development	404		401		1,427		996
Selling, general, and administrative	1,968		2,003		6,454		6,003
Restructuring	1		(16)		(21)		(44)
Total operating expenses	2,373		2,388		7,860		6,955
Loss from operations	(1,810)		(1,012)		(6,351)		(3,204)
Other expenses (income):
Interest expense	177		124		520		344
Gain on forgiveness of PPP loan	—		—		(801)		—
Loss on extinguishment of debt	—		159		—		159
Other income - employee retention tax credit	(862)		—		(862)		—
(Gain) loss from change in fair value of warrants	—		(153)		—		2,274
Other expenses	15		25		47		67
Loss before income taxes	(1,140)		(1,167)		(5,255)		(6,048)
Benefit from income taxes	—		(2)		—		(2)
Net loss	$	(1,140)	$	(1,165)	$	(5,255)	$	(6,046)
Net loss per common share - basic and diluted
Net loss	$	(0.22)	$	(0.35)	$	(1.22)	$	(1.89)
Weighted average shares of common stock outstanding:
Basic and diluted *	5,086		3,308		4,309		3,196
* Shares outstanding for the nine months ended September 30, 2020 have been restated for the 1-for-5 reverse stock split effective June 11, 2020.

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

ENERGY FOCUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(in thousands)

(Unaudited)

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net loss	$	(1,140)	$	(1,165)	$	(5,255)	$	(6,046)
Other comprehensive income:
Foreign currency translation adjustments	—		—		—		—
Comprehensive loss	$	(1,140)	$	(1,165)	$	(5,255)	$	(6,046)

The accompanying notes are an integral part of these condensed consolidated financial statements. 

7

ENERGY FOCUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(in thousands)

(Unaudited)

	Preferred Stock			Common Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Loss		Accumulated Deficit		Total Stockholders' Equity
	Shares	Amount		Shares	Amount
Balance at December 31, 2020	2,597	$	—	3,525	$	—	$	135,113	$	(3)	$	(130,855)	$	4,255
Issuance of common stock under employee stock option and stock purchase plans	—	—		1	—		—		—		—		—
Issuance of common stock upon the exercise of warrants	—	—		156	—		527		—		—		527
Common stock withheld in lieu of income tax withholding on vesting of restricted stock units	—	—		—	—		(2)		—		—		(2)
Stock-based compensation	—	—		—	—		140		—		—		140
Net loss for the three months ended March 31, 2021	—	—		—	—		—		—		(1,642)		(1,642)
Balance at March 31, 2021	2,597	$	—	3,682	$	—	$	135,778	$	(3)	$	(132,497)	$	3,278
Issuance of common stock under employee stock option and stock purchase plans	—	—		69	—		59		—		—		59
Issuance of common stock	—	—		990	—		5,000		—		—		5,000
Offering costs on issuance of common stock	—	—		—	—		(469)		—		—		(469)
Issuance of common stock upon conversion from preferred stock	(1,721)	—		344	—		—		—		—		—
Stock-based compensation	—	—		—	—		208		—		—		208
Net loss for the three months ended June 30, 2021	—	—		—	—		—		—		(2,473)		(2,473)
Balance at June 30, 2021	876	$	—	5,085	$	—	$	140,576	$	(3)	$	(134,970)	$	5,603
Issuance of common stock under employee stock option and stock purchase plans	—	—		2	—		—		—		—		—
Offering costs on issuance of common stock and warrants	—	—		—	—		(1)		—		—		(1)
Common stock withheld in lieu of income tax withholding on vesting of restricted stock units	—	—		—	—		1		—		—		1
Stock-based compensation	—	—		—	—		39		—		—		39
Net loss for the three months ended September 30, 2021	—	—		—	—		—		—		(1,140)		(1,140)
Balance at September 30, 2021	876	$	—	5,087	$	—	$	140,615	$	(3)	$	(136,110)	$	4,502

(continued on the next page)

8

ENERGY FOCUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(in thousands)

(Unaudited)

	Preferred Stock			Common Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Loss		Accumulated Deficit			Total Stockholders' Equity
	Shares	Amount		Shares*	Amount
Balance at December 31, 2019	—	$	—	2,486	$	—	$	128,873	$	(3)	$	(124,874)	-124874000	$	3,996
Issuance of common stock under employee stock option and stock purchase plans	—	—		5	—		—		—		—			—
Issuance of common stock and warrants	—	—		688	—		2,749		—		—			2,749
Offering costs on issuance of common stock and warrants	—	—		—	—		(474)		—		—			(474)
Warrant liability	—	—		—	—		(1,636)		—		—			(1,636)
Conversion of notes to preferred stock	2,709	—		—	—		1,769		—		—			1,769
Stock-based compensation	—	—		—	—		20		—		—			20
Net loss for the three months ended March 31, 2020	—	—		—	—		—		—		(541)			(541)
Balance at March 31, 2020	2,709	$	—	3,179	$	—	$	131,301	$	(3)	$	(125,415)		$	5,883
Issuance of common stock under employee stock option and stock purchase plans	—	—		—	—		30		—		—			30
Common stock withheld in lieu of income tax withholding on vesting of restricted stock units	—	—		—	—		(3)		—		—			(3)
Issuance of common stock upon the exercise of warrants	—	—		15	—		103		—		—			103
Issuance of common stock upon conversion from preferred stock	(112)	—		22	—		—		—		—			—
Stock-based compensation	—	—		—	—		41		—		—			41
Net loss for the three months ended June 30, 2020	—	—		—	—		—		—		(4,340)			(4,340)
Balance at June 30, 2020	2,597	$	—	3,216	$	—	$	131,472	$	(3)	$	(129,755)		$	1,714
Issuance of common stock under employee stock option and stock purchase plans	—	—		30	—		—		—		—			—
Issuance of common stock upon the exercise of warrants	—	—		182	—		1,555		—		—			1,555
Stock-based compensation	—	—		—	—		35		—		—			35
Net loss for the three months ended September 30, 2020	—	—		—	—		—		—		(1,165)			(1,165)
Balance at September 30, 2020	2,597	$	—	3,428	$	—	$	133,062	$	(3)	$	(130,920)		$	2,139

*Shares outstanding for prior periods have been restated for the 1-for-5 reverse stock split effective June 11, 2020.

The accompanying notes are an integral part of these condensed consolidated financial statements.

9

ENERGY FOCUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Cash flows from operating activities:
Net loss	$	(1,140)	$	(1,165)	$	(5,255)	$	(6,046)
Adjustments to reconcile net loss to net cash used in operating activities:
Other income - employee retention tax credit	(862)		—		(862)		—
Gain on forgiveness of PPP loan	—		—		(801)		—
Depreciation	43		48		143		140
Stock-based compensation	39		35		387		96
Change in fair value of warrant liabilities	—		(153)		—		2,274
Provision for doubtful accounts receivable	2		(9)		10		(21)
Provision for slow-moving and obsolete inventories	(70)		90		(9)		(229)
Provision for warranties	1		14		13		34
Amortization of loan discounts and origination fees	61		145		158		221
Changes in operating assets and liabilities (sources / (uses) of cash):
Accounts receivable	(500)		(901)		390		(1,070)
Inventories	444		551		(2,105)		1,138
Short-term deposits	(62)		(197)		87		(412)
Prepaid and other assets	(91)		(76)		(119)		(59)
Accounts payable	(164)		534		(82)		1,811
Accrued and other liabilities	53		160		(305)		453
Deferred revenue	(69)		44		(70)		87
Total adjustments	(1,175)		285		(3,165)		4,463
Net cash used in operating activities	(2,315)		(880)		(8,420)		(1,583)
Cash flows from investing activities:
Acquisitions of property and equipment	(100)		(53)		(311)		(171)
Net cash used in investing activities	(100)		(53)		(311)		(171)

(continued on next page)

10

ENERGY FOCUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Cash flows from financing activities (sources / (uses) of cash):
Proceeds from the issuance of common stock and warrants	—		(1)		5,000		2,749
Proceeds from the exercise of warrants	—		625		527		676
Offering costs paid on the issuance of common stock and warrants	(1)		—		(470)		(474)
Proceeds from PPP loan	—		—		—		795
Principal payments under finance lease obligations	(1)		(1)		(3)		(3)
Proceeds from exercise of stock options and employee stock purchase plan purchases	—		—		59		30
Common stock withheld in lieu of income tax withholding on vesting of restricted stock units	1		—		(1)		(3)
Proceeds from the Streeterville note	—		—		1,515		—
Payments on the Iliad note	—		(450)		—		(976)
Deferred financing costs	—		(320)		(30)		(320)
Net payments on credit line borrowings - AFS	—		(1,296)		—		(719)
Net proceeds from the credit line borrowings - Credit Facilities	1,128		2,223		337		2,223
Net cash provided by financing activities	1,127		780		6,934		3,978
Net (decrease) increase in cash and restricted cash	(1,288)		(153)		(1,797)		2,224
Cash and restricted cash, beginning of period	1,669		3,069		2,178		692
Cash and restricted cash, end of period	$	381	$	2,916	$	381	$	2,916
Classification of cash and restricted cash:
Cash	$	381	$	2,574	$	381	$	2,574
Restricted cash held in other assets	—		342		—		342
Cash and restricted cash	$	381	$	2,916	$	381	$	2,916

The accompanying notes are an integral part of these condensed consolidated financial statements.

11

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

NOTE 1. NATURE OF OPERATIONS

Energy Focus, Inc. engages primarily in the design, development, manufacturing, marketing and sale of energy-efficient lighting systems and controls and development of ultraviolet-C light disinfection (“UVCD”) products. We develop, market and sell high quality light-emitting diode (“LED”) lighting and controls products and UVCD products in the commercial market and military maritime market (“MMM”), and expect to expand our offerings into the consumer market starting in the fourth quarter of 2021. Our mission is to enable our customers to run their facilities, offices and homes with greater energy efficiency, productivity, and human health through advanced LED retrofit and UVCD solutions. Our goal is to be the LED and human-centric lighting (“HCL”) technology and market leader for the most demanding applications where performance, quality, value, environmental impact and health are considered paramount. We specialize in LED lighting retrofit by replacing fluorescent, high-intensity discharge lighting and other types of lamps in institutional buildings for primarily indoor lighting applications with our innovative, high-quality commercial and military tubular LED (“TLED”) products, as well as other LED and lighting control products for commercial and consumer applications. In late 2020, we announced the launch of our UVCD product portfolio, which is being brought to market throughout the fourth quarter of 2021 and into 2022.

On June 11, 2020, in accordance with previous stockholder approval, our board of directors effected a 1-for-5 (the “Split Ratio”) reverse stock split of the Company’s common stock, par value $0.0001 per share. The reverse stock split became effective immediately upon the filing of the Certificate of Amendment to the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”), with the Delaware Secretary of State (the “Effective Time”). At the Effective Time, every five shares of common stock issued and outstanding automatically combined into one validly issued, fully paid and non-assessable share of common stock. No fractional shares were issued as a result of the reverse stock split. The $0.0001 par value per share of common stock and other terms of the common stock were not affected by the reverse stock split. The number of authorized shares of common stock under the Certificate of Incorporation remained unchanged at 50,000,000 shares. Proportional adjustments were made to the conversion and exercise prices of our outstanding warrants and stock options, and to the number of shares issued and issuable under our stock incentive plans in connection with the reverse stock split. The information presented in the financial statements for all prior periods have been retroactively adjusted to reflect the reverse stock split. Preferred shares outstanding were not affected by the reverse stock split and, as such, those shares have not been adjusted.

NOTE 2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The significant accounting policies of our Company, which are summarized below, are consistent with accounting principles generally accepted in the United States (“U.S. GAAP”) and reflect practices appropriate to the business in which we operate. Unless indicated otherwise, the information in the Notes to the Consolidated Financial Statements relates to our operations.

We have prepared the accompanying financial data for the three and nine months ended September 30, 2021 and 2020 pursuant to the rules and regulations of the United States Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2020 (“2020 Annual Report”). The Condensed Consolidated Balance Sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements.

In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary to present fairly our Condensed Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020, Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020, Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2021 and 2020, Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2021 and 2020, and Condensed Consolidated Statements of Cash Flows for the three and nine months ended September 30, 2021 and 2020.

12

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

Use of estimates

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management’s best knowledge of current events and actions that may impact us in the future, actual results may vary from the estimates. Estimates include, but are not limited to, the establishment of reserves for accounts receivable, sales returns, inventory obsolescence and warranty claims; the useful lives of property and equipment; valuation allowance for net deferred taxes; the cost and offsetting income related to sub-leased property; and stock-based compensation. In addition, estimates and assumptions associated with the determination of the fair value of financial instruments and evaluation of long-lived assets for impairment requires considerable judgment. Actual results could differ from those estimates and such differences could be material.

Certain risks and concentrations

We have certain customers whose net sales individually represented 10% or more of our total net sales, or whose net trade accounts receivable balance individually represented 10% or more of our total net trade accounts receivable; we have certain suppliers, which individually represent 10% or more of our total purchases, or whose trade accounts payable balance individually represented 10% or more of our total trade accounts payable balance, as follows:

For the three months ended September 30, 2021, sales to our primary distributor for the U.S. Navy, a U.S. Navy shipbuilder, and a regional commercial lighting retrofit company accounted for approximately 19%, 17%, and 27% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 36% of net sales for the same period. For the three months ended September 30, 2020, sales to our primary distributor for the U.S. Navy and a regional commercial lighting retrofit company accounted for approximately 67% and 12% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 68% of net sales for the same period.

For the nine months ended September 30, 2021, sales to our primary distributor for the U.S. Navy, a U.S. Navy shipbuilder, and a regional commercial lighting retrofit company accounted for approximately 33%, 10%, and 17% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 43% of net sales for the same period. For the nine months ended September 30, 2020, sales to our primary distributor for the U.S. Navy and a regional commercial lighting retrofit company accounted for approximately 52% and 14% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 58% of net sales for the same period.

Our primary distributor for the U.S. Navy, a regional commercial lighting retrofit company and a U.S. Navy shipbuilder accounted for approximately 12%, 34%, and 27% of net trade accounts receivable, respectively, at September 30, 2021. At December 31, 2020, our primary distributor to the U.S. Navy accounted for 28% of our net trade accounts receivable and a shipbuilder for the U.S. Navy accounted for 21% of our net trade accounts receivable.

One offshore supplier accounted for approximately 19% and 30%, respectively, of our total expenditures for the three and nine months ended September 30, 2021. For the three months ended September 30, 2020, two offshore suppliers accounted for approximately 25% and 20%, respectively, of total expenditures. These same two suppliers accounted for approximately 19% and 14%, respectively, of total expenditures for the nine months ended September 30, 2020.

At September 30, 2021, one offshore supplier accounted for approximately 63% of our trade accounts payable balance. At December 31, 2020, this offshore supplier accounted for approximately 44% of our trade accounts payable balance.

13

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

Recent accounting pronouncement

In June 2016, the Financial Accounting Standards Board issued Accounting Standard Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which significantly changes the accounting for credit losses on instruments within its scope. The new guidance introduces an approach based on expected losses to estimate credit losses on certain financial instruments, including trade receivables, and requires an entity to recognize an allowance based on its estimate of expected credit losses rather than incurred losses. For smaller reporting companies, this standard will be effective for interim and annual periods starting after December 15, 2022 and will generally require adoption on a modified retrospective basis. We are in the process of evaluating the impact of the standard.

Revenue

Net sales include revenues from sales of products and shipping and handling charges, net of estimates for product returns. Revenue is measured at the amount of consideration we expect to receive in exchange for the transferred products. We recognize revenue at the point in time when we transfer the promised products to the customer and the customer obtains control over the products. Distributors’ obligations to us are not contingent upon the resale of our products. We recognize revenue for shipping and handling charges at the time the goods are shipped to the customer, and the costs of outbound freight are included in cost of sales. We provide for product returns based on historical return rates. While we incur costs for sales commissions to our sales employees and outside agents, we recognize commission costs concurrent with the related revenue, as the amortization period is less than one year. We do not incur any other incremental costs to obtain contracts with our customers. Our product warranties are assurance-type warranties, which promise the customer that the products are as specified in the contract. Therefore, the product warranties are not a separate performance obligation and are accounted for as described below. Sales taxes assessed by governmental authorities and collected by us are accounted for on a net basis and are excluded from net sales.

The following table provides a disaggregation of product net sales for the periods presented (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net sales:
Commercial	$	1,522	$	1,456	$	3,513	$	4,250
MMM products	1,227		4,508		3,947		8,832
Total net sales	$	2,749	$	5,964	$	7,460	$	13,082

Accounts Receivable

Our trade accounts receivable consist of amounts billed to and currently due from customers. Our customers are currently concentrated in the United States. In the normal course of business, we extend unsecured credit to our customers related to the sale of our products. Credit is extended to customers based on an evaluation of the customer’s financial condition and the amounts due are stated at their estimated net realizable value. We utilize an account receivable insurance program with a high credit worthy insurance company where we have the large majority of the accounts receivable insured with a portion of self-retention. This third party also provides creditworthiness ratings and metrics that significantly assist us in evaluating the creditworthiness of both existing and new customers. We maintain allowances for sales returns and doubtful accounts receivable to provide for the estimated number of accounts receivable that will not be collected. The allowance is based on an assessment of customer creditworthiness and historical payment experience, the age of outstanding receivables, and performance guarantees to the extent applicable. Past due amounts are written off when our internal collection efforts have been unsuccessful, and payments subsequently received on such receivables are credited to the allowance for doubtful accounts. We do not generally require collateral from our customers.

Our standard payment terms with customers are net 30 days from the date of shipment, and we do not generally offer extended payment terms to our customers, but exceptions are made in some cases to certain customers or with particular orders. Accordingly, we do not adjust trade accounts receivable for the effects of financing, as we expect the period between the transfer of product to the customer and the receipt of payment from the customer to be in line with our standard payment terms.

14

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

Geographic information

All of our long-lived fixed assets are located in the United States. For the three months ended September 30, 2021, there were less than 1% of sales attributable to customers outside the United States. For the nine months ended September 30, 2021, there were approximately 1% of sales attributable to customers outside the United States. For the three and nine months ended September 30, 2020, there were no net sales attributable to customers outside the United States. The geographic location of our net sales is derived from the destination to which we ship the product.

Net loss per share

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of shares of common stock outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted loss per share gives effect to all dilutive potential shares of common stock outstanding during the period. Dilutive potential shares of common stock consist of incremental shares upon the exercise of stock options, warrants and convertible securities, unless the effect would be anti-dilutive.

The following table presents a reconciliation of basic and diluted loss per share computations (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Numerator:
Net loss	$	(1,140)	$	(1,165)	$	(5,255)	$	(6,046)
Denominator:
Basic and diluted weighted average shares of common stock outstanding *	5,086		3,308		4,309		3,196

*Shares outstanding for the nine months ended September 30, 2020 have been restated for the 1-for-5 stock split effective June 11, 2020.

As a result of the net loss we incurred for the three months ended September 30, 2021, options, warrants and convertible securities representing approximately 41 thousand, 11 thousand and 175 thousand shares of common stock, respectively, were excluded from the basic loss per share calculation because their inclusion would have been anti-dilutive. As a result of the net loss we incurred for the three months ended September 30, 2020, options, restricted share units, warrants and convertible securities representing approximately 117 thousand, 13 thousand, 321 thousand and 519 thousand shares of common stock, respectively, were excluded from the basic loss per share calculation as their inclusion would have been anti-dilutive.

As a result of the net loss we incurred for the nine months ended September 30, 2021, options, warrants and convertible securities representing approximately 60 thousand, 56 thousand and 289 thousand shares of common stock, respectively, were excluded from the basic loss per share calculation because their inclusion would have been anti-dilutive. As a result of the net loss we incurred for the nine months ended September 30, 2020, options, restricted share units, warrants and convertible securities representing approximately 57 thousand, 7 thousand, 152 thousand and 531 thousand shares of common stock, respectively, were excluded from the basic loss per share calculation as their inclusion would have been anti-dilutive.

Product warranties

We warrant our commercial and MMM LED products and controls for periods generally ranging from five to ten years. Warranty settlement costs consist of actual amounts expensed for warranty, which are largely a result of the cost of replacement products provided to our customers. A liability for the estimated future costs under product warranties is maintained for products under warranty based on the actual claims incurred to date and the estimated nature, frequency, and costs of future claims. These estimates are inherently uncertain and changes to our historical or projected experience may cause material changes to our warranty reserves in the future. We continuously review the assumptions related to the adequacy of our warranty reserve, including product failure rates, and make adjustments to the existing warranty liability when there are changes to these estimates or the underlying replacement product costs, or the warranty period expires.

15

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

The following table summarizes warranty activity for the periods presented (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Balance at beginning of period	$	239	$	215	$	227	$	195
Warranty accruals for current period sales	10		22		49		29
Adjustments to existing warranties	4		4		16		23
In kind settlements made during the period	(13)		(11)		(52)		(17)
Accrued warranty reserve at end of period	$	240	$	230	$	240	$	230

Financial Instruments

In June 2021, we completed a registered direct offering of 990,100 shares of our common stock to certain institutional investors, at a purchase price of $5.05 per share (the “June 2021 Equity Offering”). We paid the placement agent commissions of $400 thousand, plus $51 thousand in expenses, in connection with the June 2021 Equity Offering and we also paid legal and other fees of $19 thousand related to the offering. Total offering costs of $470 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of September 30, 2021. Net proceeds to us from the June 2021 Equity Offering were approximately $4.5 million.

In January 2020, we completed a registered direct offering of 688,360 shares of our common stock to certain institutional investors, at a purchase price of $3.37 per share. We also sold, to the same institutional investors, warrants to purchase up to 688,360 shares of common stock at an exercise price of $3.37 per share in a concurrent private placement for a purchase price of $0.625 per warrant. We paid the placement agent commissions of $193 thousand, plus $50 thousand in expenses, in connection with the registered direct offering and the concurrent private placement and we also paid legal, accounting and other fees of $231 thousand related to the offering. Total offering costs of $510 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of December 31, 2020. In addition, we issued warrants to the placement agent to purchase up to 48,185 shares of common stock at an exercise price of $4.99 per share. Net proceeds to us from the sale of common stock and warrants (the “January 2020 Equity Offering”) were approximately $2.3 million. In accordance with the terms of the Iliad Note (as defined below in Note 7, “Debt”), 10% of the gross proceeds from the January 2020 Equity Offering ($275 thousand) were used to make payments on the Iliad Note, of which $226 thousand went towards the outstanding principal amount and the balance to interest.

Warrants to purchase an aggregate of 310,860 shares remain outstanding at September 30, 2021 with a weighted average exercise price of $3.59 per share. The exercise of warrants could provide us with cash proceeds of up to $1.1 million in the aggregate. During the nine months ended September 30, 2021, 156,446 warrants were exercised resulting in total proceeds of $527 thousand.

Due to a potential cash settlement upon occurrence of a fundamental transaction within the January 2020 warrant agreement, the warrants were initially classified as liabilities, as opposed to equity, and were recorded at their fair values at each balance sheet date for the first three quarters of 2020. During December 2020, the warrant holders all agreed to a modification of the terms of their warrants that removed the potential cash settlement option upon the occurrence of a fundamental transaction. As such, during the fourth quarter of 2020, the warrant liability was reclassified into equity and the warrants are no longer subject to re-measurement at each balance sheet date. Please also refer to Note 9, “Stockholders’ Equity”.

16

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

Fair Value Measurements

The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value, giving the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below. We classify the inputs used to measure fair value into the following hierarchy:

Level 1	Unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2	Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.
Level 3	Unobservable inputs for the asset or liability.

The following table provides a summary of the financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2020 (in thousands):

			Fair Value Measurements at September 30, 2020 Using
	Balance as of		Quoted Prices in Active Markets for Identical Assets  (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs  (Level 3)
Description	September 30, 2020
Warrant liabilities	$	2,928	$	—	$	—	$	2,928

The carrying amounts of certain financial instruments including cash, accounts receivable, accounts payable, and accrued liabilities approximate fair value due to their short maturities. Based on borrowing rates currently available to us for loans with similar terms, the carrying value of borrowings under our revolving credit facilities also approximates fair value.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. In determining the appropriate levels, we perform a detailed analysis of the assets and liabilities whose fair value is measured on a recurring basis. We review and reassess the fair value hierarchy classifications on a quarterly basis. Changes from one quarter to the next related to the observability of inputs in a fair value measurement may result in a reclassification between fair value hierarchy levels. There were no reclassifications for all periods presented.

The estimated fair value of warrants accounted for as liabilities, representing a level 3 fair value measure, was determined on the issuance date and subsequently marked to market at each financial reporting date until the date the warrants were reclassified into equity, after which the warrants are no longer subject to re-measurement at each balance sheet date. We use the Black-Scholes valuation model to value the warrant liabilities at fair value. The fair value is estimated using the expected volatility based on our historical volatility and is determined using probability weighted-average assumptions, when appropriate.

The following inputs were used at September 30, 2020:

	Expected	Risk-Free	Expected
	Volatility	Interest Rate	Life
Warrants with greater than one-year remaining term	103.18% - 99.38%	0.21% - 0.24%	3.79 - 4.29 years

A roll-forward of fair value measurements using significant unobservable inputs (Level 3) for the warrants is as follows (in thousands):

	Nine months ended September 30, 2020
Balance January 1, 2020	$	—
Issuance of warrants, January 2020	1,636
Settlements from exercise	(982)
Gain from change in fair value of warrants	2,274
Balance September 30, 2020	$	2,928

17

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

NOTE 3. RESTRUCTURING

For the three months ended September 30, 2021, we recorded nominal net restructuring expense and for the nine months ended September 30, 2021, we recorded a net restructuring credit of approximately $21 thousand. For three and nine months ended September 30, 2020, we recorded net restructuring credits of approximately $16 thousand and $44 thousand, respectively, related to the costs and offsetting sub-lease income and accretion expense for the remaining lease obligation for our former New York, New York office. For additional information regarding the restructuring actions taken as part of the restructuring plans, please refer to Note 3, “Restructuring,” included under Item 8, “Financial Statements and Supplementary Data,” of our 2020 Annual Report.

The lease obligation on our former New York, New York office was settled as of June 30, 2021. Our restructuring liabilities consisted of estimated ongoing costs related to long-term operating lease obligations, which the Company exited. The recorded value of the lease obligation was based on the remaining lease term and payment amount, discounted to present value. Changes in subsequent periods resulting from a revision to either the timing or the amount of estimated cash flows over the future period were measured using the credit adjusted, risk free rate that was used to measure the restructuring liabilities initially. Please also refer to Note 6, “Leases”.

The following is a reconciliation of the beginning and ending balances of our restructuring liability as it relates to the restructuring plans (in thousands):

	2021		2020
Balance at December 31, 2020 and 2019	$	11	$	38
Accretion of lease obligations	—		2
Payments	(11)		(22)
Balance at September 30, 2021 and 2020	$	—	$	18

The following is a reconciliation of the ending balance of our restructuring liability at September 30, 2021 to the balance sheet:

	2021		2020
Balance at September 30, 2021 and 2020	$	—	$	18
Less, short-term restructuring liability	—		18
Long-term restructuring liability, included in other liabilities	$	—	$	—

As a result of the restructuring actions and initiatives described above, we have reduced our operating expenses to be more commensurate with our sales volumes. However, we continue to incur losses and have a substantial accumulated deficit, and substantial doubt about our ability to continue as a going concern continues to exist at September 30, 2021.

Throughout 2020 and the first nine months of 2021, we have continued to evaluate and assess strategic options as we seek to achieve profitability. We plan to continue to develop advanced lighting and lighting control technologies and introduce impactful new products surrounding EnFocusTM, a patented, breakthrough lighting control platform we officially launched during the second quarter of 2020, and our SuncycleTM circadian lighting system, which we plan to launch in early 2022. Additionally, during the last quarter of 2020, we announced newly developed UVCD products for consumer as well as commercial and industrial markets, of which two products are expected to be available in the fourth quarter of 2021, and two products are expected to be available in early 2022.

We plan to achieve profitability by growing our sales, through existing lighting, new lighting control systems and UVCD products, and by continuing to refine and execute on our multi-channel sales strategy that targets key verticals, such as government, healthcare, education, and commercial and industrial, complemented by our marketing outreach campaigns and expanding channel partnerships, as well as our emerging consumer market focus.

As described in Note 9, “Stockholders’ Equity,” we also raised approximately $4.5 million of net proceeds upon the issuance of common stock in connection with the June 2021 Equity Offering and we raised approximately $2.3 million of net proceeds upon the issuance of common stock and warrants from the January 2020 Equity Offering. As described in Note 7, “Debt”, in April 2021, we obtained approximately $1.5 million of bridge financing and in August 2020, we entered into

18

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

two new revolving credit facilities, which allow for expanded borrowing capacity, which capacity was further increased by an April 20, 2021 amendment to one of the facilities.

The restructuring and cost cutting initiatives implemented during 2020 and continued into 2021, as well as the June 2021 Equity Offering and January 2020 Equity Offering that significantly strengthened our balance sheet, the Paycheck Protection Program (“PPP”) loan we obtained in April 2020, our enhanced debt capacity due to the debt refinancing in August 2020, the credit facility capacity increase and bridge financing in April 2021, and the funds we expect to receive related to the Employee Retention Tax Credit (“ERTC”, see Note 11, “Other Income” for details), were all designed to allow us to effectively execute these strategies. However, our efforts may not occur as quickly as we envision or be successful due to the long sales cycle in our industry, the corresponding time required to ramp up sales from new products, markets, and customers into this sales cycle, the timing of introductions of additional new products, significant competition, potential sales volatility given our customer concentration, interruptions and cost increases in the global supply chain, and the ongoing and lingering economic impact from the COVID-19 pandemic that had significantly diminished the interest and activities for our customers’ lighting retrofit projects until occupancy returns to more normal levels, among other factors. Additionally, global supply chain challenges are impacting our inventory purchasing strategy, leading to a buildup of inventory and components in an effort to manage both shortages of available components and longer lead times in obtaining components. Disruptions and cost increases in global logistics networks are also impacting our lead times and ability to efficiently and cost-effectively transport products from our third-party suppliers to our facility. As a result, we will continue to review and pursue selected external funding sources to ensure adequate financial resources to execute across the timelines required to achieve these objectives including, but not limited to, the following:

•obtaining financing from traditional or non-traditional investment capital organizations or individuals;

•obtaining funding from the sale of our common stock or other equity or debt instruments; and

•obtaining debt financing with lending terms that more closely match our business model and capital needs.

There can be no assurance that we will obtain funding on acceptable terms, in a timely fashion, or at all. Obtaining additional funding contains risks, including:

•additional equity financing may not be available to us on satisfactory terms, and any equity we are able to issue could lead to dilution for current stockholders and have rights, preferences and privileges senior to our common stock;

•loans or other debt instruments may have terms and/or conditions, such as interest rate, restrictive covenants, conversion features, refinancing demands, and control or revocation provisions, which are not acceptable to management or our board of directors; and

•the current environment in the capital markets combined with our capital constraints may prevent us from being able to obtain adequate debt financing.

If we fail to obtain the required additional financing to sustain our business before we are able to produce levels of revenue to meet our financial needs, we will need to delay, scale back or eliminate our growth plans and further reduce our operating costs and headcount, each of which would have a material adverse effect on our business, future prospects, and financial condition. A lack of additional funding could also result in our inability to continue as a going concern and force us to sell certain assets or discontinue or curtail our operations and, as a result, investors in the Company could lose their entire investment.

Considering both quantitative and qualitative information, we continue to believe that the combination of our plans to obtain additional external funding, timely re-organizational actions, current financial position, liquid resources, obligations due or anticipated within the next year, development and implementation of an excess inventory reduction plan, plans and initiatives in our research and development, product development and sales and marketing, and development of potential channel partnerships, if adequately executed, will provide us with an ability to finance our operations through the next twelve months and will mitigate the substantial doubt about our ability to continue as a going concern.

On August 17, 2020, we received a letter from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying us that we were no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders’ equity of at least $2,500,000 if they do not meet the alternative compliance standards relating to the market value of listed securities or net income from continuing operations (the “Minimum Stockholders’ Equity Rule”). Our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020, filed on August 13, 2020, reflected that our stockholders’ equity as of June 30, 2020 was $1,714,000. In addition, as of August 13, 2020, we did not meet the alternative compliance standards relating to the market value of listed securities or net income from continuing operations. On October 5, 2020, based on our timely submission of our plan to regain compliance, Nasdaq granted us an

19

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

extension through February 15, 2021, to regain compliance with the Minimum Stockholders’ Equity Rule, subject to our compliance with certain terms of the extension. In accordance with one part of the plan submitted to the Staff, we have successfully modified our outstanding warrants and are able to now classify the warrants within equity. At December 31, 2020, our stockholders’ equity was $4,255,000. On January 20, 2021, we received a letter from the Staff notifying us that, on a conditional basis, Nasdaq has determined that we have regained compliance with the Minimum Stockholders’ Equity Rule. At September 30, 2021, our stockholders’ equity was $4,502,000.

NOTE 4. INVENTORIES

Inventories are stated at the lower of standard cost (which approximates actual cost determined using the first-in, first-out cost method) or net realizable value, and consist of the following (in thousands):

	September 30, 2021		December 31, 2020
Raw materials	$	4,232	$	2,695
Finished goods	6,409		5,840
Reserves for excess, obsolete, and slow-moving inventories	(2,886)		(2,894)
Inventories, net	$	7,755	$	5,641

The following is a roll-forward of the reserves for excess, obsolete, and slow-moving inventories (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Beginning balance	$	(2,956)	$	(3,326)	$	(2,894)	$	(3,645)
Accrual	34		(187)		(64)		(75)
Reduction due to sold inventory	36		121		72		288
Write-off for disposed inventory	—		(23)		—		17
Reserves for excess, obsolete, and slow-moving inventories	$	(2,886)	$	(3,415)	$	(2,886)	$	(3,415)

20

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

NOTE 5. PROPERTY AND EQUIPMENT

Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the related assets and consist of the following (in thousands):

	September 30, 2021		December 31, 2020
Equipment (useful life 3 to 15 years)	$	1,308	$	1,281
Tooling (useful life 2 to 5 years)	324		240
Vehicles (useful life 5 years)	83		47
Furniture and fixtures (useful life 5 years)	86		137
Computer software (useful life 3 years)	1,189		1,057
Leasehold improvements (the shorter of useful life or lease life)	169		169
Finance lease right-of-use asset	13		13
UV - Robots (useful life 5 years)	105		—
Projects in progress	68		140
Property and equipment at cost	3,345		3,084
Less: accumulated depreciation	(2,757)		(2,664)
Property and equipment, net	$	588	$	420

Depreciation expense was $43 thousand and $48 thousand for the three months ended September 30, 2021 and 2020, respectively. For the nine months ended September 30, 2021 and 2020, depreciation expense was $143 thousand and $140 thousand, respectively.

NOTE 6. LEASES

The Company leases certain equipment, manufacturing, warehouse and office space under non-cancellable operating leases with expirations through 2026 under which it is responsible for related maintenance, taxes and insurance. The Company has one finance lease containing a bargain purchase option upon expiration of the lease in 2022. The lease term consists of the non-cancellable period of the lease, periods covered by options to extend the lease if the Company is reasonably certain to exercise the option, and periods covered by an option to terminate the lease if the Company is reasonably certain not to exercise the option. As of January 21, 2021, the terms of one of these equipment operating leases has been extended through 2026. In accordance with Accounting Standard Codification 842, Leases (“Topic 842”), the related right-of-use asset and lease liability was updated at the time of modification in January 2021. The present value of the lease obligation for this lease was calculated using an incremental borrowing rate of 15.93%, which was the Company’s blended borrowing rate (including interest, annual facility fees, collateral management fees, bank fees and other miscellaneous lender fees) on its revolving lines of credit with Crossroads Financial Group, LLC (as described below in Note 7, “Debt”) and Factors Southwest L.L.C. (as described below in Note 7, “Debt”). The present value of the remaining lease obligation was calculated using an incremental borrowing rate of 7.25% (which excludes the annual facility fee and other lender fees), which was the Company’s borrowing rate on its former revolving line of credit with Austin Financial Services, Inc. (the “Austin Credit Facility”). The weighted average remaining lease term for operating and finance leases is 1.4 years and 0.6 years, respectively.

The Company had one restructured lease with a sub-lease component for the New York, New York office that was closed in 2017. The lease expired in June 2021. As part of the lease agreement, there was $0.3 million in restricted cash in other current assets on the accompanying Condensed Consolidated Balance Sheets as of December 31, 2020, which represented collateral against the related letter of credit issued as part of this agreement. Per the terms of the lease agreement, the restrictions on the cash were lifted in September 2021 and the cash was returned to the Company.

The restructured lease and sub-lease were deemed to be in-scope and thus subject to the requirements of Topic 842 and were evaluated for impairment in accordance with the asset impairment provisions of Accounting Standard Codification 360, Property, Plant and Equipment (“Topic 360”). The Company concluded its net right-of-use assets were not impaired and the carrying amount approximates expected sub-lease income in future years as of December 31, 2020. The Company continued to carry certain immaterial operating expenses associated with this lease as restructuring liabilities and continued to accrete those liabilities in accordance with Accounting Standard Codification 420, Exit or Disposal Cost Obligations (“Topic 420”),

21

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

as has been done since the cease use date in 2017. For additional information regarding treatment of leases please refer to Note 4, “Leases,” included under Item 8, “Financial Statements and Supplementary Data,” of our 2020 Annual Report.

There were no finance lease costs recognized in net loss for the three and nine months ended September 30, 2021 and 2020. Components of the operating and restructured lease costs recognized in net loss for the three and nine months ended September 30, 2021 and 2020, were as follows (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Operating lease cost (income)
Sub-lease income	$	(25)	$	(26)	$	(87)	$	(80)
Lease cost	139		148		423		451
Operating lease cost, net	114		122		336		371
Restructured lease cost (income)
Sub-lease income	—		(68)		(136)		(204)
Lease cost	—		59		109		180
Restructured lease income, net	—		(9)		(27)		(24)
Total lease cost, net	$	114	$	113	$	309	$	347

Supplemental balance sheet information related to the Company’s operating and finance leases as of September 30, 2021 and December 31, 2020 are as follows (in thousands):

	September 30, 2021		December 31, 2020
Operating Leases
Operating lease right-of-use assets	$	419	$	794
Restructured lease right-of-use assets	—		107
Operating lease right-of-use assets, total	419		901
Operating lease liabilities	505		916
Restructured lease liabilities	—		168
Operating lease liabilities, total	505		1,084
Finance Leases
Property and equipment	13		13
Allowances for depreciation	(11)		(9)
Finance lease assets, net	2		4
Finance lease liabilities	1		4
Total finance lease liabilities	$	1	$	4

22

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

Future minimum lease payments required under operating and finance leases for each of the 12-month rolling periods below in effect at September 30, 2021 are as follows (in thousands):

	Operating Leases		Finance Lease
October 2021 to September 2022	$	488	$	1
October 2022 to September 2023	19		—
October 2023 to September 2024	8		—
October 2024 to September 2025	3		—
October 2025 to September 2026	2		—
Total future undiscounted lease payments	520		1
Less imputed interest	(15)		—
Total lease obligations	$	505	$	1

Supplemental cash flow information related to leases for the three and nine months ended September 30, 2021 and 2020, was as follows (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Supplemental cash flow information
Cash paid, net, for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	161	$	134	$	421	$	401
Operating cash flows from restructured leases	$	—	$	17	$	35	$	52
Financing cash flows from finance leases	$	1	$	1	$	3	$	3

23

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

NOTE 7. DEBT

Credit facilities

On August 11, 2020, we entered into two debt financing arrangements (together, the “Credit Facilities”) that allow for expanded borrowing capacity at a lower blended borrowing cost. The first arrangement is an inventory financing facility (the “Inventory Facility”) pursuant to the Loan and Security Agreement (the “Inventory Loan Agreement”) between the Company and Crossroads Financial Group, LLC, a North Carolina limited liability company (the “IF Lender”). Borrowings under the original Inventory Facility were permitted up to the lower of (i) $3.0 million, which amount was subsequently increased to $3.5 million as described below, and (ii) a borrowing base determined from time to time based on the value of the Company’s eligible inventory, valued at 75% of inventory costs or 85% of the inventory net orderly liquidation value, less the availability reserves. On April 20, 2021, the Company and the IF Lender entered into an amendment to the Inventory Loan Agreement to increase the maximum amount that may be available to the Company from $3.0 million to $3.5 million, subject to the borrowing base as set forth in the Inventory Loan Agreement. The outstanding indebtedness under the Inventory Facility accrues at an annual rate equal to the greater of (i) 5.75% and (ii) 4.00% plus the three (3) month LIBOR rate and is also subject to a service fee of 1% per month. The annualized interest rate at September 30, 2021 and December 31, 2020, which includes interest fees, the annual facility fee, bank fees and other miscellaneous lender fees, was 22.4% and 23.6%, respectively. The Inventory Facility’s interest and service fees combined amount is subject to a minimum monthly fee of $18 thousand. There would be no breakage fee for the Company for the Inventory Facility if the Company were to refinance it with an American Bankers Association (“ABA”) equivalent institution after August 11, 2021. The Inventory Facility is secured by substantially all of the present and future assets of the Company and is also governed by an intercreditor agreement among the Company, the IF Lender and the RF Lender (defined below). The Inventory Facility matures on August 11, 2022, subject to early termination upon 90 days’ notice and otherwise in accordance with the terms of the Inventory Loan Agreement. The term is automatically extended in successive one (1) year increments unless terminated by either party in accordance with the Inventory Loan Agreement. On April 20, 2021, the Company and the IF lender entered into an amendment to the Inventory Loan Agreement to increase the maximum amount that may be available to the Company from $3.0 million previously to $3.5 million, subject to the borrowing base as set forth in the Inventory Loan Agreement.

The second arrangement is a receivables financing facility (the “Receivables Facility”) pursuant to the Loan and Security Agreement (the “Receivables Loan Agreement”) between the Company and Factors Southwest L.L.C. (d/b/a FSW Funding), an Arizona limited liability company (the “RF Lender”). Borrowings under the Receivables Facility are permitted up to the lower of (i) $2.5 million or (ii) a borrowing base determined from time to time based on the value of the Company’s eligible accounts receivable, valued at 90% of the face value of such accounts receivable, less availability reserves, if any. Interest on outstanding indebtedness under the Receivables Facility accrues at an annual rate equal to (i) the highest prime rate announced from time to time by the Wall Street Journal plus (ii) 2%. At September 30, 2021 and December 31, 2020, the annualized interest rate, which includes interest fees and the annual facility fee, was 8.0% and 7.9%, respectively. The annualized interest rate on the collateral management fee was 6% at both September 30, 2021 and December 31, 2020. The Receivables Facility is also secured by substantially all of the present and future assets of the Borrower and is also governed by an intercreditor agreement among the Company, the IF Lender and the RF Lender. A $25 thousand, or 1%, facility fee was charged at closing. There would be no breakage fee for the Company for the Receivables Facility if the Company were to refinance it with an ABA equivalent institution. The Receivables Facility matures on August 11, 2022, subject to early termination in accordance with the terms of the Receivables Loan Agreement, provided that the term is automatically extended in successive one (1) year increments unless terminated by either party in accordance with the Receivables Loan Agreement.

Borrowings under the Inventory Facility were $1.4 million and $1.3 million at September 30, 2021 and December 31, 2020, respectively. Borrowings under the Receivables Facility were $1.3 million and $1.0 million at September 30, 2021 and December 31, 2020, respectively. These facilities are recorded in the Condensed Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020 as a current liability under the caption “Credit line borrowings.” Outstanding balances include unamortized net issuance costs totaling $0.1 million for the Inventory Facility and $14 thousand for the Receivables Facility as of September 30, 2021, and $0.1 million for the Inventory Facility and $40 thousand for the Receivables Facility as of December 31, 2020.

The Credit Facilities replaced the Austin Credit Facility that was entered into on December 11, 2018, and was secured by a lien on our assets. The Austin Credit Facility was a three year, $5.0 million revolving line of credit. Interest on advances under the line was due monthly at the “Prime Rate,” as published by the Wall Street Journal from time to time, plus a

24

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

margin of 2%. Additionally, an annual facility fee of 1% on the entire $5.0 million amount of the Austin Credit Facility was due at the beginning of each of the three years that the Austin Credit Facility was outstanding and a 0.5% collateral management fee on the average outstanding loan balance was payable monthly. On August 11, 2020, we paid $1.4 million to close the Austin Credit Facility, which included a $100 thousand termination fee. Additionally, we wrote off $59 thousand of the remaining related debt acquisition costs. For additional information regarding the Austin Credit Facility, please refer to Note 9, “Debt,” included under Item 8, “Financial Statements and Supplementary Data,” of our 2020 Annual Report.

For additional information regarding the Credit Facilities, please refer to Part II, Item 5, “Other Information,” included in our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020, filed on August 13, 2020.

Streeterville Note

On April 27, 2021, we entered into a note purchase agreement with Streeterville Capital, LLC (“Streeterville”) pursuant to which we sold and issued to Streeterville a promissory note in the principal amount of approximately $1.7 million (the “Streeterville Note”). The Streeterville Note was issued with an original issue discount of $194 thousand and Streeterville paid a purchase price of $1.5 million for the Streeterville Note, after deduction of $15 thousand of Streeterville’s transaction expenses.

The Streeterville Note has a maturity date of April 27, 2023, and accrues interest at 8% per annum, compounded daily, on the outstanding balance. The Company may prepay the amounts outstanding under the Streeterville Note at a premium, which is 5% during the first three months and 10% thereafter. Prepayments at the reduced rate in the first three months are limited to 50% of the outstanding balance. Beginning on November 1, 2021, Streeterville may require the Company to redeem up to $205 thousand of the Streeterville Note in any calendar month. The Company has the right on three occasions to defer all redemptions that Streeterville could otherwise require the Company to make during any calendar month. Each exercise of this deferral right by the Company will increase the amount outstanding under the Streeterville Note by 1.5%.

The total liability for the Streeterville Note, net of discount and financing fees, was $1.6 million at September 30, 2021. Unamortized loan discount and debt issuance costs were $0.1 million at September 30, 2021.

In the event our common stock is delisted from Nasdaq, the amount outstanding under the Streeterville Note will automatically increase by 15% as of the date of such delisting.

PPP Loan

On April 17, 2020, the Company was granted a loan from KeyBank National Association (“KeyBank”) in the amount of approximately $795 thousand, pursuant to the PPP under Division A of the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”), which was enacted on March 27, 2020. The funds were received on April 20, 2020 and accrued interest at a rate of 1% per annum. At December 31, 2020, $529 thousand was classified as short-term debt and $266 thousand was classified as long-term debt on the Company’s Consolidated Balance Sheet. Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses as described in the CARES Act. The entire principal balance and interest were forgiven by the Small Business Administration (“SBA”) on February 11, 2021. The $801 thousand forgiveness income was recorded as other income in the Consolidated Statements of Operations during the nine months ended September 30, 2021.

Iliad Note

On November 25, 2019, we entered into a note purchase agreement (the “Iliad Note Purchase Agreement”) with Iliad Research and Trading, L.P. (“Iliad”) pursuant to which the Company sold and issued to Iliad a promissory note in the principal amount of $1.3 million (the “Iliad Note”). The Iliad Note was issued with an original issue discount of $142 thousand and Iliad paid a purchase price of $1.1 million for the issuance of the Iliad Note, after deduction of $15 thousand of Iliad’s transaction expenses.

In December 2020, we repaid the outstanding balance on the Iliad Note in full prior to its maturity date of November 24, 2021. Remaining debt and original issue discount costs of $117 thousand were written off at that time. The Iliad Note accrued interest at 8% per annum, compounded daily, on the outstanding balance.

25

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

Pursuant to the Iliad Note Purchase Agreement and the Iliad Note, we had, among other things, agreed that, until the Iliad Note was repaid, 10% of gross proceeds the Company received from the sale of our common stock or other equity must be paid to Iliad and applied to reduce the outstanding balance of the Iliad Note. In accordance with the terms of the Iliad Note, 10% of the gross proceeds from the January 2020 Equity Offering ($275 thousand) were used to make payments on the Iliad Note, of which $226 thousand went towards the outstanding principal amount.

The total liability for the Iliad Note, excluding financing fees, was $0.2 million at September 30, 2020. Unamortized loan discount and debt issuance costs were $0.1 million at September 30, 2020.

Convertible Notes 

On March 29, 2019, we issued $1.7 million aggregate principal amount of subordinated convertible promissory notes (the “Convertible Notes”) to certain investors in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended. The Convertible Notes bore interest at a rate of 5% per annum until June 30, 2019 and at a rate of 10% thereafter. Pursuant to their terms, on January 16, 2020, following approval by our stockholders of certain amendments to the Certificate of Incorporation, the principal amount of all of the Convertible Notes and the accumulated interest thereon ($0.1 million), which totaled $1.8 million, were converted at a conversion price of $0.67 per share into an aggregate of 2,709,018 shares of the Company’s Series A Convertible Preferred Stock, par value 0.0001 per share (“Series A Preferred Stock”), which is convertible on a one-for-five basis into shares of our common stock. During the year ended December 31, 2020, 111,548 shares of the Series A Preferred Stock were converted into 22,310 shares of common stock. On April 1, 2021, 1,721,023 shares of Series A Preferred Stock were converted into 344,205 shares of common stock.

The purchase agreement related to the Convertible Notes contains customary representations and warranties and provides for resale registration rights with respect to the shares of our common stock issuable upon conversion of the Series A Preferred Stock. Please also refer to Note 9, “Stockholders’ Equity”.

NOTE 8. INCOME TAXES

As a result of the operating loss incurred during each of the three and nine months ended September 30, 2021 and 2020, and after the application of the annual limitation set forth under Section 382 of the Internal Revenue Code of 1986, as amended (the “IRC”), it was not necessary to record a provision for U.S. federal income tax.

At September 30, 2021 and December 31, 2020, we had a full valuation allowance recorded against our deferred tax assets.

The valuation allowance was recorded due to uncertainties related to our ability to realize the deferred tax assets, primarily consisting of certain net operating loss carry-forwards. The valuation allowance is based on management’s estimates of taxable income by jurisdiction and the periods over which the deferred tax assets will be recoverable.

At December 31, 2020, we had a net operating loss carry-forward of approximately $115.9 million for federal income tax purposes ($72.3 million for state and local income tax purposes). However, due to changes in our capital structure, approximately $61.5 million of the $115.9 million is available after the application of IRC Section 382 limitations. As a result of the Tax Cuts and Jobs Act of 2017 (the “Tax Act”), net operating loss carry-forwards generated in tax years beginning after December 31, 2017 can only offset 80% of taxable income and can be carried forward indefinitely. The $7.1 million and $8.3 million in net operating losses generated in 2020 and 2019, respectively, will be subject to the new limitations under the Tax Act. If not utilized, the carry-forwards generated prior to December 31, 2017 of $37.3 million will begin to expire in 2021 for federal purposes and have begun to expire for state and local purposes. For a full discussion of the estimated restrictions on our utilization of net operating loss carry-forwards, please refer to Note 12, “Income Taxes,” included under Item 8, “Financial Statements and Supplementary Data,” of our 2020 Annual Report.

26

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

NOTE 9. STOCKHOLDERS’ EQUITY

June 2021 Equity Offering

In June 2021, we completed a registered direct offering of 990,100 shares of our common stock to certain institutional investors, at a purchase price of $5.05 per share. We paid the placement agent commissions of $400 thousand, plus $51 thousand in expenses, in connection with the June 2021 Equity Offering and we also paid legal and other fees of $19 thousand related to the offering. Total offering costs of $470 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of September 30, 2021. Net proceeds to us from the June 2021 Equity Offering were approximately $4.5 million.

Preferred Stock

Pursuant to the terms of the Convertible Notes, on January 16, 2020, following approval by our stockholders of certain amendments to the Certificate of Incorporation, the principal amount of all of the Convertible Notes and the accumulated interest thereon at the date of conversion (totaling $1.8 million) were converted at a conversion price of $0.67 per share into an aggregate of 2,709,018 shares of the Company’s Series A Preferred Stock, which is convertible on a one-for-five basis into shares of our common stock. During the year ended December 31, 2020, 111,548 shares of the Series A Preferred Stock were converted into 22,310 shares of common stock. On April 1, 2021, 1,721,023 shares of Series A Preferred Stock were converted into 344,205 shares of common stock. The Series A Preferred Stock that was converted in 2021 was held by a Schedule 13D ownership group (under Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, and Rule 13d-5 promulgated thereunder) that includes Fusion Park LLC (“Fusion Park”) and 5 Elements Global Fund L.P. (controlled affiliates of James Tu, the Company's Executive Chairman and Chief Executive Officer), as well as Brilliant Start Enterprise Inc. (“Brilliant Start”) and Jag International Ltd. (controlled affiliates of Gina Huang, a member of the Company's board of directors). Upon conversion of their respective shares of Series A Preferred Stock, Fusion Park and Brilliant Start received 184,851 and 159,354 shares, respectively, of the Company’s common stock.

The Series A Preferred Stock was created by the filing of a Certificate of Designation with the Secretary of State of the State of Delaware on March 29, 2019, which designated 2,000,000 shares of the Company’s preferred stock, par value $0.0001 per share, as Series A Preferred Stock (the “Original Series A Certificate of Designation”). On January 15, 2020 with prior stockholder approval, the Company amended the Certificate of Incorporation to increase the number of authorized shares of preferred stock to 5,000,000. The Original Series A Certificate of Designation was also amended on January 15, 2020, to increase the number of shares of preferred stock designated as Series A Preferred Stock to 3,300,000 (the Original Series A Certificate of Designation, as so amended, the “Series A Certificate of Designation”).

Pursuant to the Series A Certificate of Designation, each holder of outstanding shares of Series A Preferred Stock is entitled to vote with holders of outstanding shares of common stock, voting together as a single class, with respect to any and all matters presented to the stockholders of the Company for their action or consideration, except as provided by law. In any such vote, each share of Series A Preferred Stock shall entitle its holder to a number of votes equal to 11.07% of the number of shares of common stock into which such share of Series A Preferred Stock is convertible.

The Series A Preferred Stock (a) has a preference upon liquidation equal to $0.67 per share and then participates on an as-converted basis with the common stock with respect to any additional distributions, (b) shall receive any dividends declared and payable on our common stock on an as-converted basis, and (c) is convertible at the option of the holder into shares of our common stock on a one-for-five basis. On March 29, 2019, the Company also filed a Certificate of Elimination with respect to its authorized, but unissued, Series A Participating Preferred Stock, to return such shares to the status of undesignated preferred stock available for designation as Series A Preferred Stock.

The purchase agreement related to the Convertible Notes contains customary representations and warranties and provides for resale registration rights with respect to the shares of our common stock issuable upon conversion of the Series A Preferred Stock.

27

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

1-for-5 Reverse Stock Split

On June 11, 2020, in accordance with previous stockholder approval, our board of directors effected a 1-for-5 reverse stock split of the Company’s common stock, par value $0.0001 per share. The reverse stock split became effective at the Effective Time upon the filing of the Certificate of Amendment to the Certificate of Incorporation with the Delaware Secretary of State. At the Effective Time, every five shares of common stock issued and outstanding automatically combined into one validly issued, fully paid and non-assessable share of common stock. No fractional shares were issued as a result of the reverse stock split. The fractional shares were settled in cash in an amount not material to the Company. The $0.0001 par value per share of common stock and other terms of the common stock were not affected by the reverse stock split. The number of authorized shares of common stock under the Certificate of Incorporation remained unchanged at 50,000,000 shares.

Proportional adjustments were made to the conversion and exercise prices of our outstanding warrants and stock options, and to the number of shares issued and issuable under our stock incentive plans in connection with the reverse stock split. The financial statements for the nine months ended September 30, 2020 have been retroactively adjusted to reflect the reverse stock split. Preferred shares outstanding were not affected by the reverse stock split and, as such, those shares have not been adjusted.

The reverse stock split was effected solely to increase the per share trading price of the common stock to satisfy the $1.00 minimum bid price requirement pursuant to Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq. The common stock began trading on Nasdaq on a split-adjusted basis at the opening of trading on June 12, 2020.

January 2020 Equity Offering

Issuance of Common Stock and Warrants

In January 2020, we completed a registered direct offering of 688,360 shares of our common stock to certain institutional investors, at a purchase price of $3.37 per share. We also sold, to the same institutional investors, warrants to purchase up to 688,360 shares of common stock at an exercise price of $3.37 per share in a concurrent private placement for a purchase price of $0.625 per warrant. We paid the placement agent commissions of $193 thousand, plus $50 thousand in expenses, in connection with the registered direct offering and the concurrent private placement and we also paid legal, accounting and other fees of $231 thousand related to the offering. Total offering costs of $510 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of December 31, 2020. In addition, we issued warrants to the placement agent to purchase up to 48,185 shares of common stock at an exercise price of $4.99 per share. Net proceeds to us from the sale of common stock and warrants were approximately $2.3 million. In accordance with the terms of the Iliad Note (as defined above in Note 7, “Debt”), 10% of the gross proceeds from the January 2020 Equity Offering ($275 thousand) were used to make payments on the Iliad Note, of which $226 thousand went towards the outstanding principal amount and the balance to interest.

Warrants to purchase an aggregate of 310,860 shares remain outstanding at September 30, 2021 with a weighted average exercise price of $3.59 per share. The exercise of warrants could provide us with cash proceeds of up to $1.1 million in the aggregate if all warrants are exercised. During the nine months ended September 30, 2021, 156,446 warrants were exercised resulting in total proceeds of $527 thousand.

As of September 30, 2021, we had the following outstanding warrants to purchase shares of common stock:

	Number of Underlying Shares	Exercise Price	Expiration
Investor Warrants	269,180	$3.3700	January 13, 2025
Placement Agent Warrants	41,680	$4.9940	January 13, 2025
	310,860

28

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

As of September 30, 2020, we had the following outstanding warrants to purchase shares of common stock:

	Number of Underlying Shares	Exercise Price	Expiration
Investor Warrants	497,472	$3.3700	January 13, 2025
Placement Agent Warrants	41,680	$4.9940	January 13, 2025
	539,152

Warrant Classification

We account for common stock warrants as either liabilities or equity instruments depending on the specific terms of the warrant agreement. Common stock warrants that could require cash settlement are accounted for as liabilities and are revalued at fair value at each balance sheet date subsequent to the initial issuance. Changes in the fair market value of the warrant are reflected in the consolidated statement of operations as income (expense) based upon the change in fair value of warrants. Common stock warrants without cash settlement provisions are accounted for as equity and re-measurement at each balance sheet date is not required.

The warrants we issued in the January 2020 Equity Offering contained a provision for net cash settlement in the event that there is a fundamental transaction involving the Company (e.g., merger, sale of substantially all assets, tender offer, or share exchange). Due to this provision, the warrants were initially classified as liabilities, as opposed to equity, and were recorded at their fair values at each balance sheet date with fair value adjustments recognized as a component of earnings. During December 2020, the warrant holders agreed to a modification of the terms of their warrants which removed the potential cash settlement option upon the occurrence of a fundamental transaction. As such, during the fourth quarter of 2020, the warrant liability was reclassified into equity and the warrants are no longer subject to re-measurement at each balance sheet date.

Stock-based compensation

Stock-based compensation expense is attributable to stock options and restricted stock unit awards. For all stock-based awards, we recognize expense using a straight-line amortization method.

The following table summarizes stock-based compensation expense and the impact it had on operations for the periods presented (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Cost of sales	$	2	$	1	$	7	$	2
Product development	2		3		10		5
Selling, general, and administrative	35		31		370		89
Total stock-based compensation	$	39	$	35	$	387	$	96

Total unearned stock-based compensation was $0.3 million at September 30, 2021, compared to $0.2 million at September 30, 2020. These costs will be charged to expense and amortized on a straight-line basis in future periods. The weighted average period over which the unearned compensation at September 30, 2021 is expected to be recognized is approximately 2.9 years.

29

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

Stock options

The fair value of each stock option is estimated on the date of grant using the Black-Scholes option pricing model. Estimates utilized in the calculation include the expected life of the option, risk-free interest rate, and expected volatility, and are further detailed below.

	Nine months ended September 30,
	2021			2020
Fair value of options issued	$	4.18		$	2.00
Exercise price	$	5.39		$	2.61
Expected life of options (in years)	6.2			6.2
Risk-free interest rate	0.8		%	0.7		%
Expected volatility	96.5		%	93.5		%
Dividend yield	0.0		%	0.0		%

A summary of option activity under all outstanding stock incentive plans for the nine months ended September 30, 2021 is presented as follows:

	Number of Options	Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in years)
Balance at December 31, 2020	221,450	$	3.45
Granted	76,900	5.39
Canceled/forfeited	(35,287)	5.43
Expired	(1,500)	53.50
Balance at September 30, 2021	257,338	$	3.49	8.4
Vested and expected to vest at September 30, 2021	218,795	$	3.43	8.3
Exercisable at September 30, 2021	78,156	$	3.48	7.8

Restricted stock units

A summary of restricted stock unit activity under all outstanding stock incentive plans for the nine months ended September 30, 2021 is presented as follows:

	Restricted Stock Units	Weighted Average Grant Date Fair Value		Weighted Average Remaining Contractual Life (in years)
Balance at December 31, 2020	4,480	$	8.64
Granted	50,000	5.26
Vested	(52,080)	5.46
Balance at September 30, 2021	2,400	$	7.14	9.0

30

ENERGY FOCUS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

NOTE 10. COMMITMENTS AND CONTINGENCIES

Purchase Commitments

As of September 30, 2021, we had approximately $2.9 million in outstanding purchase commitments for inventory. Of this amount, approximately $2.6 million is expected to ship in the fourth quarter of 2021, with the balance expected to ship in the first quarter of 2022 and thereafter.

NOTE 11. OTHER INCOME

Employee Retention Tax Credit

The CARES Act, which was enacted on March 27, 2020, provides an ERTC that is a refundable tax credit against certain employer taxes. The ERTC was subsequently amended by the Taxpayer Certainty and Disaster Tax Relief Act of 2020, the Consolidated Appropriation Act of 2021, and the American Rescue Plan Act of 2021, all of which amended and extended the ERTC availability and guidelines under the CARES Act. Following these amendments, we and other businesses became retroactively eligible for the ERTC, and as a result of the foregoing legislation, are eligible to claim a refundable tax credit against the employer share of Social Security taxes equal to seventy percent (70%) of the qualified wages paid to employees between December 31, 2020, and December 31, 2021. Qualified wages are limited to $10,000 per employee per calendar quarter in 2021 for a maximum allowable ERTC per employee of $7,000 per calendar quarter in 2021.

For purposes of the amended ERTC, an eligible employer is defined as having experienced a significant (20% or more) decline in gross receipts during each 2021 calendar quarter when compared with the same quarter in 2019 or the immediately preceding quarter to the corresponding calendar quarter in 2019. The credit is taken against the Company’s share of Social Security Tax when the Company’s payroll provider files, or subsequently amends the applicable quarterly employer tax filings.

Under the amended guidelines, we are eligible to receive the ERTC for the second and third quarters of 2021. As part of the filing of our employer tax filings for the third quarter of 2021, we expect to receive a refund of $431 thousand, and we plan to amend our filing for the second quarter of 2021, for which we expect to receive an additional refund of approximately $431 thousand. These amounts are recorded as other income in the Consolidated Statements of Operations during the three and nine months ended September 30, 2021, and included in prepaid and other current assets in the Consolidated Balance Sheet as of September 30, 2021.

PPP Loan

On April 17, 2020, the Company was granted a loan from KeyBank in the amount of approximately $795 thousand, pursuant to the PPP under the CARES Act, which was enacted on March 27, 2020. The funds were received on April 20, 2020 and accrued interest at a rate of 1% per annum. At December 31, 2020, $529 thousand was classified as short-term debt and $266 thousand was classified as long-term debt on the Company’s Consolidated Balance Sheet. Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses as described in the CARES Act. The entire principal balance and interest were forgiven by the SBA on February 11, 2021. The $801 thousand forgiveness income was recorded as other income in the Consolidated Statements of Operations during the nine months ended September 30, 2021.

31

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and related notes thereto included in Part I, Item 1, “Financial Statements” of this Quarterly Report, as well as Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” of our Annual Report on Form 10-K for the year ended December 31, 2020 (“2020 Annual Report”).

Overview

Energy Focus, Inc. engages primarily in the design, development, manufacturing, marketing and sale of energy-efficient light-emitting diode (“LED”) lighting systems and controls and development of ultraviolet-C light disinfection (“UVCD”) products. We develop, market and sell high quality LED lighting and controls products and UVCD products in the commercial market and military maritime market (“MMM”), and expect to expand our offerings into the consumer market starting in the fourth quarter of 2021. Our mission is to enable our customers to run their facilities, offices and homes with greater energy efficiency, productivity, and human health through advanced LED retrofit and UVCD solutions. Our goal is to be the LED and human-centric lighting (“HCL”) technology and market leader for the most demanding applications where performance, quality, value, environmental impact and health are considered paramount. We specialize in LED lighting retrofit by replacing fluorescent, high-intensity discharge lighting and other types of lamps and fixtures in institutional buildings for primarily indoor lighting applications with our innovative, high-quality commercial and military tubular LED (“TLED”) products, as well as other LED and lighting control products for commercial and consumer applications. In late 2020, we announced the launch of our UVCD product portfolio, which is being brought to market throughout the fourth quarter of 2021 and into 2022.

Net sales decreased 43% for the nine months ended September 30, 2021 as compared to the nine months ended September 30, 2020, primarily driven by a 55% decrease in military sales period-over-period, and a decrease in net sales of our commercial products of 17% for the nine months ended September 30, 2021 as compared to the prior year period. The sales cycles for the MMM is dependent on many factors, including the availability of government funding, the timing and fulfillment of U.S. Navy awards, new ship construction, diversion of funds to other government needs, and the timing of vessel maintenance schedules, and our financial results reflect volatility from fluctuations in the timing, pace and size of MMM projects. The sales cycles for our commercial target markets can range from several months to over one year and our financial results reflect volatility from the continued fluctuations in the timing, pace and size of commercial projects due to, among other reasons, the ongoing effects on our customers of the coronavirus (“COVID-19”) pandemic.

Operating losses increased by $3.1 million, or 98%, in the first nine months of 2021 over the first nine months of 2020. The Company’s results reflect the challenges due to long and unpredictable sales cycles, delays in customer retrofit budgets and project starts, and supply chain issues exacerbated by the continuing effects of the COVID-19 pandemic. We have been challenged by continuing and intensifying aggressive price competition in the lighting industry, particularly in our retrofit market. We continued to incur losses and we have a substantial accumulated deficit, which continues to raise substantial doubt about our ability to continue as a going concern at September 30, 2021.

The COVID-19 pandemic in particular has, and may continue to have, a significant economic and business impact on our company. In the first three quarters of 2021, following a slowdown throughout 2020, we have seen a continuing weakness in commercial sales as our customers in the healthcare, education, and commercial and industrial sectors delayed order placements in reaction to the ongoing impacts of the COVID-19 pandemic that caused our customers to suspend or postpone lighting retrofit projects due to budget and occupancy uncertainties.

We continue to monitor the impact of the COVID-19 pandemic on our customers, suppliers and logistics providers, and to evaluate governmental actions being taken to curtail and respond to the spread of the virus. The significance and duration of the ongoing impact on us is still uncertain. Material adverse effects of the COVID-19 pandemic on market drivers, our customers, suppliers or logistics providers could significantly impact our operating results. We also plan to continue to actively follow, assess and analyze the ongoing impact of the COVID-19 pandemic and continue to adjust our organizational structure, strategies, plans and processes to respond.

Because the situation continues to evolve, we cannot reasonably estimate the ultimate impact to our business, results of operations, cash flows and financial position that the COVID-19 pandemic may have. Continuation of the COVID-19 pandemic and government actions in response thereto could cause further disruptions to our operations and the operations of our customers, suppliers and logistics partners and could significantly adversely affect our near-term and long-term revenues, earnings, liquidity and cash flows. We will remain agile as an organization to respond to potential or continuing

32

weakness in the macro environment and in the meantime expand sales channels and enter new markets, such as the UVCD and consumer markets, that we believe will provide additional growth opportunities.

It is our belief that the momentum of the efforts undertaken in 2020, as described in our 2020 Annual Report, along with our continuing efforts to date in 2021, including the development and launch of new and innovative products, in both lighting controls surrounding the EnFocusTM platform and the UVCD market, as well as our planned entry into the consumer markets with these new products, will over time result in improved sales and bottom-line performance for the Company.

We launched our patented EnFocusTM platform during the second quarter of 2020 and, despite the ongoing, significant delay and slowdown in our customers’ lighting projects following the impacts of the COVID-19 pandemic, we continue to receive positive feedback from existing, new, and potential new customers. The EnFocusTM platform offers two immediately available product lines: EnFocusTM DM, which provides a dimmable lighting solution, and EnFocusTM DCT, which provides both a dimmable and color tunable lighting solution. EnFocusTM enables buildings to have dimmable, color tunable and circadian-ready lighting using existing wiring, without requiring laying additional data cables or any wireless communication systems, through a relatively simple upgrade with EnFocusTM switches and tubular LEDs, a far more secure, affordable and environmentally sustainable solution compared with replacing entire lighting fixtures and incorporating additional wired or wireless communication. In addition, we recently announced plans for the second generation of EnFocusTM switches and the award-winning SuncycleTM circadian lighting system for both commercial and residential markets, which we plan to launch in early 2022.

In addition, in response to the COVID-19 pandemic and an anticipated increase in sanitation and hygiene demand for buildings, facilities and homes, we have been developing advanced UVCD air and surface disinfection products for both consumer as well as the commercial and industrial markets. We announced the following UVCD products beginning in the fourth quarter of 2020: abUVTM circadian lighting and UVCD air disinfection integrated troffers controlled by the EnFocusTM platform technology; nUVoTM Tower portable air disinfection device for offices and homes; nUVoTM Traveler portable personal air disinfection device; and mUVeTM autonomous robot designed for surface disinfection. The nUVoTM Tower and nUVoTM Traveler are expected to be available in the fourth quarter of 2021, and the abUVTM and mUVeTM are expected to be available in the first half of 2022.

In our MMM business, significant efforts undertaken to reduce costs in our product offerings have positioned us to be more competitive along with improved production efficiencies. Such efforts allowed us to continue to win bids and proposals that helped grow our MMM sales throughout 2020, offsetting some of the weakness being experienced in our commercial business that year. In addition, during the fourth quarter of 2020, we became an approved supplier for the General Services Administration (“GSA”) and our products are now listed in the GSA website for all federal and military agencies to view and order our products. While we continue to aggressively seek to increase sales of our commercial products, the MMM business offers us continued sales opportunities, in addition to validating our product quality and strengthening our brand trust in the marketplace. However, due to product mix impacts resulting from the continued impact of the COVID-19 pandemic on commercial sales, our current financial results are primarily driven by, and reflect volatility in, our MMM sales. In the first three quarters of 2021, our MMM business continued to face challenges resulting from the delayed availability of government funding and the timing of U.S. Navy awards. We continue to pursue opportunities from the U.S. Navy and the government sector to minimize such volatility.

Meanwhile, we continue to seek additional external funding alternatives and sources to support our growth strategies, plans and initiatives. We plan to achieve profitability through developing and launching new, innovative products, such as EnFocusTM and our UVCD products, as well as executing on our multi-channel sales strategy that targets key verticals, such as government, healthcare, education and commercial and industrial, complemented by our marketing outreach campaigns and expanding channel partnerships. We also plan to continue to develop advanced lighting and lighting control applications built upon the EnFocusTM platform such as our SuncycleTM products that aim to serve both consumer and commercial markets. In addition, we intend to continue to apply rigorous financial discipline in our organizational structure, business processes and policies, strategic sourcing activities and supply chain practices to help accelerate our path towards profitability.

At September 30, 2021, we had $0.4 million in cash and a total of $4.3 million of debt. Total debt at September 30, 2021 included $1.4 million outstanding under our inventory financing facility (the “Inventory Facility”), $1.3 million outstanding under our receivables financing facility (the “Receivables Facility” and, together with the Inventory Facility, the “Credit Facilities”) and $1.6 million outstanding on the Streeterville Note (as defined below). At September 30, 2021, we had additional availability of $1.6 million under the Inventory Facility and $0.1 million under the Receivables Facility, for a total of $1.7 million of additional availability. Previously, on April 20, 2021, we entered into an amendment to the Loan and Security Agreement governing the Inventory Facility (the “Inventory Loan Agreement”) to increase the maximum amount

33

that may be available to the Company from $3.0 million previously to $3.5 million, subject to the borrowing base as set forth in the Inventory Loan Agreement.

In June 2021, we completed a registered direct offering of 990,100 shares of our common stock to certain institutional investors, at a purchase price of $5.05 per share (the “June 2021 Equity Offering”). We paid the placement agent commissions of $400 thousand, plus $51 thousand in expenses, in connection with the June 2021 Equity Offering and we also paid legal and other fees of $19 thousand related to the offering. Total offering costs of $470 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of September 30, 2021. Net proceeds to us from the June 2021 Equity Offering were approximately $4.5 million.

On April 27, 2021, we entered into a note purchase agreement (the “Streeterville Note Purchase Agreement”) with Streeterville Capital, LLC (“Streeterville”) pursuant to which the Company sold and issued to Streeterville a promissory note in the principal amount of approximately $1.7 million (the “Streeterville Note”). The Streeterville Note was issued with an original issue discount of $194 thousand and Streeterville paid a purchase price of $1.5 million for the Streeterville Note, after deduction of $15 thousand of Streeterville’s transaction expenses.

The Streeterville Note has a maturity date of April 27, 2023, and accrues interest at 8% per annum, compounded daily, on the outstanding balance. The Company may prepay the amounts outstanding under the Note at a premium, which is 5% during the first three months and 10% thereafter. Prepayments at the reduced rate in the first three months are limited to 50% of the outstanding balance. Beginning on the first day of the calendar month following the date that is six months after the date of purchase, Streeterville may require the Company to redeem up to $205 thousand of the Streeterville Note in any calendar month. The Company has the right on three occasions to defer all redemptions that Streeterville could otherwise require the Company to make during any calendar month. Each exercise of this deferral right by the Company will increase the amount outstanding under the Streeterville Note by 1.5%.

34

Results of operations

The following table sets forth items in our Condensed Consolidated Statements of Operations as a percentage of net sales for the periods indicated:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net sales	100.0	%	100.0	%	100.0	%	100.0	%
Cost of sales	79.5		76.9		79.8		71.3
Gross profit	20.5		23.1		20.2		28.7
Operating expenses:
Product development	14.7		6.7		19.1		7.6
Selling, general, and administrative	71.6		33.6		86.5		45.9
Restructuring	—		(0.3)		(0.3)		(0.3)
Total operating expenses	86.3		40.0		105.3		53.2
Loss from operations	(65.8)		(16.9)		(85.1)		(24.5)
Other expenses (income):
Interest expense	6.4		2.1		7.0		2.6
Gain on forgiveness of PPP loan	—		—		(10.7)		—
Loss on extinguishment of debt	—		2.7		—		1.2
Other income - employee retention tax credit	(31.4)		—		(11.6)		—
(Gain) loss from change in fair value of warrants	—		(2.6)		—		17.4
Other expenses	0.5		0.4		0.6		0.5
Net income before income taxes
Benefit from income taxes	—		—		—		—
Net loss	(41.3)	%	(19.5)	%	(70.4)	%	(46.2)	%

Net sales

A further breakdown of our net sales is presented in the following table (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Commercial	$	1,522	$	1,456	$	3,513	$	4,250
MMM products	1,227		4,508		3,947		8,832
Total net sales	$	2,749	$	5,964	$	7,460	$	13,082

Net sales of $2.7 million for the third quarter of 2021 decreased 54% compared to third quarter of 2020 net sales of $6.0 million, primarily driven by a decrease in MMM product sales. Net MMM product sales decreased in the third quarter of 2021 compared to the same period in 2020, mainly due to availability of government funding and the delayed timing of expected orders as well as a large military contract fulfilled during the third quarter of 2020.

Net sales of $7.5 million for the first nine months of 2021 decreased 43% compared to the same period in 2020, primarily driven by a decrease in MMM product sales and somewhat by reduced commercial sales. Net sales of our MMM products decreased mainly due to availability of government funding and the delayed timing of expected orders in the first nine months of 2021. Net sales of our commercial products decreased in the first nine months of 2021 compared to the same period of 2020, reflecting (i) a decrease in sales, caused by delayed orders that have occurred mainly in the healthcare, education, commercial and industrial sectors because of the macroeconomic slowdown and purchasing decisions being put

35

on hold due to the COVID-19 pandemic, (ii) lower sales from our agency network, which was also impacted by the COVID-19 pandemic, and (iii) fluctuations in the timing, pace and size of commercial projects.

Gross profit 

Gross profit was $0.6 million, or 20.5% of net sales, for the third quarter of 2021, compared to $1.4 million, or 23.1% of net sales, for the third quarter of 2020. Gross margin for the third quarter of 2021 included favorable price and usage variances for material and labor of $0.1 million, or 2.6% of net sales, and favorable inventory and warranty reserves of $0.1 million, or 2.0% of net sales. Gross margin for the third quarter of 2020 included favorable price and usage variances for material and labor of $0.4 million, or 7.2% of net sales.

Gross profit was $1.5 million, or 20.2% of net sales, for the first nine months of 2021 compared to $3.8 million, or 28.7% of net sales, for the first nine months of 2020. The decrease was primarily related to product mix and included favorable price and usage variances for material and labor of $0.6 million, or 8.6% of net sales, and unfavorable inventory and warranty reserves recorded of $0.1 million, or 0.8% of net sales. The gross margin for the first nine months of 2020 was primarily a result of unexpected additional manufacturing costs as a result of supply chain challenges relating primarily to our MMM products, which adversely impacted our gross profit by approximately 2.1% of net sales. The remaining increase was primarily related to relatively higher profit margin of sold product, favorable price and usage variances for material and labor of $0.7 million, or 5.5% of net sales, and favorable inventory reserves recorded of $0.4 million, or 3.0% of net sales.

Operating expenses

Product development 

Product development expenses include salaries and related expenses, contractor and consulting fees, legal fees, supplies and materials, as well as overhead, such as depreciation and facility costs. Product development costs are expensed as they are incurred.

Product development expenses were $0.4 million for the third quarter of 2021, flat compared to the third quarter of 2020. Product development expenses mainly relate to the development and launch of our UVCD product portfolio.

Product development expenses were $1.4 million for the first nine months of 2021, a $0.4 million increase compared to $1.0 million for the first nine months of 2020. The increase is primarily related to payroll expense and product testing associated with the development and launch of our UVCD product portfolio.

Selling, general and administrative

Selling, general and administrative expenses were $2.0 million for the third quarter of 2021, flat as compared to the third quarter of 2020. The primary drivers of expenses in both the third quarter of 2021 and third quarter of 2020 were $0.9 million in payroll and payroll related expenses, $0.1 million in marketing, advertising and related expenses, $0.3 million in dues and fees, supplies, utilities and rent, software contracts, and miscellaneous taxes, $0.1 million in commissions and employee bonuses, $0.1 million in insurance expense and $0.1 million in external reporting expenses. For the third quarter of 2021, professional, legal, consulting and recruiting fees were $0.2 million as compared to $0.4 million in the third quarter of 2020.

Selling, general and administrative expenses were $6.5 million for the first nine months of 2021, compared to $6.0 million for the first nine months of 2020. The increase is primarily due to increases in payroll of $0.5 million, stock compensation expense of $0.3 million, and marketing, advertising and related expenses of $0.2 million as well as a total of $0.4 million for dues and fees, supplies, utilities and rent, software contracts, commissions and miscellaneous taxes. These increases were partially offset by decreases of $0.5 million in professional service fees, $0.2 million in employee bonuses, $0.1 million in recruiting fees and $0.1 million in external reporting fees.

Restructuring

For the three months ended September 30, 2021, we recorded nominal restructuring expense and for the three months ended September 30, 2020, we recorded restructuring credits totaling approximately $16 thousand. For the nine months ended September 30, 2021 and 2020, we recorded restructuring credits totaling approximately $21 thousand and $44 thousand, respectively. All restructuring costs are related to the cost and offsetting sub-lease income for the lease obligations for the former New York, New York office, which ended as of June 30, 2021.

36

Interest expense

Interest expense was $0.2 million for the third quarter of 2021, compared to interest expense of $0.1 million for the third quarter of 2020. The increase in interest expense of $0.1 million is primarily related to interest pursuant to the Credit Facilities as well as the Streeterville note. The actual cash interest paid in the third quarter of 2021 was $95 thousand compared to $40 thousand in the third quarter of 2020.

Interest expense was $0.5 million for the first nine months of 2021, compared to interest expense of $0.3 million for the first nine months of 2020. The increase in interest expense of $0.2 million was primarily related to fees associated with the increase in the borrowing capacity on the Inventory Facility during the second quarter of 2021. The actual cash interest paid for the nine months ended September 30, 2021 was $0.3 million compared to $0.1 million for the nine months ended September 30, 2020.

Employee Retention Tax Credit

We recognized other income of $0.9 million during the third quarter 2021, which represents the refund amount we expect to receive from the Employee Retention Tax Credit (“ERTC”) for which we became eligible. The expected refund is related to eligible expenses incurred during the second and third quarters of 2021.

Gain on forgiveness of PPP loan

Forgiveness income of $0.8 million related to the Paycheck Protection Program (“PPP”) loan taken out during 2020 and forgiven in 2021 was recognized during the first quarter 2021.

Loss on extinguishment of debt

A loss of $159 thousand on the extinguishment of our former revolving line of credit with Austin Financial Services, Inc. (the “Austin Credit Facility”) was recognized during the three and nine months ended September 30, 2020, consisting of a $100 thousand termination fee and the write-off of the remaining related debt acquisition costs of $59 thousand.

Loss from change in fair value of warrants

A loss of $2.3 million was recognized during the nine months ended September 30, 2020 for the market value change in our warrant liabilities. The loss recognized in the first nine months of 2020 was a result of the revaluation of the warrant liability using the market price of the Company’s common stock at September 30, 2020 versus the market price of the Company’s common stock at the time of initial issuance of the warrants (January 13, 2020). The terms of the warrants were amended in December 2020 such that they were reclassified as equity, and no warrant liability exists at September 30, 2021. As such, there is no related gain or loss recorded for the nine months ended September 30, 2021.

Other expenses

Other expenses were $15 thousand for the third quarter of 2021, compared to other expenses of $25 thousand for the third quarter of 2020. Other expenses were $47 thousand for the nine months ended September 30, 2020 compared to other expenses of $67 thousand for the nine months ended September 30, 2020. Other expenses are mainly comprised of bank and collateral management fees.

Provision for income taxes

Due to the operating losses incurred during the three and nine months ended September 30, 2021 and 2020, and after application of the annual limitation set forth under Section 382 of the Internal Revenue Code of 1986, as amended, it was not necessary to record a provision for U.S. federal income tax or various state income taxes as income tax benefits are fully offset by a valuation allowance recorded. The Company recorded a 2019 provision to return benefit of $2 thousand for various state income tax returns filed during the period ended September 30, 2020.

Net loss

For the three months ended September 30, 2021, our net loss of $1.1 million was flat when compared to the net loss for the three months ended September 30, 2020. The decrease in gross profit of $0.8 million was offset entirely by the other income recorded related to the ERTC.

37

For the nine months ended September 30, 2021, our net loss was $5.3 million compared to $6.0 million for the nine months ended September 30, 2020. The decrease in the net loss was primarily driven by a decrease in gross profit of $2.2 million, increases in product development costs of $0.4 million, increases in selling, general and administrative costs of $0.5 million and increases in interest costs of $0.2 million. These cost increases were offset by other income of $0.9 million relating to the ERTC, the gain on the forgiveness of the PPP loan of $0.8 million, and the first nine months of 2021 do not reflect the impact of the $2.3 million loss from the fair value of warrants, which occurred during the nine months ended September 30, 2020.

Financial condition

At September 30, 2021, we had $0.4 million in cash and a total of $4.3 million of debt, including $1.4 million outstanding under our Inventory Facility and $1.3 million outstanding under our Receivables Facility, and $1.5 million outstanding on the Streeterville Note. At September 30, 2021, we had additional availability of $1.6 million under the Inventory Facility and $0.1 million under the Receivables Facility, for a total of $1.7 million of additional availability. We have historically incurred substantial losses, and as of September 30, 2021, we had an accumulated deficit of $136.1 million. Additionally, our sales have been concentrated among a few major customers and for the nine months ended September 30, 2021, three customers accounted for approximately 60% of net sales.

As a result of the restructuring actions and initiatives described above, we have previously reduced our operating expenses to be more commensurate with our expected sales volumes. However, we continue to incur losses and have a substantial accumulated deficit, and substantial doubt about our ability to continue as a going concern continues to exist at September 30, 2021.

Throughout 2020 and the first nine months of 2021, we have continued to evaluate and assess strategic options as we seek to achieve profitability. We plan to continue to develop advanced lighting and lighting control technologies and introduce impactful new products surrounding EnFocusTM, a breakthrough lighting control platform we officially launched during the second quarter of 2020, and our SuncycleTM circadian lighting system, which we plan to launch in early 2022. Additionally, during the last quarter of 2020, we announced newly developed UVCD products for consumer as well as commercial and industrial markets, of which two products are expected to be available in the fourth quarter of 2021, and two products are expected to be available in early 2022.

We plan to achieve profitability through growing our sales, through existing lighting and new lighting control and UVCD products, and by continuing to refine and execute on our multi-channel sales strategy that targets key verticals, such as government, healthcare, education, and commercial and industrial, complemented by our marketing outreach campaigns and expanding channel partnerships, as well as our emerging consumer market focus.

As described in Note 9, “Stockholders’ Equity,” included under Part I, Item 1, “Financial Statements,” of this Quarterly Report, we raised approximately $4.5 million of net proceeds from the June 2021 Equity Offering and, in January 2020, we raised approximately $2.3 million of net proceeds upon the issuance common stock and warrants (the “January 2020 Equity Offering”). In April 2021, we obtained approximately $1.5 million of net proceeds from bridge financing and separately increased the capacity of the Inventory Facility, which allows for expanded borrowing capacity under the Credit Facilities entered into in August 2020 as described in Note 7, “Debt,” included under Part I, Item 1, “Financial Statements,” of this Quarterly Report.

The restructuring and cost cutting initiatives implemented during 2020 and continued into 2021, as well as the June 2021 Equity Offering and January 2020 Equity Offering that significantly strengthened our balance sheet, the Paycheck Protection Program (“PPP”) loan we obtained in April 2020, our enhanced debt capacity due to the debt refinancing in August 2020, the credit facility capacity increase and bridge financing in April 2021, and the funds we expect to receive related to the Employee Retention Tax Credit (“ERTC”, see Note 11, “Other Income” for details), were all designed to allow us to effectively execute these strategies. However, our efforts may not occur as quickly as we envision or be successful due to the long sales cycle in our industry, the corresponding time required to ramp up sales from new products, markets, and customers into this sales cycle, the timing of introductions of additional new products, significant competition, potential sales volatility given our customer concentration, interruptions and cost increases in the global supply chain, and the ongoing and lingering economic impact from the COVID-19 pandemic that had significantly diminished the interest and activities for our customers’ lighting retrofit projects until occupancy returns to more normal levels, among other factors. Additionally, global supply chain challenges are impacting our inventory purchasing strategy, leading to a buildup of inventory and components in an effort to manage both shortages of available components and longer lead times in obtaining components. Disruptions and cost increases in global logistics networks are also impacting our lead times and ability to efficiently and cost-effectively transport products from our third-party suppliers to our facility. As a result, we will continue

38

to review and pursue selected external funding sources to ensure adequate financial resources to execute across the timelines required to achieve these objectives including, but not limited to, the following:

•obtaining financing from traditional or non-traditional investment capital organizations or individuals;

•obtaining funding from the sale of our common stock or other equity or debt instruments; and

•obtaining debt financing with lending terms that more closely match our business model and capital needs.

There can be no assurance that we will obtain funding on acceptable terms, in a timely fashion, or at all. Obtaining additional funding contains risks, including:

•additional equity financing may not be available to us on satisfactory terms, and any equity we are able to issue could lead to dilution for current stockholders and have rights, preferences and privileges senior to our common stock;

•loans or other debt instruments may have terms and/or conditions, such as interest rate, restrictive covenants, conversion features, refinancing demands, and control or revocation provisions, which are not acceptable to management or our board of directors; and

•the current environment in the capital markets combined with our capital constraints may prevent us from being able to obtain adequate debt financing.

If we fail to obtain the required additional financing to sustain our business before we are able to produce levels of revenue to meet our financial needs, we will need to delay, scale back or eliminate our growth plans and further reduce our operating costs and headcount, each of which would have a material adverse effect on our business, future prospects, and financial condition. A lack of additional funding could also result in our inability to continue as a going concern and force us to sell certain assets or discontinue or curtail our operations and, as a result, investors in the Company could lose their entire investment.

Considering both quantitative and qualitative information, we continue to believe that the combination of our plans to obtain additional external funding, timely re-organizational actions, current financial position, liquid resources, obligations due or anticipated within the next year, development and implementation of an excess inventory reduction plan, plans and initiatives in our research and development, product development and sales and marketing, and development of potential channel partnerships, if adequately executed, will provide us with an ability to finance our operations through the next twelve months and will mitigate the substantial doubt about our ability to continue as a going concern.

On August 17, 2020, we received a letter from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying us that we are no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders’ equity of at least $2,500,000 if they do not meet the alternative compliance standards relating to the market value of listed securities or net income from continuing operations (the “Minimum Stockholders’ Equity Rule”). Our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020, filed on August 13, 2020, reflected that our stockholders’ equity as of June 30, 2020 was $1,714,000. In addition, as of August 13, 2020, we did not meet the alternative compliance standards relating to the market value of listed securities or net income from continuing operations. On October 5, 2020, based on our timely submission of our plan to regain compliance, Nasdaq granted us an extension through February 15, 2021, to regain compliance with the Minimum Stockholders’ Equity Rule, subject to our compliance with certain terms of the extension. In accordance with one part of the plan submitted to the Staff, we have successfully modified our outstanding warrants and are able to now classify the warrants within equity. At December 31, 2020, our stockholders’ equity was $4,255,000. On January 20, 2021, we received a letter from the Staff notifying us that, on a conditional basis, Nasdaq has determined that we have regained compliance with the Minimum Stockholders’ Equity Rule. At September 30, 2021 our stockholders’ equity was $4,502,000.

39

Liquidity and capital resources

Cash

At September 30, 2021, our cash balance was approximately $0.4 million, compared to approximately $1.8 million at December 31, 2020. The balance at December 31, 2020 excluded restricted cash of $0.3 million for a letter of credit requirement under a lease obligation. Per the terms of the lease agreement, the restrictions on the cash were lifted in September 2021 and the cash was returned to the Company.

The following summarizes cash flows from operating, investing, and financing activities, as reflected in the Condensed Consolidated Statements of Cash Flows included in Part I, Item 1, “Financial Statements,” of this Quarterly Report (in thousands):

	Nine months ended September 30,
	2021		2020
Net cash used in operating activities	$	(8,420)	$	(1,583)
Net cash used in investing activities	$	(311)	$	(171)
Net cash provided by financing activities	$	6,934	$	3,978

Net cash used in operating activities

Net cash used in operating activities was $8.4 million for the nine months ended September 30, 2021. The net loss was $5.3 million and was adjusted for non-cash items, including depreciation and amortization, stock-based compensation, provisions for inventory, warranty, gain on forgiveness of the PPP loan, other income related to the ERTC, and accounts receivable reserves and working capital changes. During the nine months ended September 30, 2021, we generated $0.4 million through the timing of collection of accounts receivable and $0.1 million due to the timing of inventory receipts and payments. We used $0.1 million through the timing of the receipt of inventory against short-term deposits and $2.1 million for inventory primarily due to global supply chain challenges that are impacting our inventory purchasing strategy, leading to a buildup of inventory and inventory components in an effort to manage both shortages of available components and longer lead times in obtaining components. We also used $0.3 million due to changes in accrued and other liabilities (primarily due to an increase in accrued payroll of $0.2 million; this increase was offset by a reduction of $0.2 million in accrued accounting and legal fees and $0.2 million in accrued bonuses), and $0.1 million from changes in prepaid and other current assets.

Net cash used in operating activities was $1.6 million for the nine months ended September 30, 2020. The net loss incurred of $6.0 million was adjusted for non-cash items, including depreciation and amortization, stock-based compensation, change in fair value of warrant liabilities, provisions for inventory, warranty and accounts receivable reserves and working capital changes. During the nine months ended September 30, 2020, we generated $1.8 million in cash for accounts payable due to the timing of inventory receipts and payments, and $1.1 million for inventories primarily due to the timing of inventory receipts and we used $0.5 million of short-term deposits due to prepaid deposits to our contract manufacturers for inventory for the EnFocusTM platform. During the nine months ended September 30, 2020, we used cash of $1.1 million through the timing of collection of accounts receivable.

Net cash used in investing activities

Net cash used in investing activities was $311 thousand for the nine months ended September 30, 2021 and resulted primarily from the purchase of software and a development of the mUVeTM UVCD robot.

For the nine months ended September 30, 2020, net cash used in investing activities was $171 thousand and resulted primarily from the purchase of software and tooling to support production operations and development of e-commerce platforms.

Net cash provided by financing activities

Net cash provided by financing activities during the nine months ended September 30, 2021 was $6.9 million, primarily related to $4.5 million of net proceeds from the June 2021 Equity Offering, $1.5 million of net proceeds from the

40

Streeterville Note, proceeds from the exercise of 156,446 warrants of $0.5 million and net proceeds from the Credit Facilities of $0.3 million. Investors in the January 2020 Equity Offering received warrants to purchase shares of our common stock, of which warrants to purchase an aggregate of 310,860 shares remain outstanding at September 30, 2021 with a weighted average exercise price of $3.59 per share. The exercise of the outstanding warrants could provide us with cash proceeds of up to $1.1 million in the aggregate.

Net cash provided by financing activities during the nine months ended September 30, 2020 was $4.0 million, primarily resulting from the $2.7 million in proceeds received from the January 2020 Equity Offering, partially offset by $0.5 million in offering costs for the issuance. During the nine months ended September 30, 2020, 197,394 warrants were exercised resulting in $0.7 million in proceeds.

Also during the nine months ended September 30, 2020, we received $0.8 million in proceeds from the PPP loan, $1.2 million from borrowings under the Inventory Facility and $1.0 million from borrowings under the Receivables Facility and paid $0.7 million, net, on the Austin Credit Facility. Additionally, we paid $0.2 million in deferred financing fees on the Inventory and Receivables Facilities combined. On August 11, 2020, we paid the outstanding balance of $1.4 million to close out our former Austin Credit Facility, which included a $100 thousand termination fee.

During the nine months ended September 30, 2020, we repaid $1.0 million aggregate principal amount under the Iliad Note, which included a mandatory repayment pursuant to the terms of the Iliad Note in connection with the issuance of common stock in the January 2020 Equity Offering, of which $0.2 million was allocated against principal. At September 30, 2020, we had additional availability for us to borrow of $1.1 million under the Inventory Facility and $1.2 million under the Receivables Facility.

Contractual obligations

As of September 30, 2021, we had approximately $2.9 million in outstanding purchase commitments for inventory. Of this amount, approximately $2.6 million is expected to ship in the fourth quarter of 2021, with the balance expected to ship in the first quarter of 2022 and thereafter.

There have been no other material changes to our contractual obligations as compared to those included in our 2020 Annual Report.

Critical accounting policies

Fair value of warrant liabilities

Due to a potential cash settlement upon occurrence of a fundamental transaction within the warrant agreement, the warrants were initially classified as liabilities, as opposed to equity, and were recorded at their fair values at each balance sheet date for the first three quarters of 2020. We used the Black-Scholes valuation model to value the warrant liabilities at fair value. The fair value is estimated using the expected volatility based on our historical volatility and is determined using probability weighted average assumptions, when appropriate.

During December 2020, the warrant holders agreed to a modification of the terms of their warrants which removed the potential cash settlement option upon the occurrence of a fundamental transaction. As such, during the fourth quarter of 2020, the warrant liability was reclassified into equity and the warrants are no longer subject to re-measurement at each balance sheet date.

There have been no other material changes to our critical accounting policies as compared to those included in our 2020 Annual Report.

41

Certain risks and concentrations

We have certain customers whose net sales individually represented 10% or more of our total net sales, or whose net trade accounts receivable balance individually represented 10% or more of our total net trade accounts receivable; we have certain suppliers, which individually represent 10% or more of our total purchases, or whose trade accounts payable balance individually represented 10% or more of our total trade accounts payable balance, as follows:

For the three months ended September 30, 2021, sales to our primary distributor for the U.S. Navy, a U.S. Navy shipbuilder, and a regional commercial lighting retrofit company accounted for approximately 19%, 17%, and 27% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 36% of net sales for the same period. For the three months ended September 30, 2020, sales to our primary distributor for the U.S. Navy and a regional commercial lighting retrofit company accounted for approximately 67% and 12% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 68% of net sales for the same period.

For the nine months ended September 30, 2021, sales to our primary distributor for the U.S. Navy, a U.S. Navy shipbuilder, and a regional commercial lighting retrofit company accounted for approximately 33%, 10%, and 17% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 43% of net sales for the same period. For the nine months ended September 30, 2020, sales to our primary distributor for the U.S. Navy and a regional commercial lighting retrofit company accounted for approximately 52% and 14% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 58% of net sales for the same period.

Our primary distributor for the U.S. Navy, a regional commercial lighting retrofit company and a U.S. Navy shipbuilder accounted for approximately 12%, 34%, and 27% of net trade accounts receivable, respectively, at September 30, 2021. At December 31, 2020, our primary distributor to the U.S. Navy accounted for 28% of our net trade accounts receivable and a shipbuilder for the U.S. Navy accounted for 21% of our net trade accounts receivable.

One offshore supplier accounted for approximately 19% and 30%, respectively, of our total expenditures for the three and nine months ended September 30, 2021. For the three months ended September 30, 2020, two offshore suppliers accounted for approximately 25% and 20%, respectively, of total expenditures. These same two suppliers accounted for approximately 19% and 14%, respectively, of total expenditures for the nine months ended September 30, 2020.

At September 30, 2021, one offshore supplier accounted for approximately 63% of our trade accounts payable balance. At December 31, 2020, this offshore supplier accounted for approximately 44% of our trade accounts payable balance.

Recent accounting pronouncements

For information on recent accounting pronouncements, please refer to Note 2, “Basis of Presentation and Summary of Significant Accounting Policies,” included under Part I, Item 1, “Financial Statements,” of this Quarterly Report.

42

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure.

Pursuant to Rule 13a-15(b) under the Exchange Act, our management must evaluate, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures, as of September 30, 2021, the end of the period covered by this Quarterly Report. Management, with the participation of our Chief Executive Officer and Chief Financial Officer, did evaluate the effectiveness of our disclosure controls and procedures as of the end of period covered by this Quarterly Report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2021.

Changes in internal control over financial reporting

During the quarterly period covered by this Quarterly Report, there have not been any changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

43

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, we may be involved in various claims and legal actions arising in the ordinary course of business. As of September 30, 2021, we were not involved in any material legal proceedings.

ITEM 1A. RISK FACTORS

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable.

ITEM 5. OTHER INFORMATION

On November 11, 2021, Geraldine McManus, a member of the board of directors of the Company, provided her notice of resignation from the board, effective November 11, 2021. Ms. McManus’ term would have otherwise expired at the 2022 annual meeting of stockholders of the Company. Ms. McManus resigned to focus on other professional commitments in her capacity as a Managing Member of Granger Management, an independent investment business. Ms. McManus’ resignation did not involve any disagreement with the Company.

44

ITEM 6. EXHIBITS

EXHIBIT INDEX

Exhibit Number	Description of Documents
3.1	Certificate of Incorporation of Energy Focus, Inc. (incorporated by reference to Appendix A to the Registrant’s Definitive Proxy Statement on Schedule 14A filed on May 1, 2006).
3.2	Certificate of Amendment to the Certificate of Incorporation of Energy Focus, Inc. filed with the Secretary of State of the State of Delaware on June 21, 2010 (incorporated by reference to Exhibit 3.2 to the Registrant’s Annual Report on Form 10-K filed on March 24, 2020).
3.3	Certificate of Amendment to the Certificate of Incorporation of Energy Focus, Inc. filed with the Secretary of State of the State of Delaware on October 9, 2012 (incorporated by reference to Exhibit 3.3 to the Registrant’s Annual Report on Form 10-K filed on March 24, 2020).
3.4	Certificate of Amendment to the Certificate of Incorporation of Energy Focus, Inc. filed with the Secretary of State of the State of Delaware on October 28, 2013 (incorporated by reference to Exhibit 3.4 to the Registrant’s Annual Report on Form 10-K filed on March 24, 2020).
3.5	Certificate of Amendment to the Certificate of Incorporation of Energy Focus, Inc. filed with the Secretary of State of the State of Delaware on July 16, 2014 (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on July 16, 2014).
3.6	Certificate of Amendment to the Certificate of Incorporation of Energy Focus, Inc. filed with the Secretary of State of the State of Delaware on July 24, 2015 (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on July 27, 2015).
3.7	Certificate of Amendment to the Certificate of Incorporation of Energy Focus, Inc. filed with the Secretary of State of the State of Delaware on January 15, 2020 (incorporated by reference to Exhibit 3.7 to the Registrant’s Annual Report on Form 10-K filed on March 24, 2020).
3.8	Certificate of Designation of Series A Convertible Preferred Stock of Energy Focus, Inc. (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on April 1, 2019).
3.9	Amendment to the Certificate of Designation of Series A Convertible Preferred Stock of Energy Focus, Inc. (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on May 30, 2019).
3.10	Amendment to the Certificate of Designation of Series A Convertible Preferred Stock of Energy Focus, Inc. filed with the Secretary of State of the State of Delaware on January 15, 2020 (incorporated by reference to Exhibit 3.10 to the Registrant’s Annual Report on Form 10-K filed on March 24, 2020).
3.11	Certificate of Amendment of Certificate of Incorporation, dated June 11, 2020 (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on June 11, 2020).
3.12	Bylaws of Energy Focus, Inc. (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on May 18, 2020).
3.13	Certificate of Ownership and Merger, Merging Energy Focus, Inc., a Delaware corporation, into Fiberstars, Inc., a Delaware corporation, filed with the Secretary of State of the State of Delaware on May 4, 2007 (incorporated by reference to Exhibit 3.1 to the Registrant’s Quarterly Report on Form 10-Q filed on May 10, 2007).
31.1+	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2+	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1++	Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
*101	The following financial information from our Quarterly Report for the quarter ended September 30, 2021, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets at September 30, 2021 and December 31, 2020, (ii) Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020, (iii) Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2021 and 2020, (iv) Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2021 and 2020, (v) Condensed Consolidated Statements of Cash Flows for the three and nine months ended September 30, 2021 and 2020, and (vi) the Notes to Condensed Consolidated Financial Statements.
*104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

*    Pursuant to Regulation S-T, this interactive data file is not deemed filed for purposes of Section 11 of the Securities Act, or Section 18 of the Exchange Act, or otherwise subject to the liabilities of these sections.

+     Filed herewith.

++ This exhibit shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section. Such exhibit shall not be deemed incorporated into any filing under the Securities Act or the Exchange Act.

45

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

			ENERGY FOCUS, INC.
Date:	November 12, 2021	By:	/s/ James Tu
			James Tu
			Executive Chairman and Chief Executive Officer
			(Principal Executive Officer)

Date:	November 12, 2021	By:	/s/ Tod A. Nestor
			Tod A. Nestor
			Chief Operating Officer and Chief Financial Officer
			(Principal Financial and Accounting Officer)

46

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, James Tu, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Energy Focus, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have;

(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

    /s/ James Tu            

    James Tu
    Executive Chairman and Chief Executive Officer

                                Date: November 12, 2021

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Tod A. Nestor, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Energy Focus, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have;

(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

    /s/ Tod A. Nestor            

    Tod A. Nestor

    Chief Operating Officer and Chief Financial Officer

    Date: November 12, 2021

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Energy Focus, Inc. (the “Company”) for the quarterly period ended September 30, 2021 (the “Report”), I, James Tu, Executive Chairman and Chief Executive Officer of the Company and I, Tod A. Nestor, Chief Operating Officer and Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002, that to the best of my knowledge:

(i) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ James Tu
James Tu Executive Chairman and Chief Executive Officer
Date:	November 12, 2021

/s/ Tod A. Nestor
Tod A. Nestor Chief Operating Officer and Chief Financial Officer
Date:	November 12, 2021

A signed original of this written statement required by Section 906 has been provided to Energy Focus, Inc. and will be retained by Energy Focus, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover Page - shares	9 Months Ended
	Sep. 30, 2021	Nov. 09, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-36583
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-3021850
Entity Address, Address Line One	32000 Aurora Road
Entity Address, Address Line Two	Suite B
Entity Address, City or Town	Solon
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44139
City Area Code	(440)
Local Phone Number	715-1300
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	EFOI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		5,087,574
Entity Central Index Key	0000924168
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Registrant Name	ENERGY FOCUS, INC/DE

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash	$ 381	$ 1,836
Trade accounts receivable, less allowances of $18 and $8, respectively	1,628	2,021
Inventories, net	7,755	5,641
Short-term deposits	913	796
Prepaid and other current assets	1,421	782
Total current assets	12,098	11,076
Property and equipment, net	588	420
Operating lease right-of-use assets	419	794
Restructured lease right-of-use assets	0	107
Total assets	13,105	12,397
Current liabilities:
Accounts payable	2,606	2,477
Accrued liabilities	233	45
Accrued legal and professional fees	17	149
Accrued payroll and related benefits	691	885
Accrued sales commissions	40	95
Accrued restructuring	0	11
Accrued warranty reserve	240	227
Deferred revenue	2	72
Operating lease liabilities	475	598
Restructured lease liabilities	0	168
Finance lease liabilities	1	3
Streeterville note, net of discount and loan origination fees	1,602	0
PPP loan	0	529
Credit line borrowings, net of loan origination fees	2,666	2,298
Total current liabilities	8,573	7,557
Operating lease liabilities, net of current portion	30	318
Finance lease liabilities, net of current portion	0	1
PPP loan, net of current maturities	0	266
Total liabilities	8,603	8,142
STOCKHOLDERS' EQUITY
Preferred stock, par value $0.0001 per share	0	0
Common stock, par value $0.0001 per share	0	0
Additional paid-in capital	140,615	135,113
Accumulated other comprehensive loss	(3)	(3)
Accumulated deficit	(136,110)	(130,855)
Total stockholders' equity	4,502	4,255
Total liabilities and stockholders' equity	$ 13,105	$ 12,397

XML

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Trade accounts receivable, less allowances	$ 18	$ 8
Preferred stock, par value (USD per share)	$ 0.0001	$ 0.0001
Preferred stock, authorized (in shares)	5,000,000	5,000,000
Preferred stock, issued (in shares)	876,447	2,597,470
Preferred stock, outstanding (in shares)	876,447	2,597,470
Common stock, par value (USD per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	50,000,000	50,000,000
Common stock, issued (in shares)	5,087,574	3,525,374
Common stock, outstanding (in shares)	5,087,574	3,525,374
Series A Convertible Preferred Stock
Preferred stock, authorized (in shares)	3,300,000	3,300,000

XML

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Net sales		$ 2,749	$ 5,964	$ 7,460	$ 13,082
Cost of sales		2,186	4,588	5,951	9,331
Gross profit		563	1,376	1,509	3,751
Operating expenses:
Product development		404	401	1,427	996
Selling, general, and administrative		1,968	2,003	6,454	6,003
Restructuring		1	(16)	(21)	(44)
Total operating expenses		2,373	2,388	7,860	6,955
Loss from operations		(1,810)	(1,012)	(6,351)	(3,204)
Other expenses (income):
Interest expense		177	124	520	344
Gain on forgiveness of PPP loan		0	0	(801)	0
Loss on extinguishment of debt		0	159	0	159
Other income - employee retention tax credit		(862)	0	(862)	0
(Gain) loss from change in fair value of warrants		0	(153)	0	2,274
Other expenses		15	25	47	67
Loss before income taxes		(1,140)	(1,167)	(5,255)	(6,048)
Benefit from income taxes		0	(2)	0	(2)
Net loss		$ (1,140)	$ (1,165)	$ (5,255)	$ (6,046)
Net loss per common share - basic and diluted
Net loss, basic (USD per share)		$ (0.22)	$ (0.35)	$ (1.22)	$ (1.89)
Net loss, diluted (USD per share)		$ (0.22)	$ (0.35)	$ (1.22)	$ (1.89)
Weighted average shares of common stock outstanding:
Basic (in shares)	[1]	5,086	3,308	4,309	3,196
Diluted (in shares)	[1]	5,086	3,308	4,309	3,196

[1] * Shares outstanding for the nine months ended September 30, 2020 have been restated for the 1-for-5 reverse stock split effective June 11, 2020.

XML

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (1,140)	$ (1,165)	$ (5,255)	$ (6,046)
Other comprehensive income:
Foreign currency translation adjustments	0	0	0	0
Comprehensive loss	$ (1,140)	$ (1,165)	$ (5,255)	$ (6,046)

XML

Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands		Total	Preferred Stock	Preferred Stock	Preferred Stock Preferred Stock	Common Stock		Additional Paid-in Capital	Additional Paid-in Capital Preferred Stock	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance at the beginning of the period (in shares) at Dec. 31, 2019				0		2,486,000	[1]
Balance at the beginning of the period at Dec. 31, 2019		$ 3,996		$ 0		$ 0		$ 128,873		$ (3)	$ (124,874)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock option and stock purchase plans (in shares)	[1]					5,000
Issuance of common stock under employee stock option and stock purchase plans		0
Offering costs on issuance of common stock and warrants		(474)						(474)
Warrant liability		(1,636)						(1,636)
Issuance of common stock and warrants (in shares)	[1]					688,000
Issuance of common stock and warrants		2,749						2,749
Conversion of notes to preferred stock (in shares)					2,709,000
Conversion of notes to preferred stock			$ 1,769						$ 1,769
Stock-based compensation		20						20
Net loss		(541)									(541)
Balance at the end of the period (in shares) at Mar. 31, 2020				2,709,000		3,179,000	[1]
Balance at the end of the period at Mar. 31, 2020		5,883		$ 0		$ 0		131,301		(3)	(125,415)
Balance at the beginning of the period (in shares) at Dec. 31, 2019				0		2,486,000	[1]
Balance at the beginning of the period at Dec. 31, 2019		3,996		$ 0		$ 0		128,873		(3)	(124,874)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(6,046)
Balance at the end of the period (in shares) at Sep. 30, 2020				2,597,000		3,428,000	[1],[2]
Balance at the end of the period at Sep. 30, 2020		2,139		$ 0		$ 0		133,062		(3)	(130,920)
Balance at the beginning of the period (in shares) at Mar. 31, 2020				2,709,000		3,179,000	[1]
Balance at the beginning of the period at Mar. 31, 2020		5,883		$ 0		$ 0		131,301		(3)	(125,415)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock option and stock purchase plans (in shares)	[1]					0
Issuance of common stock under employee stock option and stock purchase plans		30						30
Issuance of common stock upon the exercise of warrants (in shares)	[1]					15,000
Issuance of common stock upon the exercise of warrants		103						103
Common stock withheld in lieu of income tax withholding on vesting of restricted stock units		(3)						(3)
Conversion of notes to preferred stock (in shares)				112,000		22,000	[1]
Stock-based compensation		41						41
Net loss		(4,340)									(4,340)
Balance at the end of the period (in shares) at Jun. 30, 2020				2,597,000		3,216,000	[1]
Balance at the end of the period at Jun. 30, 2020		1,714		$ 0		$ 0		131,472		(3)	(129,755)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock option and stock purchase plans (in shares)	[1]					30,000
Issuance of common stock under employee stock option and stock purchase plans		0						0
Issuance of common stock upon the exercise of warrants (in shares)	[1]					182,000
Issuance of common stock upon the exercise of warrants		1,555						1,555
Stock-based compensation		35						35
Net loss		(1,165)									(1,165)
Balance at the end of the period (in shares) at Sep. 30, 2020				2,597,000		3,428,000	[1],[2]
Balance at the end of the period at Sep. 30, 2020		2,139		$ 0		$ 0		133,062		(3)	(130,920)
Balance at the beginning of the period (in shares) at Dec. 31, 2020				2,597,000		3,525,000
Balance at the beginning of the period at Dec. 31, 2020		4,255		$ 0		$ 0		135,113		(3)	(130,855)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock option and stock purchase plans (in shares)						1,000
Issuance of common stock under employee stock option and stock purchase plans		0
Issuance of common stock upon the exercise of warrants (in shares)						156,000
Issuance of common stock upon the exercise of warrants		527						527
Common stock withheld in lieu of income tax withholding on vesting of restricted stock units (in shares)						0
Common stock withheld in lieu of income tax withholding on vesting of restricted stock units		(2)						(2)
Stock-based compensation		140						140
Net loss		(1,642)									(1,642)
Balance at the end of the period (in shares) at Mar. 31, 2021				2,597,000		3,682,000
Balance at the end of the period at Mar. 31, 2021		3,278		$ 0		$ 0		135,778		(3)	(132,497)
Balance at the beginning of the period (in shares) at Dec. 31, 2020				2,597,000		3,525,000
Balance at the beginning of the period at Dec. 31, 2020		$ 4,255		$ 0		$ 0		135,113		(3)	(130,855)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of warrants (in shares)		156,446
Net loss		$ (5,255)
Balance at the end of the period (in shares) at Sep. 30, 2021				876,000		5,087,000
Balance at the end of the period at Sep. 30, 2021		4,502		$ 0		$ 0		140,615		(3)	(136,110)
Balance at the beginning of the period (in shares) at Mar. 31, 2021				2,597,000		3,682,000
Balance at the beginning of the period at Mar. 31, 2021		3,278		$ 0		$ 0		135,778		(3)	(132,497)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock option and stock purchase plans (in shares)						69,000
Issuance of common stock under employee stock option and stock purchase plans		59						59
Offering costs on issuance of common stock and warrants		(469)						(469)
Issuance of common stock and warrants (in shares)						990,000
Issuance of common stock and warrants		5,000						5,000
Conversion of notes to preferred stock (in shares)				1,721,000		344,000
Stock-based compensation		208						208
Net loss		(2,473)									(2,473)
Balance at the end of the period (in shares) at Jun. 30, 2021				876,000		5,085,000
Balance at the end of the period at Jun. 30, 2021		5,603		$ 0		$ 0		140,576		(3)	(134,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock option and stock purchase plans (in shares)						2,000
Issuance of common stock under employee stock option and stock purchase plans		0
Offering costs on issuance of common stock and warrants		(1)						(1)
Common stock withheld in lieu of income tax withholding on vesting of restricted stock units		1						1
Stock-based compensation		39						39
Net loss		(1,140)									(1,140)
Balance at the end of the period (in shares) at Sep. 30, 2021				876,000		5,087,000
Balance at the end of the period at Sep. 30, 2021		$ 4,502		$ 0		$ 0		$ 140,615		$ (3)	$ (136,110)

[1] Shares outstanding for prior periods have been restated for the 1-for-5 reverse stock split effective June 11, 2020.

[2] * Shares outstanding for the nine months ended September 30, 2020 have been restated for the 1-for-5 reverse stock split effective June 11, 2020.

XML

Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)	Jun. 11, 2020
Statement of Financial Position [Abstract]
Reverse stock split ratio	0.2

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended						9 Months Ended		12 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (1,140)	$ (2,473)	$ (1,642)	$ (1,165)	$ (4,340)	$ (541)	$ (5,255)	$ (6,046)
Adjustments to reconcile net loss to net cash used in operating activities:
Other income - employee retention tax credit	(862)			0			(862)	0
Gain on forgiveness of PPP loan	0			0			(801)	0
Depreciation	43			48			143	140
Stock-based compensation	39			35			387	96
Change in fair value of warrant liabilities	0			(153)			0	2,274
Provision for doubtful accounts receivable	2			(9)			10	(21)
Provision for slow-moving and obsolete inventories	(70)			90			(9)	(229)
Provision for warranties	1			14			13	34
Amortization of loan discounts and origination fees	61			145			158	221
Changes in operating assets and liabilities (sources / (uses) of cash):
Accounts receivable	(500)			(901)			390	(1,070)
Inventories	444			551			(2,105)	1,138
Short-term deposits	(62)			(197)			87	(412)
Prepaid and other assets	(91)			(76)			(119)	(59)
Accounts payable	(164)			534			(82)	1,811
Accrued and other liabilities	53			160			(305)	453
Deferred revenue	(69)			44			(70)	87
Total adjustments	(1,175)			285			(3,165)	4,463
Net cash used in operating activities	(2,315)			(880)			(8,420)	(1,583)
Cash flows from investing activities:
Acquisitions of property and equipment	(100)			(53)			(311)	(171)
Net cash used in investing activities	(100)			(53)			(311)	(171)
Cash flows from financing activities (sources / (uses) of cash):
Proceeds from the issuance of common stock and warrants	0			(1)			5,000	2,749
Proceeds from the exercise of warrants	0			625			527	676
Offering costs paid on the issuance of common stock and warrants	(1)			0			(470)	(474)	$ (510)
Proceeds from PPP loan	0			0			0	795
Principal payments under finance lease obligations	(1)			(1)			(3)	(3)
Proceeds from exercise of stock options and employee stock purchase plan purchases	0			0			59	30
Common stock withheld in lieu of income tax withholding on vesting of restricted stock units	1			0			(1)	(3)
Proceeds from the Streeterville note	0			0			1,515	0
Payments on the Iliad note	0			(450)			0	(976)
Deferred financing costs	0			(320)			(30)	(320)
Net payments on credit line borrowings - AFS	0			(1,296)			0	(719)
Net proceeds from the credit line borrowings - Credit Facilities	1,128			2,223			337	2,223
Net cash provided by financing activities	1,127			780			6,934	3,978
Net (decrease) increase in cash and restricted cash	(1,288)			(153)			(1,797)	2,224
Cash and restricted cash, beginning of period	1,669		$ 2,178	3,069		$ 692	2,178	692	692
Cash and restricted cash, end of period	381	1,669		2,916	3,069		381	2,916	2,178
Classification of cash and restricted cash:
Cash	381			2,574			381	2,574	1,836
Restricted cash held in other assets	0			342			0	342	300
Cash and restricted cash	$ 381	$ 1,669		$ 2,916	$ 3,069		$ 381	$ 2,916	$ 2,178

XML

Nature of Operations

9 Months Ended

Sep. 30, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Operations

NATURE OF OPERATIONS

Energy Focus, Inc. engages primarily in the design, development, manufacturing, marketing and sale of energy-efficient lighting systems and controls and development of ultraviolet-C light disinfection (“UVCD”) products. We develop, market and sell high quality light-emitting diode (“LED”) lighting and controls products and UVCD products in the commercial market and military maritime market (“MMM”), and expect to expand our offerings into the consumer market starting in the fourth quarter of 2021. Our mission is to enable our customers to run their facilities, offices and homes with greater energy efficiency, productivity, and human health through advanced LED retrofit and UVCD solutions. Our goal is to be the LED and human-centric lighting (“HCL”) technology and market leader for the most demanding applications where performance, quality, value, environmental impact and health are considered paramount. We specialize in LED lighting retrofit by replacing fluorescent, high-intensity discharge lighting and other types of lamps in institutional buildings for primarily indoor lighting applications with our innovative, high-quality commercial and military tubular LED (“TLED”) products, as well as other LED and lighting control products for commercial and consumer applications. In late 2020, we announced the launch of our UVCD product portfolio, which is being brought to market throughout the fourth quarter of 2021 and into 2022.

On June 11, 2020, in accordance with previous stockholder approval, our board of directors effected a 1-for-5 (the “Split Ratio”) reverse stock split of the Company’s common stock, par value $0.0001 per share. The reverse stock split became effective immediately upon the filing of the Certificate of Amendment to the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”), with the Delaware Secretary of State (the “Effective Time”). At the Effective Time, every five shares of common stock issued and outstanding automatically combined into one validly issued, fully paid and non-assessable share of common stock. No fractional shares were issued as a result of the reverse stock split. The $0.0001 par value per share of common stock and other terms of the common stock were not affected by the reverse stock split. The number of authorized shares of common stock under the Certificate of Incorporation remained unchanged at 50,000,000 shares. Proportional adjustments were made to the conversion and exercise prices of our outstanding warrants and stock options, and to the number of shares issued and issuable under our stock incentive plans in connection with the reverse stock split. The information presented in the financial statements for all prior periods have been retroactively adjusted to reflect the reverse stock split. Preferred shares outstanding were not affected by the reverse stock split and, as such, those shares have not been adjusted.

XML

Basis of Presentation and Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Basis of Presentation and Summary of Significant Accounting Policies

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The significant accounting policies of our Company, which are summarized below, are consistent with accounting principles generally accepted in the United States (“U.S. GAAP”) and reflect practices appropriate to the business in which we operate. Unless indicated otherwise, the information in the Notes to the Consolidated Financial Statements relates to our operations.

We have prepared the accompanying financial data for the three and nine months ended September 30, 2021 and 2020 pursuant to the rules and regulations of the United States Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2020 (“2020 Annual Report”). The Condensed Consolidated Balance Sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements.

In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary to present fairly our Condensed Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020, Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020, Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2021 and 2020, Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2021 and 2020, and Condensed Consolidated Statements of Cash Flows for the three and nine months ended September 30, 2021 and 2020.

Use of estimates

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management’s best knowledge of current events and actions that may impact us in the future, actual results may vary from the estimates. Estimates include, but are not limited to, the establishment of reserves for accounts receivable, sales returns, inventory obsolescence and warranty claims; the useful lives of property and equipment; valuation allowance for net deferred taxes; the cost and offsetting income related to sub-leased property; and stock-based compensation. In addition, estimates and assumptions associated with the determination of the fair value of financial instruments and evaluation of long-lived assets for impairment requires considerable judgment. Actual results could differ from those estimates and such differences could be material.

Certain risks and concentrations

We have certain customers whose net sales individually represented 10% or more of our total net sales, or whose net trade accounts receivable balance individually represented 10% or more of our total net trade accounts receivable; we have certain suppliers, which individually represent 10% or more of our total purchases, or whose trade accounts payable balance individually represented 10% or more of our total trade accounts payable balance, as follows:

For the three months ended September 30, 2021, sales to our primary distributor for the U.S. Navy, a U.S. Navy shipbuilder, and a regional commercial lighting retrofit company accounted for approximately 19%, 17%, and 27% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 36% of net sales for the same period. For the three months ended September 30, 2020, sales to our primary distributor for the U.S. Navy and a regional commercial lighting retrofit company accounted for approximately 67% and 12% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 68% of net sales for the same period.

For the nine months ended September 30, 2021, sales to our primary distributor for the U.S. Navy, a U.S. Navy shipbuilder, and a regional commercial lighting retrofit company accounted for approximately 33%, 10%, and 17% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 43% of net sales for the same period. For the nine months ended September 30, 2020, sales to our primary distributor for the U.S. Navy and a regional commercial lighting retrofit company accounted for approximately 52% and 14% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 58% of net sales for the same period.

Our primary distributor for the U.S. Navy, a regional commercial lighting retrofit company and a U.S. Navy shipbuilder accounted for approximately 12%, 34%, and 27% of net trade accounts receivable, respectively, at September 30, 2021. At December 31, 2020, our primary distributor to the U.S. Navy accounted for 28% of our net trade accounts receivable and a shipbuilder for the U.S. Navy accounted for 21% of our net trade accounts receivable.

One offshore supplier accounted for approximately 19% and 30%, respectively, of our total expenditures for the three and nine months ended September 30, 2021. For the three months ended September 30, 2020, two offshore suppliers accounted for approximately 25% and 20%, respectively, of total expenditures. These same two suppliers accounted for approximately 19% and 14%, respectively, of total expenditures for the nine months ended September 30, 2020.

At September 30, 2021, one offshore supplier accounted for approximately 63% of our trade accounts payable balance. At December 31, 2020, this offshore supplier accounted for approximately 44% of our trade accounts payable balance.

Recent accounting pronouncement

In June 2016, the Financial Accounting Standards Board issued Accounting Standard Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which significantly changes the accounting for credit losses on instruments within its scope. The new guidance introduces an approach based on expected losses to estimate credit losses on certain financial instruments, including trade receivables, and requires an entity to recognize an allowance based on its estimate of expected credit losses rather than incurred losses. For smaller reporting companies, this standard will be effective for interim and annual periods starting after December 15, 2022 and will generally require adoption on a modified retrospective basis. We are in the process of evaluating the impact of the standard.

Revenue

Net sales include revenues from sales of products and shipping and handling charges, net of estimates for product returns. Revenue is measured at the amount of consideration we expect to receive in exchange for the transferred products. We recognize revenue at the point in time when we transfer the promised products to the customer and the customer obtains control over the products. Distributors’ obligations to us are not contingent upon the resale of our products. We recognize revenue for shipping and handling charges at the time the goods are shipped to the customer, and the costs of outbound freight are included in cost of sales. We provide for product returns based on historical return rates. While we incur costs for sales commissions to our sales employees and outside agents, we recognize commission costs concurrent with the related revenue, as the amortization period is less than one year. We do not incur any other incremental costs to obtain contracts with our customers. Our product warranties are assurance-type warranties, which promise the customer that the products are as specified in the contract. Therefore, the product warranties are not a separate performance obligation and are accounted for as described below. Sales taxes assessed by governmental authorities and collected by us are accounted for on a net basis and are excluded from net sales.

The following table provides a disaggregation of product net sales for the periods presented (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net sales:
Commercial	$	1,522	$	1,456	$	3,513	$	4,250
MMM products	1,227		4,508		3,947		8,832
Total net sales	$	2,749	$	5,964	$	7,460	$	13,082

Accounts Receivable

Our trade accounts receivable consist of amounts billed to and currently due from customers. Our customers are currently concentrated in the United States. In the normal course of business, we extend unsecured credit to our customers related to the sale of our products. Credit is extended to customers based on an evaluation of the customer’s financial condition and the amounts due are stated at their estimated net realizable value. We utilize an account receivable insurance program with a high credit worthy insurance company where we have the large majority of the accounts receivable insured with a portion of self-retention. This third party also provides creditworthiness ratings and metrics that significantly assist us in evaluating the creditworthiness of both existing and new customers. We maintain allowances for sales returns and doubtful accounts receivable to provide for the estimated number of accounts receivable that will not be collected. The allowance is based on an assessment of customer creditworthiness and historical payment experience, the age of outstanding receivables, and performance guarantees to the extent applicable. Past due amounts are written off when our internal collection efforts have been unsuccessful, and payments subsequently received on such receivables are credited to the allowance for doubtful accounts. We do not generally require collateral from our customers.

Our standard payment terms with customers are net 30 days from the date of shipment, and we do not generally offer extended payment terms to our customers, but exceptions are made in some cases to certain customers or with particular orders. Accordingly, we do not adjust trade accounts receivable for the effects of financing, as we expect the period between the transfer of product to the customer and the receipt of payment from the customer to be in line with our standard payment terms.

Geographic information

All of our long-lived fixed assets are located in the United States. For the three months ended September 30, 2021, there were less than 1% of sales attributable to customers outside the United States. For the nine months ended September 30, 2021, there were approximately 1% of sales attributable to customers outside the United States. For the three and nine months ended September 30, 2020, there were no net sales attributable to customers outside the United States. The geographic location of our net sales is derived from the destination to which we ship the product.

Net loss per share

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of shares of common stock outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted loss per share gives effect to all dilutive potential shares of common stock outstanding during the period. Dilutive potential shares of common stock consist of incremental shares upon the exercise of stock options, warrants and convertible securities, unless the effect would be anti-dilutive.

The following table presents a reconciliation of basic and diluted loss per share computations (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Numerator:
Net loss	$	(1,140)	$	(1,165)	$	(5,255)	$	(6,046)
Denominator:
Basic and diluted weighted average shares of common stock outstanding *	5,086		3,308		4,309		3,196

*Shares outstanding for the nine months ended September 30, 2020 have been restated for the 1-for-5 stock split effective June 11, 2020.

As a result of the net loss we incurred for the three months ended September 30, 2021, options, warrants and convertible securities representing approximately 41 thousand, 11 thousand and 175 thousand shares of common stock, respectively, were excluded from the basic loss per share calculation because their inclusion would have been anti-dilutive. As a result of the net loss we incurred for the three months ended September 30, 2020, options, restricted share units, warrants and convertible securities representing approximately 117 thousand, 13 thousand, 321 thousand and 519 thousand shares of common stock, respectively, were excluded from the basic loss per share calculation as their inclusion would have been anti-dilutive.

As a result of the net loss we incurred for the nine months ended September 30, 2021, options, warrants and convertible securities representing approximately 60 thousand, 56 thousand and 289 thousand shares of common stock, respectively, were excluded from the basic loss per share calculation because their inclusion would have been anti-dilutive. As a result of the net loss we incurred for the nine months ended September 30, 2020, options, restricted share units, warrants and convertible securities representing approximately 57 thousand, 7 thousand, 152 thousand and 531 thousand shares of common stock, respectively, were excluded from the basic loss per share calculation as their inclusion would have been anti-dilutive.

Product warranties

We warrant our commercial and MMM LED products and controls for periods generally ranging from five to ten years. Warranty settlement costs consist of actual amounts expensed for warranty, which are largely a result of the cost of replacement products provided to our customers. A liability for the estimated future costs under product warranties is maintained for products under warranty based on the actual claims incurred to date and the estimated nature, frequency, and costs of future claims. These estimates are inherently uncertain and changes to our historical or projected experience may cause material changes to our warranty reserves in the future. We continuously review the assumptions related to the adequacy of our warranty reserve, including product failure rates, and make adjustments to the existing warranty liability when there are changes to these estimates or the underlying replacement product costs, or the warranty period expires.

The following table summarizes warranty activity for the periods presented (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Balance at beginning of period	$	239	$	215	$	227	$	195
Warranty accruals for current period sales	10		22		49		29
Adjustments to existing warranties	4		4		16		23
In kind settlements made during the period	(13)		(11)		(52)		(17)
Accrued warranty reserve at end of period	$	240	$	230	$	240	$	230

Financial Instruments

In June 2021, we completed a registered direct offering of 990,100 shares of our common stock to certain institutional investors, at a purchase price of $5.05 per share (the “June 2021 Equity Offering”). We paid the placement agent commissions of $400 thousand, plus $51 thousand in expenses, in connection with the June 2021 Equity Offering and we also paid legal and other fees of $19 thousand related to the offering. Total offering costs of $470 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of September 30, 2021. Net proceeds to us from the June 2021 Equity Offering were approximately $4.5 million.

In January 2020, we completed a registered direct offering of 688,360 shares of our common stock to certain institutional investors, at a purchase price of $3.37 per share. We also sold, to the same institutional investors, warrants to purchase up to 688,360 shares of common stock at an exercise price of $3.37 per share in a concurrent private placement for a purchase price of $0.625 per warrant. We paid the placement agent commissions of $193 thousand, plus $50 thousand in expenses, in connection with the registered direct offering and the concurrent private placement and we also paid legal, accounting and other fees of $231 thousand related to the offering. Total offering costs of $510 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of December 31, 2020. In addition, we issued warrants to the placement agent to purchase up to 48,185 shares of common stock at an exercise price of $4.99 per share. Net proceeds to us from the sale of common stock and warrants (the “January 2020 Equity Offering”) were approximately $2.3 million. In accordance with the terms of the Iliad Note (as defined below in Note 7, “Debt”), 10% of the gross proceeds from the January 2020 Equity Offering ($275 thousand) were used to make payments on the Iliad Note, of which $226 thousand went towards the outstanding principal amount and the balance to interest.

Warrants to purchase an aggregate of 310,860 shares remain outstanding at September 30, 2021 with a weighted average exercise price of $3.59 per share. The exercise of warrants could provide us with cash proceeds of up to $1.1 million in the aggregate. During the nine months ended September 30, 2021, 156,446 warrants were exercised resulting in total proceeds of $527 thousand.

Due to a potential cash settlement upon occurrence of a fundamental transaction within the January 2020 warrant agreement, the warrants were initially classified as liabilities, as opposed to equity, and were recorded at their fair values at each balance sheet date for the first three quarters of 2020. During December 2020, the warrant holders all agreed to a modification of the terms of their warrants that removed the potential cash settlement option upon the occurrence of a fundamental transaction. As such, during the fourth quarter of 2020, the warrant liability was reclassified into equity and the warrants are no longer subject to re-measurement at each balance sheet date. Please also refer to Note 9, “Stockholders’ Equity”.

Fair Value Measurements

The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value, giving the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below. We classify the inputs used to measure fair value into the following hierarchy:

Level 1	Unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2	Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.
Level 3	Unobservable inputs for the asset or liability.

The following table provides a summary of the financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2020 (in thousands):

			Fair Value Measurements at September 30, 2020 Using
	Balance as of		Quoted Prices in Active Markets for Identical Assets  (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs  (Level 3)
Description	September 30, 2020
Warrant liabilities	$	2,928	$	—	$	—	$	2,928

The carrying amounts of certain financial instruments including cash, accounts receivable, accounts payable, and accrued liabilities approximate fair value due to their short maturities. Based on borrowing rates currently available to us for loans with similar terms, the carrying value of borrowings under our revolving credit facilities also approximates fair value.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. In determining the appropriate levels, we perform a detailed analysis of the assets and liabilities whose fair value is measured on a recurring basis. We review and reassess the fair value hierarchy classifications on a quarterly basis. Changes from one quarter to the next related to the observability of inputs in a fair value measurement may result in a reclassification between fair value hierarchy levels. There were no reclassifications for all periods presented.

The estimated fair value of warrants accounted for as liabilities, representing a level 3 fair value measure, was determined on the issuance date and subsequently marked to market at each financial reporting date until the date the warrants were reclassified into equity, after which the warrants are no longer subject to re-measurement at each balance sheet date. We use the Black-Scholes valuation model to value the warrant liabilities at fair value. The fair value is estimated using the expected volatility based on our historical volatility and is determined using probability weighted-average assumptions, when appropriate.

The following inputs were used at September 30, 2020:

	Expected	Risk-Free	Expected
	Volatility	Interest Rate	Life
Warrants with greater than one-year remaining term	103.18% - 99.38%	0.21% - 0.24%	3.79 - 4.29 years

A roll-forward of fair value measurements using significant unobservable inputs (Level 3) for the warrants is as follows (in thousands):

	Nine months ended September 30, 2020
Balance January 1, 2020	$	—
Issuance of warrants, January 2020	1,636
Settlements from exercise	(982)
Gain from change in fair value of warrants	2,274
Balance September 30, 2020	$	2,928

XML

Restructuring

9 Months Ended

Sep. 30, 2021

Restructuring and Related Activities [Abstract]

Restructuring

RESTRUCTURING

For the three months ended September 30, 2021, we recorded nominal net restructuring expense and for the nine months ended September 30, 2021, we recorded a net restructuring credit of approximately $21 thousand. For three and nine months ended September 30, 2020, we recorded net restructuring credits of approximately $16 thousand and $44 thousand, respectively, related to the costs and offsetting sub-lease income and accretion expense for the remaining lease obligation for our former New York, New York office. For additional information regarding the restructuring actions taken as part of the restructuring plans, please refer to Note 3, “Restructuring,” included under Item 8, “Financial Statements and Supplementary Data,” of our 2020 Annual Report.

The lease obligation on our former New York, New York office was settled as of June 30, 2021. Our restructuring liabilities consisted of estimated ongoing costs related to long-term operating lease obligations, which the Company exited. The recorded value of the lease obligation was based on the remaining lease term and payment amount, discounted to present value. Changes in subsequent periods resulting from a revision to either the timing or the amount of estimated cash flows over the future period were measured using the credit adjusted, risk free rate that was used to measure the restructuring liabilities initially. Please also refer to Note 6, “Leases”.

The following is a reconciliation of the beginning and ending balances of our restructuring liability as it relates to the restructuring plans (in thousands):

	2021		2020
Balance at December 31, 2020 and 2019	$	11	$	38
Accretion of lease obligations	—		2
Payments	(11)		(22)
Balance at September 30, 2021 and 2020	$	—	$	18

The following is a reconciliation of the ending balance of our restructuring liability at September 30, 2021 to the balance sheet:

	2021		2020
Balance at September 30, 2021 and 2020	$	—	$	18
Less, short-term restructuring liability	—		18
Long-term restructuring liability, included in other liabilities	$	—	$	—

As a result of the restructuring actions and initiatives described above, we have reduced our operating expenses to be more commensurate with our sales volumes. However, we continue to incur losses and have a substantial accumulated deficit, and substantial doubt about our ability to continue as a going concern continues to exist at September 30, 2021.

Throughout 2020 and the first nine months of 2021, we have continued to evaluate and assess strategic options as we seek to achieve profitability. We plan to continue to develop advanced lighting and lighting control technologies and introduce impactful new products surrounding EnFocusTM, a patented, breakthrough lighting control platform we officially launched during the second quarter of 2020, and our SuncycleTM circadian lighting system, which we plan to launch in early 2022. Additionally, during the last quarter of 2020, we announced newly developed UVCD products for consumer as well as commercial and industrial markets, of which two products are expected to be available in the fourth quarter of 2021, and two products are expected to be available in early 2022.

We plan to achieve profitability by growing our sales, through existing lighting, new lighting control systems and UVCD products, and by continuing to refine and execute on our multi-channel sales strategy that targets key verticals, such as government, healthcare, education, and commercial and industrial, complemented by our marketing outreach campaigns and expanding channel partnerships, as well as our emerging consumer market focus.

As described in Note 9, “Stockholders’ Equity,” we also raised approximately $4.5 million of net proceeds upon the issuance of common stock in connection with the June 2021 Equity Offering and we raised approximately $2.3 million of net proceeds upon the issuance of common stock and warrants from the January 2020 Equity Offering. As described in Note 7, “Debt”, in April 2021, we obtained approximately $1.5 million of bridge financing and in August 2020, we entered into

two new revolving credit facilities, which allow for expanded borrowing capacity, which capacity was further increased by an April 20, 2021 amendment to one of the facilities.

The restructuring and cost cutting initiatives implemented during 2020 and continued into 2021, as well as the June 2021 Equity Offering and January 2020 Equity Offering that significantly strengthened our balance sheet, the Paycheck Protection Program (“PPP”) loan we obtained in April 2020, our enhanced debt capacity due to the debt refinancing in August 2020, the credit facility capacity increase and bridge financing in April 2021, and the funds we expect to receive related to the Employee Retention Tax Credit (“ERTC”, see Note 11, “Other Income” for details), were all designed to allow us to effectively execute these strategies. However, our efforts may not occur as quickly as we envision or be successful due to the long sales cycle in our industry, the corresponding time required to ramp up sales from new products, markets, and customers into this sales cycle, the timing of introductions of additional new products, significant competition, potential sales volatility given our customer concentration, interruptions and cost increases in the global supply chain, and the ongoing and lingering economic impact from the COVID-19 pandemic that had significantly diminished the interest and activities for our customers’ lighting retrofit projects until occupancy returns to more normal levels, among other factors. Additionally, global supply chain challenges are impacting our inventory purchasing strategy, leading to a buildup of inventory and components in an effort to manage both shortages of available components and longer lead times in obtaining components. Disruptions and cost increases in global logistics networks are also impacting our lead times and ability to efficiently and cost-effectively transport products from our third-party suppliers to our facility. As a result, we will continue to review and pursue selected external funding sources to ensure adequate financial resources to execute across the timelines required to achieve these objectives including, but not limited to, the following:

•obtaining financing from traditional or non-traditional investment capital organizations or individuals;

•obtaining funding from the sale of our common stock or other equity or debt instruments; and

•obtaining debt financing with lending terms that more closely match our business model and capital needs.

There can be no assurance that we will obtain funding on acceptable terms, in a timely fashion, or at all. Obtaining additional funding contains risks, including:

•additional equity financing may not be available to us on satisfactory terms, and any equity we are able to issue could lead to dilution for current stockholders and have rights, preferences and privileges senior to our common stock;

•loans or other debt instruments may have terms and/or conditions, such as interest rate, restrictive covenants, conversion features, refinancing demands, and control or revocation provisions, which are not acceptable to management or our board of directors; and

•the current environment in the capital markets combined with our capital constraints may prevent us from being able to obtain adequate debt financing.

If we fail to obtain the required additional financing to sustain our business before we are able to produce levels of revenue to meet our financial needs, we will need to delay, scale back or eliminate our growth plans and further reduce our operating costs and headcount, each of which would have a material adverse effect on our business, future prospects, and financial condition. A lack of additional funding could also result in our inability to continue as a going concern and force us to sell certain assets or discontinue or curtail our operations and, as a result, investors in the Company could lose their entire investment.

Considering both quantitative and qualitative information, we continue to believe that the combination of our plans to obtain additional external funding, timely re-organizational actions, current financial position, liquid resources, obligations due or anticipated within the next year, development and implementation of an excess inventory reduction plan, plans and initiatives in our research and development, product development and sales and marketing, and development of potential channel partnerships, if adequately executed, will provide us with an ability to finance our operations through the next twelve months and will mitigate the substantial doubt about our ability to continue as a going concern.

On August 17, 2020, we received a letter from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying us that we were no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders’ equity of at least $2,500,000 if they do not meet the alternative compliance standards relating to the market value of listed securities or net income from continuing operations (the “Minimum Stockholders’ Equity Rule”). Our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020, filed on August 13, 2020, reflected that our stockholders’ equity as of June 30, 2020 was $1,714,000. In addition, as of August 13, 2020, we did not meet the alternative compliance standards relating to the market value of listed securities or net income from continuing operations. On October 5, 2020, based on our timely submission of our plan to regain compliance, Nasdaq granted us an

extension through February 15, 2021, to regain compliance with the Minimum Stockholders’ Equity Rule, subject to our compliance with certain terms of the extension. In accordance with one part of the plan submitted to the Staff, we have successfully modified our outstanding warrants and are able to now classify the warrants within equity. At December 31, 2020, our stockholders’ equity was $4,255,000. On January 20, 2021, we received a letter from the Staff notifying us that, on a conditional basis, Nasdaq has determined that we have regained compliance with the Minimum Stockholders’ Equity Rule. At September 30, 2021, our stockholders’ equity was $4,502,000.

XML

Inventories

9 Months Ended

Sep. 30, 2021

Inventory Disclosure [Abstract]

Inventories

INVENTORIES

Inventories are stated at the lower of standard cost (which approximates actual cost determined using the first-in, first-out cost method) or net realizable value, and consist of the following (in thousands):

	September 30, 2021		December 31, 2020
Raw materials	$	4,232	$	2,695
Finished goods	6,409		5,840
Reserves for excess, obsolete, and slow-moving inventories	(2,886)		(2,894)
Inventories, net	$	7,755	$	5,641

The following is a roll-forward of the reserves for excess, obsolete, and slow-moving inventories (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Beginning balance	$	(2,956)	$	(3,326)	$	(2,894)	$	(3,645)
Accrual	34		(187)		(64)		(75)
Reduction due to sold inventory	36		121		72		288
Write-off for disposed inventory	—		(23)		—		17
Reserves for excess, obsolete, and slow-moving inventories	$	(2,886)	$	(3,415)	$	(2,886)	$	(3,415)

XML

Property and Equipment

9 Months Ended

Sep. 30, 2021

Property, Plant and Equipment [Abstract]

Property and Equipment

PROPERTY AND EQUIPMENT

Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the related assets and consist of the following (in thousands):

	September 30, 2021		December 31, 2020
Equipment (useful life 3 to 15 years)	$	1,308	$	1,281
Tooling (useful life 2 to 5 years)	324		240
Vehicles (useful life 5 years)	83		47
Furniture and fixtures (useful life 5 years)	86		137
Computer software (useful life 3 years)	1,189		1,057
Leasehold improvements (the shorter of useful life or lease life)	169		169
Finance lease right-of-use asset	13		13
UV - Robots (useful life 5 years)	105		—
Projects in progress	68		140
Property and equipment at cost	3,345		3,084
Less: accumulated depreciation	(2,757)		(2,664)
Property and equipment, net	$	588	$	420

Depreciation expense was $43 thousand and $48 thousand for the three months ended September 30, 2021 and 2020, respectively. For the nine months ended September 30, 2021 and 2020, depreciation expense was $143 thousand and $140 thousand, respectively.

XML

Leases

9 Months Ended

Sep. 30, 2021

Leases [Abstract]

Leases

LEASES

The Company leases certain equipment, manufacturing, warehouse and office space under non-cancellable operating leases with expirations through 2026 under which it is responsible for related maintenance, taxes and insurance. The Company has one finance lease containing a bargain purchase option upon expiration of the lease in 2022. The lease term consists of the non-cancellable period of the lease, periods covered by options to extend the lease if the Company is reasonably certain to exercise the option, and periods covered by an option to terminate the lease if the Company is reasonably certain not to exercise the option. As of January 21, 2021, the terms of one of these equipment operating leases has been extended through 2026. In accordance with Accounting Standard Codification 842, Leases (“Topic 842”), the related right-of-use asset and lease liability was updated at the time of modification in January 2021. The present value of the lease obligation for this lease was calculated using an incremental borrowing rate of 15.93%, which was the Company’s blended borrowing rate (including interest, annual facility fees, collateral management fees, bank fees and other miscellaneous lender fees) on its revolving lines of credit with Crossroads Financial Group, LLC (as described below in Note 7, “Debt”) and Factors Southwest L.L.C. (as described below in Note 7, “Debt”). The present value of the remaining lease obligation was calculated using an incremental borrowing rate of 7.25% (which excludes the annual facility fee and other lender fees), which was the Company’s borrowing rate on its former revolving line of credit with Austin Financial Services, Inc. (the “Austin Credit Facility”). The weighted average remaining lease term for operating and finance leases is 1.4 years and 0.6 years, respectively.

The Company had one restructured lease with a sub-lease component for the New York, New York office that was closed in 2017. The lease expired in June 2021. As part of the lease agreement, there was $0.3 million in restricted cash in other current assets on the accompanying Condensed Consolidated Balance Sheets as of December 31, 2020, which represented collateral against the related letter of credit issued as part of this agreement. Per the terms of the lease agreement, the restrictions on the cash were lifted in September 2021 and the cash was returned to the Company.

The restructured lease and sub-lease were deemed to be in-scope and thus subject to the requirements of Topic 842 and were evaluated for impairment in accordance with the asset impairment provisions of Accounting Standard Codification 360, Property, Plant and Equipment (“Topic 360”). The Company concluded its net right-of-use assets were not impaired and the carrying amount approximates expected sub-lease income in future years as of December 31, 2020. The Company continued to carry certain immaterial operating expenses associated with this lease as restructuring liabilities and continued to accrete those liabilities in accordance with Accounting Standard Codification 420, Exit or Disposal Cost Obligations (“Topic 420”),

as has been done since the cease use date in 2017. For additional information regarding treatment of leases please refer to Note 4, “Leases,” included under Item 8, “Financial Statements and Supplementary Data,” of our 2020 Annual Report.

There were no finance lease costs recognized in net loss for the three and nine months ended September 30, 2021 and 2020. Components of the operating and restructured lease costs recognized in net loss for the three and nine months ended September 30, 2021 and 2020, were as follows (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Operating lease cost (income)
Sub-lease income	$	(25)	$	(26)	$	(87)	$	(80)
Lease cost	139		148		423		451
Operating lease cost, net	114		122		336		371
Restructured lease cost (income)
Sub-lease income	—		(68)		(136)		(204)
Lease cost	—		59		109		180
Restructured lease income, net	—		(9)		(27)		(24)
Total lease cost, net	$	114	$	113	$	309	$	347

Supplemental balance sheet information related to the Company’s operating and finance leases as of September 30, 2021 and December 31, 2020 are as follows (in thousands):

	September 30, 2021		December 31, 2020
Operating Leases
Operating lease right-of-use assets	$	419	$	794
Restructured lease right-of-use assets	—		107
Operating lease right-of-use assets, total	419		901
Operating lease liabilities	505		916
Restructured lease liabilities	—		168
Operating lease liabilities, total	505		1,084
Finance Leases
Property and equipment	13		13
Allowances for depreciation	(11)		(9)
Finance lease assets, net	2		4
Finance lease liabilities	1		4
Total finance lease liabilities	$	1	$	4

Future minimum lease payments required under operating and finance leases for each of the 12-month rolling periods below in effect at September 30, 2021 are as follows (in thousands):

	Operating Leases		Finance Lease
October 2021 to September 2022	$	488	$	1
October 2022 to September 2023	19		—
October 2023 to September 2024	8		—
October 2024 to September 2025	3		—
October 2025 to September 2026	2		—
Total future undiscounted lease payments	520		1
Less imputed interest	(15)		—
Total lease obligations	$	505	$	1

Supplemental cash flow information related to leases for the three and nine months ended September 30, 2021 and 2020, was as follows (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Supplemental cash flow information
Cash paid, net, for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	161	$	134	$	421	$	401
Operating cash flows from restructured leases	$	—	$	17	$	35	$	52
Financing cash flows from finance leases	$	1	$	1	$	3	$	3

Leases

LEASES

The Company leases certain equipment, manufacturing, warehouse and office space under non-cancellable operating leases with expirations through 2026 under which it is responsible for related maintenance, taxes and insurance. The Company has one finance lease containing a bargain purchase option upon expiration of the lease in 2022. The lease term consists of the non-cancellable period of the lease, periods covered by options to extend the lease if the Company is reasonably certain to exercise the option, and periods covered by an option to terminate the lease if the Company is reasonably certain not to exercise the option. As of January 21, 2021, the terms of one of these equipment operating leases has been extended through 2026. In accordance with Accounting Standard Codification 842, Leases (“Topic 842”), the related right-of-use asset and lease liability was updated at the time of modification in January 2021. The present value of the lease obligation for this lease was calculated using an incremental borrowing rate of 15.93%, which was the Company’s blended borrowing rate (including interest, annual facility fees, collateral management fees, bank fees and other miscellaneous lender fees) on its revolving lines of credit with Crossroads Financial Group, LLC (as described below in Note 7, “Debt”) and Factors Southwest L.L.C. (as described below in Note 7, “Debt”). The present value of the remaining lease obligation was calculated using an incremental borrowing rate of 7.25% (which excludes the annual facility fee and other lender fees), which was the Company’s borrowing rate on its former revolving line of credit with Austin Financial Services, Inc. (the “Austin Credit Facility”). The weighted average remaining lease term for operating and finance leases is 1.4 years and 0.6 years, respectively.

The Company had one restructured lease with a sub-lease component for the New York, New York office that was closed in 2017. The lease expired in June 2021. As part of the lease agreement, there was $0.3 million in restricted cash in other current assets on the accompanying Condensed Consolidated Balance Sheets as of December 31, 2020, which represented collateral against the related letter of credit issued as part of this agreement. Per the terms of the lease agreement, the restrictions on the cash were lifted in September 2021 and the cash was returned to the Company.

The restructured lease and sub-lease were deemed to be in-scope and thus subject to the requirements of Topic 842 and were evaluated for impairment in accordance with the asset impairment provisions of Accounting Standard Codification 360, Property, Plant and Equipment (“Topic 360”). The Company concluded its net right-of-use assets were not impaired and the carrying amount approximates expected sub-lease income in future years as of December 31, 2020. The Company continued to carry certain immaterial operating expenses associated with this lease as restructuring liabilities and continued to accrete those liabilities in accordance with Accounting Standard Codification 420, Exit or Disposal Cost Obligations (“Topic 420”),

as has been done since the cease use date in 2017. For additional information regarding treatment of leases please refer to Note 4, “Leases,” included under Item 8, “Financial Statements and Supplementary Data,” of our 2020 Annual Report.

There were no finance lease costs recognized in net loss for the three and nine months ended September 30, 2021 and 2020. Components of the operating and restructured lease costs recognized in net loss for the three and nine months ended September 30, 2021 and 2020, were as follows (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Operating lease cost (income)
Sub-lease income	$	(25)	$	(26)	$	(87)	$	(80)
Lease cost	139		148		423		451
Operating lease cost, net	114		122		336		371
Restructured lease cost (income)
Sub-lease income	—		(68)		(136)		(204)
Lease cost	—		59		109		180
Restructured lease income, net	—		(9)		(27)		(24)
Total lease cost, net	$	114	$	113	$	309	$	347

Supplemental balance sheet information related to the Company’s operating and finance leases as of September 30, 2021 and December 31, 2020 are as follows (in thousands):

	September 30, 2021		December 31, 2020
Operating Leases
Operating lease right-of-use assets	$	419	$	794
Restructured lease right-of-use assets	—		107
Operating lease right-of-use assets, total	419		901
Operating lease liabilities	505		916
Restructured lease liabilities	—		168
Operating lease liabilities, total	505		1,084
Finance Leases
Property and equipment	13		13
Allowances for depreciation	(11)		(9)
Finance lease assets, net	2		4
Finance lease liabilities	1		4
Total finance lease liabilities	$	1	$	4

Future minimum lease payments required under operating and finance leases for each of the 12-month rolling periods below in effect at September 30, 2021 are as follows (in thousands):

	Operating Leases		Finance Lease
October 2021 to September 2022	$	488	$	1
October 2022 to September 2023	19		—
October 2023 to September 2024	8		—
October 2024 to September 2025	3		—
October 2025 to September 2026	2		—
Total future undiscounted lease payments	520		1
Less imputed interest	(15)		—
Total lease obligations	$	505	$	1

Supplemental cash flow information related to leases for the three and nine months ended September 30, 2021 and 2020, was as follows (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Supplemental cash flow information
Cash paid, net, for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	161	$	134	$	421	$	401
Operating cash flows from restructured leases	$	—	$	17	$	35	$	52
Financing cash flows from finance leases	$	1	$	1	$	3	$	3

XML

Debt

9 Months Ended

Sep. 30, 2021

Debt Disclosure [Abstract]

Debt

DEBT

Credit facilities

On August 11, 2020, we entered into two debt financing arrangements (together, the “Credit Facilities”) that allow for expanded borrowing capacity at a lower blended borrowing cost. The first arrangement is an inventory financing facility (the “Inventory Facility”) pursuant to the Loan and Security Agreement (the “Inventory Loan Agreement”) between the Company and Crossroads Financial Group, LLC, a North Carolina limited liability company (the “IF Lender”). Borrowings under the original Inventory Facility were permitted up to the lower of (i) $3.0 million, which amount was subsequently increased to $3.5 million as described below, and (ii) a borrowing base determined from time to time based on the value of the Company’s eligible inventory, valued at 75% of inventory costs or 85% of the inventory net orderly liquidation value, less the availability reserves. On April 20, 2021, the Company and the IF Lender entered into an amendment to the Inventory Loan Agreement to increase the maximum amount that may be available to the Company from $3.0 million to $3.5 million, subject to the borrowing base as set forth in the Inventory Loan Agreement. The outstanding indebtedness under the Inventory Facility accrues at an annual rate equal to the greater of (i) 5.75% and (ii) 4.00% plus the three (3) month LIBOR rate and is also subject to a service fee of 1% per month. The annualized interest rate at September 30, 2021 and December 31, 2020, which includes interest fees, the annual facility fee, bank fees and other miscellaneous lender fees, was 22.4% and 23.6%, respectively. The Inventory Facility’s interest and service fees combined amount is subject to a minimum monthly fee of $18 thousand. There would be no breakage fee for the Company for the Inventory Facility if the Company were to refinance it with an American Bankers Association (“ABA”) equivalent institution after August 11, 2021. The Inventory Facility is secured by substantially all of the present and future assets of the Company and is also governed by an intercreditor agreement among the Company, the IF Lender and the RF Lender (defined below). The Inventory Facility matures on August 11, 2022, subject to early termination upon 90 days’ notice and otherwise in accordance with the terms of the Inventory Loan Agreement. The term is automatically extended in successive one (1) year increments unless terminated by either party in accordance with the Inventory Loan Agreement. On April 20, 2021, the Company and the IF lender entered into an amendment to the Inventory Loan Agreement to increase the maximum amount that may be available to the Company from $3.0 million previously to $3.5 million, subject to the borrowing base as set forth in the Inventory Loan Agreement.

The second arrangement is a receivables financing facility (the “Receivables Facility”) pursuant to the Loan and Security Agreement (the “Receivables Loan Agreement”) between the Company and Factors Southwest L.L.C. (d/b/a FSW Funding), an Arizona limited liability company (the “RF Lender”). Borrowings under the Receivables Facility are permitted up to the lower of (i) $2.5 million or (ii) a borrowing base determined from time to time based on the value of the Company’s eligible accounts receivable, valued at 90% of the face value of such accounts receivable, less availability reserves, if any. Interest on outstanding indebtedness under the Receivables Facility accrues at an annual rate equal to (i) the highest prime rate announced from time to time by the Wall Street Journal plus (ii) 2%. At September 30, 2021 and December 31, 2020, the annualized interest rate, which includes interest fees and the annual facility fee, was 8.0% and 7.9%, respectively. The annualized interest rate on the collateral management fee was 6% at both September 30, 2021 and December 31, 2020. The Receivables Facility is also secured by substantially all of the present and future assets of the Borrower and is also governed by an intercreditor agreement among the Company, the IF Lender and the RF Lender. A $25 thousand, or 1%, facility fee was charged at closing. There would be no breakage fee for the Company for the Receivables Facility if the Company were to refinance it with an ABA equivalent institution. The Receivables Facility matures on August 11, 2022, subject to early termination in accordance with the terms of the Receivables Loan Agreement, provided that the term is automatically extended in successive one (1) year increments unless terminated by either party in accordance with the Receivables Loan Agreement.

Borrowings under the Inventory Facility were $1.4 million and $1.3 million at September 30, 2021 and December 31, 2020, respectively. Borrowings under the Receivables Facility were $1.3 million and $1.0 million at September 30, 2021 and December 31, 2020, respectively. These facilities are recorded in the Condensed Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020 as a current liability under the caption “Credit line borrowings.” Outstanding balances include unamortized net issuance costs totaling $0.1 million for the Inventory Facility and $14 thousand for the Receivables Facility as of September 30, 2021, and $0.1 million for the Inventory Facility and $40 thousand for the Receivables Facility as of December 31, 2020.

The Credit Facilities replaced the Austin Credit Facility that was entered into on December 11, 2018, and was secured by a lien on our assets. The Austin Credit Facility was a three year, $5.0 million revolving line of credit. Interest on advances under the line was due monthly at the “Prime Rate,” as published by the Wall Street Journal from time to time, plus a

margin of 2%. Additionally, an annual facility fee of 1% on the entire $5.0 million amount of the Austin Credit Facility was due at the beginning of each of the three years that the Austin Credit Facility was outstanding and a 0.5% collateral management fee on the average outstanding loan balance was payable monthly. On August 11, 2020, we paid $1.4 million to close the Austin Credit Facility, which included a $100 thousand termination fee. Additionally, we wrote off $59 thousand of the remaining related debt acquisition costs. For additional information regarding the Austin Credit Facility, please refer to Note 9, “Debt,” included under Item 8, “Financial Statements and Supplementary Data,” of our 2020 Annual Report.

For additional information regarding the Credit Facilities, please refer to Part II, Item 5, “Other Information,” included in our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020, filed on August 13, 2020.

Streeterville Note

On April 27, 2021, we entered into a note purchase agreement with Streeterville Capital, LLC (“Streeterville”) pursuant to which we sold and issued to Streeterville a promissory note in the principal amount of approximately $1.7 million (the “Streeterville Note”). The Streeterville Note was issued with an original issue discount of $194 thousand and Streeterville paid a purchase price of $1.5 million for the Streeterville Note, after deduction of $15 thousand of Streeterville’s transaction expenses.

The Streeterville Note has a maturity date of April 27, 2023, and accrues interest at 8% per annum, compounded daily, on the outstanding balance. The Company may prepay the amounts outstanding under the Streeterville Note at a premium, which is 5% during the first three months and 10% thereafter. Prepayments at the reduced rate in the first three months are limited to 50% of the outstanding balance. Beginning on November 1, 2021, Streeterville may require the Company to redeem up to $205 thousand of the Streeterville Note in any calendar month. The Company has the right on three occasions to defer all redemptions that Streeterville could otherwise require the Company to make during any calendar month. Each exercise of this deferral right by the Company will increase the amount outstanding under the Streeterville Note by 1.5%.

The total liability for the Streeterville Note, net of discount and financing fees, was $1.6 million at September 30, 2021. Unamortized loan discount and debt issuance costs were $0.1 million at September 30, 2021.

In the event our common stock is delisted from Nasdaq, the amount outstanding under the Streeterville Note will automatically increase by 15% as of the date of such delisting.

PPP Loan

On April 17, 2020, the Company was granted a loan from KeyBank National Association (“KeyBank”) in the amount of approximately $795 thousand, pursuant to the PPP under Division A of the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”), which was enacted on March 27, 2020. The funds were received on April 20, 2020 and accrued interest at a rate of 1% per annum. At December 31, 2020, $529 thousand was classified as short-term debt and $266 thousand was classified as long-term debt on the Company’s Consolidated Balance Sheet. Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses as described in the CARES Act. The entire principal balance and interest were forgiven by the Small Business Administration (“SBA”) on February 11, 2021. The $801 thousand forgiveness income was recorded as other income in the Consolidated Statements of Operations during the nine months ended September 30, 2021.

Iliad Note

On November 25, 2019, we entered into a note purchase agreement (the “Iliad Note Purchase Agreement”) with Iliad Research and Trading, L.P. (“Iliad”) pursuant to which the Company sold and issued to Iliad a promissory note in the principal amount of $1.3 million (the “Iliad Note”). The Iliad Note was issued with an original issue discount of $142 thousand and Iliad paid a purchase price of $1.1 million for the issuance of the Iliad Note, after deduction of $15 thousand of Iliad’s transaction expenses.

In December 2020, we repaid the outstanding balance on the Iliad Note in full prior to its maturity date of November 24, 2021. Remaining debt and original issue discount costs of $117 thousand were written off at that time. The Iliad Note accrued interest at 8% per annum, compounded daily, on the outstanding balance.

Pursuant to the Iliad Note Purchase Agreement and the Iliad Note, we had, among other things, agreed that, until the Iliad Note was repaid, 10% of gross proceeds the Company received from the sale of our common stock or other equity must be paid to Iliad and applied to reduce the outstanding balance of the Iliad Note. In accordance with the terms of the Iliad Note, 10% of the gross proceeds from the January 2020 Equity Offering ($275 thousand) were used to make payments on the Iliad Note, of which $226 thousand went towards the outstanding principal amount.

The total liability for the Iliad Note, excluding financing fees, was $0.2 million at September 30, 2020. Unamortized loan discount and debt issuance costs were $0.1 million at September 30, 2020.

Convertible Notes 

On March 29, 2019, we issued $1.7 million aggregate principal amount of subordinated convertible promissory notes (the “Convertible Notes”) to certain investors in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended. The Convertible Notes bore interest at a rate of 5% per annum until June 30, 2019 and at a rate of 10% thereafter. Pursuant to their terms, on January 16, 2020, following approval by our stockholders of certain amendments to the Certificate of Incorporation, the principal amount of all of the Convertible Notes and the accumulated interest thereon ($0.1 million), which totaled $1.8 million, were converted at a conversion price of $0.67 per share into an aggregate of 2,709,018 shares of the Company’s Series A Convertible Preferred Stock, par value 0.0001 per share (“Series A Preferred Stock”), which is convertible on a one-for-five basis into shares of our common stock. During the year ended December 31, 2020, 111,548 shares of the Series A Preferred Stock were converted into 22,310 shares of common stock. On April 1, 2021, 1,721,023 shares of Series A Preferred Stock were converted into 344,205 shares of common stock.

The purchase agreement related to the Convertible Notes contains customary representations and warranties and provides for resale registration rights with respect to the shares of our common stock issuable upon conversion of the Series A Preferred Stock. Please also refer to Note 9, “Stockholders’ Equity”

XML

Income Taxes

9 Months Ended

Sep. 30, 2021

Income Tax Disclosure [Abstract]

Income Taxes

INCOME TAXES

As a result of the operating loss incurred during each of the three and nine months ended September 30, 2021 and 2020, and after the application of the annual limitation set forth under Section 382 of the Internal Revenue Code of 1986, as amended (the “IRC”), it was not necessary to record a provision for U.S. federal income tax.

At September 30, 2021 and December 31, 2020, we had a full valuation allowance recorded against our deferred tax assets.

The valuation allowance was recorded due to uncertainties related to our ability to realize the deferred tax assets, primarily consisting of certain net operating loss carry-forwards. The valuation allowance is based on management’s estimates of taxable income by jurisdiction and the periods over which the deferred tax assets will be recoverable.

At December 31, 2020, we had a net operating loss carry-forward of approximately $115.9 million for federal income tax purposes ($72.3 million for state and local income tax purposes). However, due to changes in our capital structure, approximately $61.5 million of the $115.9 million is available after the application of IRC Section 382 limitations. As a result of the Tax Cuts and Jobs Act of 2017 (the “Tax Act”), net operating loss carry-forwards generated in tax years beginning after December 31, 2017 can only offset 80% of taxable income and can be carried forward indefinitely. The $7.1 million and $8.3 million in net operating losses generated in 2020 and 2019, respectively, will be subject to the new limitations under the Tax Act. If not utilized, the carry-forwards generated prior to December 31, 2017 of $37.3 million will begin to expire in 2021 for federal purposes and have begun to expire for state and local purposes. For a full discussion of the estimated restrictions on our utilization of net operating loss carry-forwards, please refer to Note 12, “Income Taxes,” included under Item 8, “Financial Statements and Supplementary Data,” of our 2020 Annual Report.

XML

Stockholders' Equity

9 Months Ended

Sep. 30, 2021

Stockholders' Equity Note [Abstract]

Stockholders' Equity

STOCKHOLDERS’ EQUITY

June 2021 Equity Offering

In June 2021, we completed a registered direct offering of 990,100 shares of our common stock to certain institutional investors, at a purchase price of $5.05 per share. We paid the placement agent commissions of $400 thousand, plus $51 thousand in expenses, in connection with the June 2021 Equity Offering and we also paid legal and other fees of $19 thousand related to the offering. Total offering costs of $470 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of September 30, 2021. Net proceeds to us from the June 2021 Equity Offering were approximately $4.5 million.

Preferred Stock

Pursuant to the terms of the Convertible Notes, on January 16, 2020, following approval by our stockholders of certain amendments to the Certificate of Incorporation, the principal amount of all of the Convertible Notes and the accumulated interest thereon at the date of conversion (totaling $1.8 million) were converted at a conversion price of $0.67 per share into an aggregate of 2,709,018 shares of the Company’s Series A Preferred Stock, which is convertible on a one-for-five basis into shares of our common stock. During the year ended December 31, 2020, 111,548 shares of the Series A Preferred Stock were converted into 22,310 shares of common stock. On April 1, 2021, 1,721,023 shares of Series A Preferred Stock were converted into 344,205 shares of common stock. The Series A Preferred Stock that was converted in 2021 was held by a Schedule 13D ownership group (under Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, and Rule 13d-5 promulgated thereunder) that includes Fusion Park LLC (“Fusion Park”) and 5 Elements Global Fund L.P. (controlled affiliates of James Tu, the Company's Executive Chairman and Chief Executive Officer), as well as Brilliant Start Enterprise Inc. (“Brilliant Start”) and Jag International Ltd. (controlled affiliates of Gina Huang, a member of the Company's board of directors). Upon conversion of their respective shares of Series A Preferred Stock, Fusion Park and Brilliant Start received 184,851 and 159,354 shares, respectively, of the Company’s common stock.

The Series A Preferred Stock was created by the filing of a Certificate of Designation with the Secretary of State of the State of Delaware on March 29, 2019, which designated 2,000,000 shares of the Company’s preferred stock, par value $0.0001 per share, as Series A Preferred Stock (the “Original Series A Certificate of Designation”). On January 15, 2020 with prior stockholder approval, the Company amended the Certificate of Incorporation to increase the number of authorized shares of preferred stock to 5,000,000. The Original Series A Certificate of Designation was also amended on January 15, 2020, to increase the number of shares of preferred stock designated as Series A Preferred Stock to 3,300,000 (the Original Series A Certificate of Designation, as so amended, the “Series A Certificate of Designation”).

Pursuant to the Series A Certificate of Designation, each holder of outstanding shares of Series A Preferred Stock is entitled to vote with holders of outstanding shares of common stock, voting together as a single class, with respect to any and all matters presented to the stockholders of the Company for their action or consideration, except as provided by law. In any such vote, each share of Series A Preferred Stock shall entitle its holder to a number of votes equal to 11.07% of the number of shares of common stock into which such share of Series A Preferred Stock is convertible.

The Series A Preferred Stock (a) has a preference upon liquidation equal to $0.67 per share and then participates on an as-converted basis with the common stock with respect to any additional distributions, (b) shall receive any dividends declared and payable on our common stock on an as-converted basis, and (c) is convertible at the option of the holder into shares of our common stock on a one-for-five basis. On March 29, 2019, the Company also filed a Certificate of Elimination with respect to its authorized, but unissued, Series A Participating Preferred Stock, to return such shares to the status of undesignated preferred stock available for designation as Series A Preferred Stock.

The purchase agreement related to the Convertible Notes contains customary representations and warranties and provides for resale registration rights with respect to the shares of our common stock issuable upon conversion of the Series A Preferred Stock.

1-for-5 Reverse Stock Split

On June 11, 2020, in accordance with previous stockholder approval, our board of directors effected a 1-for-5 reverse stock split of the Company’s common stock, par value $0.0001 per share. The reverse stock split became effective at the Effective Time upon the filing of the Certificate of Amendment to the Certificate of Incorporation with the Delaware Secretary of State. At the Effective Time, every five shares of common stock issued and outstanding automatically combined into one validly issued, fully paid and non-assessable share of common stock. No fractional shares were issued as a result of the reverse stock split. The fractional shares were settled in cash in an amount not material to the Company. The $0.0001 par value per share of common stock and other terms of the common stock were not affected by the reverse stock split. The number of authorized shares of common stock under the Certificate of Incorporation remained unchanged at 50,000,000 shares.

Proportional adjustments were made to the conversion and exercise prices of our outstanding warrants and stock options, and to the number of shares issued and issuable under our stock incentive plans in connection with the reverse stock split. The financial statements for the nine months ended September 30, 2020 have been retroactively adjusted to reflect the reverse stock split. Preferred shares outstanding were not affected by the reverse stock split and, as such, those shares have not been adjusted.

The reverse stock split was effected solely to increase the per share trading price of the common stock to satisfy the $1.00 minimum bid price requirement pursuant to Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq. The common stock began trading on Nasdaq on a split-adjusted basis at the opening of trading on June 12, 2020.

January 2020 Equity Offering

Issuance of Common Stock and Warrants

In January 2020, we completed a registered direct offering of 688,360 shares of our common stock to certain institutional investors, at a purchase price of $3.37 per share. We also sold, to the same institutional investors, warrants to purchase up to 688,360 shares of common stock at an exercise price of $3.37 per share in a concurrent private placement for a purchase price of $0.625 per warrant. We paid the placement agent commissions of $193 thousand, plus $50 thousand in expenses, in connection with the registered direct offering and the concurrent private placement and we also paid legal, accounting and other fees of $231 thousand related to the offering. Total offering costs of $510 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of December 31, 2020. In addition, we issued warrants to the placement agent to purchase up to 48,185 shares of common stock at an exercise price of $4.99 per share. Net proceeds to us from the sale of common stock and warrants were approximately $2.3 million. In accordance with the terms of the Iliad Note (as defined above in Note 7, “Debt”), 10% of the gross proceeds from the January 2020 Equity Offering ($275 thousand) were used to make payments on the Iliad Note, of which $226 thousand went towards the outstanding principal amount and the balance to interest.

Warrants to purchase an aggregate of 310,860 shares remain outstanding at September 30, 2021 with a weighted average exercise price of $3.59 per share. The exercise of warrants could provide us with cash proceeds of up to $1.1 million in the aggregate if all warrants are exercised. During the nine months ended September 30, 2021, 156,446 warrants were exercised resulting in total proceeds of $527 thousand.

As of September 30, 2021, we had the following outstanding warrants to purchase shares of common stock:

	Number of Underlying Shares	Exercise Price	Expiration
Investor Warrants	269,180	$3.3700	January 13, 2025
Placement Agent Warrants	41,680	$4.9940	January 13, 2025
	310,860

As of September 30, 2020, we had the following outstanding warrants to purchase shares of common stock:

	Number of Underlying Shares	Exercise Price	Expiration
Investor Warrants	497,472	$3.3700	January 13, 2025
Placement Agent Warrants	41,680	$4.9940	January 13, 2025
	539,152

Warrant Classification

We account for common stock warrants as either liabilities or equity instruments depending on the specific terms of the warrant agreement. Common stock warrants that could require cash settlement are accounted for as liabilities and are revalued at fair value at each balance sheet date subsequent to the initial issuance. Changes in the fair market value of the warrant are reflected in the consolidated statement of operations as income (expense) based upon the change in fair value of warrants. Common stock warrants without cash settlement provisions are accounted for as equity and re-measurement at each balance sheet date is not required.

The warrants we issued in the January 2020 Equity Offering contained a provision for net cash settlement in the event that there is a fundamental transaction involving the Company (e.g., merger, sale of substantially all assets, tender offer, or share exchange). Due to this provision, the warrants were initially classified as liabilities, as opposed to equity, and were recorded at their fair values at each balance sheet date with fair value adjustments recognized as a component of earnings. During December 2020, the warrant holders agreed to a modification of the terms of their warrants which removed the potential cash settlement option upon the occurrence of a fundamental transaction. As such, during the fourth quarter of 2020, the warrant liability was reclassified into equity and the warrants are no longer subject to re-measurement at each balance sheet date.

Stock-based compensation

Stock-based compensation expense is attributable to stock options and restricted stock unit awards. For all stock-based awards, we recognize expense using a straight-line amortization method.

The following table summarizes stock-based compensation expense and the impact it had on operations for the periods presented (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Cost of sales	$	2	$	1	$	7	$	2
Product development	2		3		10		5
Selling, general, and administrative	35		31		370		89
Total stock-based compensation	$	39	$	35	$	387	$	96

Total unearned stock-based compensation was $0.3 million at September 30, 2021, compared to $0.2 million at September 30, 2020. These costs will be charged to expense and amortized on a straight-line basis in future periods. The weighted average period over which the unearned compensation at September 30, 2021 is expected to be recognized is approximately 2.9 years.

Stock options

The fair value of each stock option is estimated on the date of grant using the Black-Scholes option pricing model. Estimates utilized in the calculation include the expected life of the option, risk-free interest rate, and expected volatility, and are further detailed below.

	Nine months ended September 30,
	2021			2020
Fair value of options issued	$	4.18		$	2.00
Exercise price	$	5.39		$	2.61
Expected life of options (in years)	6.2			6.2
Risk-free interest rate	0.8		%	0.7		%
Expected volatility	96.5		%	93.5		%
Dividend yield	0.0		%	0.0		%

A summary of option activity under all outstanding stock incentive plans for the nine months ended September 30, 2021 is presented as follows:

	Number of Options	Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in years)
Balance at December 31, 2020	221,450	$	3.45
Granted	76,900	5.39
Canceled/forfeited	(35,287)	5.43
Expired	(1,500)	53.50
Balance at September 30, 2021	257,338	$	3.49	8.4
Vested and expected to vest at September 30, 2021	218,795	$	3.43	8.3
Exercisable at September 30, 2021	78,156	$	3.48	7.8

Restricted stock units

A summary of restricted stock unit activity under all outstanding stock incentive plans for the nine months ended September 30, 2021 is presented as follows:

	Restricted Stock Units	Weighted Average Grant Date Fair Value		Weighted Average Remaining Contractual Life (in years)
Balance at December 31, 2020	4,480	$	8.64
Granted	50,000	5.26
Vested	(52,080)	5.46
Balance at September 30, 2021	2,400	$	7.14	9.0

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

Purchase Commitments

As of September 30, 2021, we had approximately $2.9 million in outstanding purchase commitments for inventory. Of this amount, approximately $2.6 million is expected to ship in the fourth quarter of 2021, with the balance expected to ship in the first quarter of 2022 and thereafter.

XML

Other Income

9 Months Ended

Sep. 30, 2021

Other Income and Expenses [Abstract]

Other Income

OTHER INCOME

Employee Retention Tax Credit

The CARES Act, which was enacted on March 27, 2020, provides an ERTC that is a refundable tax credit against certain employer taxes. The ERTC was subsequently amended by the Taxpayer Certainty and Disaster Tax Relief Act of 2020, the Consolidated Appropriation Act of 2021, and the American Rescue Plan Act of 2021, all of which amended and extended the ERTC availability and guidelines under the CARES Act. Following these amendments, we and other businesses became retroactively eligible for the ERTC, and as a result of the foregoing legislation, are eligible to claim a refundable tax credit against the employer share of Social Security taxes equal to seventy percent (70%) of the qualified wages paid to employees between December 31, 2020, and December 31, 2021. Qualified wages are limited to $10,000 per employee per calendar quarter in 2021 for a maximum allowable ERTC per employee of $7,000 per calendar quarter in 2021.

For purposes of the amended ERTC, an eligible employer is defined as having experienced a significant (20% or more) decline in gross receipts during each 2021 calendar quarter when compared with the same quarter in 2019 or the immediately preceding quarter to the corresponding calendar quarter in 2019. The credit is taken against the Company’s share of Social Security Tax when the Company’s payroll provider files, or subsequently amends the applicable quarterly employer tax filings.

Under the amended guidelines, we are eligible to receive the ERTC for the second and third quarters of 2021. As part of the filing of our employer tax filings for the third quarter of 2021, we expect to receive a refund of $431 thousand, and we plan to amend our filing for the second quarter of 2021, for which we expect to receive an additional refund of approximately $431 thousand. These amounts are recorded as other income in the Consolidated Statements of Operations during the three and nine months ended September 30, 2021, and included in prepaid and other current assets in the Consolidated Balance Sheet as of September 30, 2021.

PPP Loan

On April 17, 2020, the Company was granted a loan from KeyBank in the amount of approximately $795 thousand, pursuant to the PPP under the CARES Act, which was enacted on March 27, 2020. The funds were received on April 20, 2020 and accrued interest at a rate of 1% per annum. At December 31, 2020, $529 thousand was classified as short-term debt and $266 thousand was classified as long-term debt on the Company’s Consolidated Balance Sheet. Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses as described in the CARES Act. The entire principal balance and interest were forgiven by the SBA on February 11, 2021. The $801 thousand forgiveness income was recorded as other income in the Consolidated Statements of Operations during the nine months ended September 30, 2021.

XML

Basis of Presentation and Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Basis of presentation

Basis of presentation

The significant accounting policies of our Company, which are summarized below, are consistent with accounting principles generally accepted in the United States (“U.S. GAAP”) and reflect practices appropriate to the business in which we operate. Unless indicated otherwise, the information in the Notes to the Consolidated Financial Statements relates to our operations.

We have prepared the accompanying financial data for the three and nine months ended September 30, 2021 and 2020 pursuant to the rules and regulations of the United States Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2020 (“2020 Annual Report”). The Condensed Consolidated Balance Sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements.

In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary to present fairly our Condensed Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020, Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020, Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2021 and 2020, Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2021 and 2020, and Condensed Consolidated Statements of Cash Flows for the three and nine months ended September 30, 2021 and 2020.

Use of estimates

Use of estimates

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management’s best knowledge of current events and actions that may impact us in the future, actual results may vary from the estimates. Estimates include, but are not limited to, the establishment of reserves for accounts receivable, sales returns, inventory obsolescence and warranty claims; the useful lives of property and equipment; valuation allowance for net deferred taxes; the cost and offsetting income related to sub-leased property; and stock-based compensation. In addition, estimates and assumptions associated with the determination of the fair value of financial instruments and evaluation of long-lived assets for impairment requires considerable judgment. Actual results could differ from those estimates and such differences could be material.

Certain risks and concentrations

Certain risks and concentrations

We have certain customers whose net sales individually represented 10% or more of our total net sales, or whose net trade accounts receivable balance individually represented 10% or more of our total net trade accounts receivable; we have certain suppliers, which individually represent 10% or more of our total purchases, or whose trade accounts payable balance individually represented 10% or more of our total trade accounts payable balance, as follows:

For the three months ended September 30, 2021, sales to our primary distributor for the U.S. Navy, a U.S. Navy shipbuilder, and a regional commercial lighting retrofit company accounted for approximately 19%, 17%, and 27% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 36% of net sales for the same period. For the three months ended September 30, 2020, sales to our primary distributor for the U.S. Navy and a regional commercial lighting retrofit company accounted for approximately 67% and 12% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 68% of net sales for the same period.

For the nine months ended September 30, 2021, sales to our primary distributor for the U.S. Navy, a U.S. Navy shipbuilder, and a regional commercial lighting retrofit company accounted for approximately 33%, 10%, and 17% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 43% of net sales for the same period. For the nine months ended September 30, 2020, sales to our primary distributor for the U.S. Navy and a regional commercial lighting retrofit company accounted for approximately 52% and 14% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 58% of net sales for the same period.

Our primary distributor for the U.S. Navy, a regional commercial lighting retrofit company and a U.S. Navy shipbuilder accounted for approximately 12%, 34%, and 27% of net trade accounts receivable, respectively, at September 30, 2021. At December 31, 2020, our primary distributor to the U.S. Navy accounted for 28% of our net trade accounts receivable and a shipbuilder for the U.S. Navy accounted for 21% of our net trade accounts receivable.

One offshore supplier accounted for approximately 19% and 30%, respectively, of our total expenditures for the three and nine months ended September 30, 2021. For the three months ended September 30, 2020, two offshore suppliers accounted for approximately 25% and 20%, respectively, of total expenditures. These same two suppliers accounted for approximately 19% and 14%, respectively, of total expenditures for the nine months ended September 30, 2020.

At September 30, 2021, one offshore supplier accounted for approximately 63% of our trade accounts payable balance. At December 31, 2020, this offshore supplier accounted for approximately 44% of our trade accounts payable balance.

Recent accounting pronouncements

Recent accounting pronouncement

In June 2016, the Financial Accounting Standards Board issued Accounting Standard Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which significantly changes the accounting for credit losses on instruments within its scope. The new guidance introduces an approach based on expected losses to estimate credit losses on certain financial instruments, including trade receivables, and requires an entity to recognize an allowance based on its estimate of expected credit losses rather than incurred losses. For smaller reporting companies, this standard will be effective for interim and annual periods starting after December 15, 2022 and will generally require adoption on a modified retrospective basis. We are in the process of evaluating the impact of the standard.

Revenue

Revenue

Net sales include revenues from sales of products and shipping and handling charges, net of estimates for product returns. Revenue is measured at the amount of consideration we expect to receive in exchange for the transferred products. We recognize revenue at the point in time when we transfer the promised products to the customer and the customer obtains control over the products. Distributors’ obligations to us are not contingent upon the resale of our products. We recognize revenue for shipping and handling charges at the time the goods are shipped to the customer, and the costs of outbound freight are included in cost of sales. We provide for product returns based on historical return rates. While we incur costs for sales commissions to our sales employees and outside agents, we recognize commission costs concurrent with the related revenue, as the amortization period is less than one year. We do not incur any other incremental costs to obtain contracts with our customers. Our product warranties are assurance-type warranties, which promise the customer that the products are as specified in the contract. Therefore, the product warranties are not a separate performance obligation and are accounted for as described below. Sales taxes assessed by governmental authorities and collected by us are accounted for on a net basis and are excluded from net sales.

Accounts Receivable

Accounts Receivable

Our trade accounts receivable consist of amounts billed to and currently due from customers. Our customers are currently concentrated in the United States. In the normal course of business, we extend unsecured credit to our customers related to the sale of our products. Credit is extended to customers based on an evaluation of the customer’s financial condition and the amounts due are stated at their estimated net realizable value. We utilize an account receivable insurance program with a high credit worthy insurance company where we have the large majority of the accounts receivable insured with a portion of self-retention. This third party also provides creditworthiness ratings and metrics that significantly assist us in evaluating the creditworthiness of both existing and new customers. We maintain allowances for sales returns and doubtful accounts receivable to provide for the estimated number of accounts receivable that will not be collected. The allowance is based on an assessment of customer creditworthiness and historical payment experience, the age of outstanding receivables, and performance guarantees to the extent applicable. Past due amounts are written off when our internal collection efforts have been unsuccessful, and payments subsequently received on such receivables are credited to the allowance for doubtful accounts. We do not generally require collateral from our customers.

Our standard payment terms with customers are net 30 days from the date of shipment, and we do not generally offer extended payment terms to our customers, but exceptions are made in some cases to certain customers or with particular orders. Accordingly, we do not adjust trade accounts receivable for the effects of financing, as we expect the period between the transfer of product to the customer and the receipt of payment from the customer to be in line with our standard payment terms.

Net loss per share

Net loss per share

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of shares of common stock outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted loss per share gives effect to all dilutive potential shares of common stock outstanding during the period. Dilutive potential shares of common stock consist of incremental shares upon the exercise of stock options, warrants and convertible securities, unless the effect would be anti-dilutive.

Product warranties

Product warranties

We warrant our commercial and MMM LED products and controls for periods generally ranging from five to ten years. Warranty settlement costs consist of actual amounts expensed for warranty, which are largely a result of the cost of replacement products provided to our customers. A liability for the estimated future costs under product warranties is maintained for products under warranty based on the actual claims incurred to date and the estimated nature, frequency, and costs of future claims. These estimates are inherently uncertain and changes to our historical or projected experience may cause material changes to our warranty reserves in the future. We continuously review the assumptions related to the adequacy of our warranty reserve, including product failure rates, and make adjustments to the existing warranty liability when there are changes to these estimates or the underlying replacement product costs, or the warranty period expires.

Financial Instruments

Financial Instruments

In June 2021, we completed a registered direct offering of 990,100 shares of our common stock to certain institutional investors, at a purchase price of $5.05 per share (the “June 2021 Equity Offering”). We paid the placement agent commissions of $400 thousand, plus $51 thousand in expenses, in connection with the June 2021 Equity Offering and we also paid legal and other fees of $19 thousand related to the offering. Total offering costs of $470 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of September 30, 2021. Net proceeds to us from the June 2021 Equity Offering were approximately $4.5 million.

In January 2020, we completed a registered direct offering of 688,360 shares of our common stock to certain institutional investors, at a purchase price of $3.37 per share. We also sold, to the same institutional investors, warrants to purchase up to 688,360 shares of common stock at an exercise price of $3.37 per share in a concurrent private placement for a purchase price of $0.625 per warrant. We paid the placement agent commissions of $193 thousand, plus $50 thousand in expenses, in connection with the registered direct offering and the concurrent private placement and we also paid legal, accounting and other fees of $231 thousand related to the offering. Total offering costs of $510 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of December 31, 2020. In addition, we issued warrants to the placement agent to purchase up to 48,185 shares of common stock at an exercise price of $4.99 per share. Net proceeds to us from the sale of common stock and warrants (the “January 2020 Equity Offering”) were approximately $2.3 million. In accordance with the terms of the Iliad Note (as defined below in Note 7, “Debt”), 10% of the gross proceeds from the January 2020 Equity Offering ($275 thousand) were used to make payments on the Iliad Note, of which $226 thousand went towards the outstanding principal amount and the balance to interest.

Warrants to purchase an aggregate of 310,860 shares remain outstanding at September 30, 2021 with a weighted average exercise price of $3.59 per share. The exercise of warrants could provide us with cash proceeds of up to $1.1 million in the aggregate. During the nine months ended September 30, 2021, 156,446 warrants were exercised resulting in total proceeds of $527 thousand.

Due to a potential cash settlement upon occurrence of a fundamental transaction within the January 2020 warrant agreement, the warrants were initially classified as liabilities, as opposed to equity, and were recorded at their fair values at each balance sheet date for the first three quarters of 2020. During December 2020, the warrant holders all agreed to a modification of the terms of their warrants that removed the potential cash settlement option upon the occurrence of a fundamental transaction. As such, during the fourth quarter of 2020, the warrant liability was reclassified into equity and the warrants are no longer subject to re-measurement at each balance sheet date. Please also refer to Note 9, “Stockholders’ Equity”.

Fair Value Measurements

The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value, giving the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below. We classify the inputs used to measure fair value into the following hierarchy:

Level 1	Unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2	Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.
Level 3	Unobservable inputs for the asset or liability.

The carrying amounts of certain financial instruments including cash, accounts receivable, accounts payable, and accrued liabilities approximate fair value due to their short maturities. Based on borrowing rates currently available to us for loans with similar terms, the carrying value of borrowings under our revolving credit facilities also approximates fair value.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. In determining the appropriate levels, we perform a detailed analysis of the assets and liabilities whose fair value is measured on a recurring basis. We review and reassess the fair value hierarchy classifications on a quarterly basis. Changes from one quarter to the next related to the observability of inputs in a fair value measurement may result in a reclassification between fair value hierarchy levels. There were no reclassifications for all periods presented.

The estimated fair value of warrants accounted for as liabilities, representing a level 3 fair value measure, was determined on the issuance date and subsequently marked to market at each financial reporting date until the date the warrants were reclassified into equity, after which the warrants are no longer subject to re-measurement at each balance sheet date. We use the Black-Scholes valuation model to value the warrant liabilities at fair value. The fair value is estimated using the expected volatility based on our historical volatility and is determined using probability weighted-average assumptions, when appropriate.

XML

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Disaggregation of revenue

The following table provides a disaggregation of product net sales for the periods presented (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Net sales:
Commercial	$	1,522	$	1,456	$	3,513	$	4,250
MMM products	1,227		4,508		3,947		8,832
Total net sales	$	2,749	$	5,964	$	7,460	$	13,082

Reconciliation of basic and diluted income (loss) per share

The following table presents a reconciliation of basic and diluted loss per share computations (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Numerator:
Net loss	$	(1,140)	$	(1,165)	$	(5,255)	$	(6,046)
Denominator:
Basic and diluted weighted average shares of common stock outstanding *	5,086		3,308		4,309		3,196

*Shares outstanding for the nine months ended September 30, 2020 have been restated for the 1-for-5 stock split effective June 11, 2020.

Schedule of warranty activity

The following table summarizes warranty activity for the periods presented (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Balance at beginning of period	$	239	$	215	$	227	$	195
Warranty accruals for current period sales	10		22		49		29
Adjustments to existing warranties	4		4		16		23
In kind settlements made during the period	(13)		(11)		(52)		(17)
Accrued warranty reserve at end of period	$	240	$	230	$	240	$	230

Summary of assets and liabilities measured on recurring basis

The following table provides a summary of the financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2020 (in thousands):

			Fair Value Measurements at September 30, 2020 Using
	Balance as of		Quoted Prices in Active Markets for Identical Assets  (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs  (Level 3)
Description	September 30, 2020
Warrant liabilities	$	2,928	$	—	$	—	$	2,928

Schedule of valuation assumptions

The following inputs were used at September 30, 2020:

	Expected	Risk-Free	Expected
	Volatility	Interest Rate	Life
Warrants with greater than one-year remaining term	103.18% - 99.38%	0.21% - 0.24%	3.79 - 4.29 years

Level 3 fair value reconciliation

A roll-forward of fair value measurements using significant unobservable inputs (Level 3) for the warrants is as follows (in thousands):

	Nine months ended September 30, 2020
Balance January 1, 2020	$	—
Issuance of warrants, January 2020	1,636
Settlements from exercise	(982)
Gain from change in fair value of warrants	2,274
Balance September 30, 2020	$	2,928

XML

Restructuring (Tables)

9 Months Ended

Sep. 30, 2021

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Reserve by Type of Cost

The following is a reconciliation of the beginning and ending balances of our restructuring liability as it relates to the restructuring plans (in thousands):

	2021		2020
Balance at December 31, 2020 and 2019	$	11	$	38
Accretion of lease obligations	—		2
Payments	(11)		(22)
Balance at September 30, 2021 and 2020	$	—	$	18

The following is a reconciliation of the ending balance of our restructuring liability at September 30, 2021 to the balance sheet:

	2021		2020
Balance at September 30, 2021 and 2020	$	—	$	18
Less, short-term restructuring liability	—		18
Long-term restructuring liability, included in other liabilities	$	—	$	—

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2021

Inventory Disclosure [Abstract]

Schedule of inventory

Inventories are stated at the lower of standard cost (which approximates actual cost determined using the first-in, first-out cost method) or net realizable value, and consist of the following (in thousands):

	September 30, 2021		December 31, 2020
Raw materials	$	4,232	$	2,695
Finished goods	6,409		5,840
Reserves for excess, obsolete, and slow-moving inventories	(2,886)		(2,894)
Inventories, net	$	7,755	$	5,641

The following is a roll-forward of the reserves for excess, obsolete, and slow-moving inventories (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Beginning balance	$	(2,956)	$	(3,326)	$	(2,894)	$	(3,645)
Accrual	34		(187)		(64)		(75)
Reduction due to sold inventory	36		121		72		288
Write-off for disposed inventory	—		(23)		—		17
Reserves for excess, obsolete, and slow-moving inventories	$	(2,886)	$	(3,415)	$	(2,886)	$	(3,415)

XML

Property and Equipment (Tables)

9 Months Ended

Sep. 30, 2021

Property, Plant and Equipment [Abstract]

Schedule of property and equipment

Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the related assets and consist of the following (in thousands):

	September 30, 2021		December 31, 2020
Equipment (useful life 3 to 15 years)	$	1,308	$	1,281
Tooling (useful life 2 to 5 years)	324		240
Vehicles (useful life 5 years)	83		47
Furniture and fixtures (useful life 5 years)	86		137
Computer software (useful life 3 years)	1,189		1,057
Leasehold improvements (the shorter of useful life or lease life)	169		169
Finance lease right-of-use asset	13		13
UV - Robots (useful life 5 years)	105		—
Projects in progress	68		140
Property and equipment at cost	3,345		3,084
Less: accumulated depreciation	(2,757)		(2,664)
Property and equipment, net	$	588	$	420

XML

Leases (Tables)

9 Months Ended

Sep. 30, 2021

Leases [Abstract]

Components of Lease Cost and Supplemental Cash Flow Information

Components of the operating and restructured lease costs recognized in net loss for the three and nine months ended September 30, 2021 and 2020, were as follows (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Operating lease cost (income)
Sub-lease income	$	(25)	$	(26)	$	(87)	$	(80)
Lease cost	139		148		423		451
Operating lease cost, net	114		122		336		371
Restructured lease cost (income)
Sub-lease income	—		(68)		(136)		(204)
Lease cost	—		59		109		180
Restructured lease income, net	—		(9)		(27)		(24)
Total lease cost, net	$	114	$	113	$	309	$	347

Schedule of Supplemental Balance Sheet Information

Supplemental balance sheet information related to the Company’s operating and finance leases as of September 30, 2021 and December 31, 2020 are as follows (in thousands):

	September 30, 2021		December 31, 2020
Operating Leases
Operating lease right-of-use assets	$	419	$	794
Restructured lease right-of-use assets	—		107
Operating lease right-of-use assets, total	419		901
Operating lease liabilities	505		916
Restructured lease liabilities	—		168
Operating lease liabilities, total	505		1,084
Finance Leases
Property and equipment	13		13
Allowances for depreciation	(11)		(9)
Finance lease assets, net	2		4
Finance lease liabilities	1		4
Total finance lease liabilities	$	1	$	4

Schedule of Future Maturities of Finance Lease Liabilities

Future minimum lease payments required under operating and finance leases for each of the 12-month rolling periods below in effect at September 30, 2021 are as follows (in thousands):

	Operating Leases		Finance Lease
October 2021 to September 2022	$	488	$	1
October 2022 to September 2023	19		—
October 2023 to September 2024	8		—
October 2024 to September 2025	3		—
October 2025 to September 2026	2		—
Total future undiscounted lease payments	520		1
Less imputed interest	(15)		—
Total lease obligations	$	505	$	1

Schedule of Future Maturities of Operating Lease Liabilities

Future minimum lease payments required under operating and finance leases for each of the 12-month rolling periods below in effect at September 30, 2021 are as follows (in thousands):

	Operating Leases		Finance Lease
October 2021 to September 2022	$	488	$	1
October 2022 to September 2023	19		—
October 2023 to September 2024	8		—
October 2024 to September 2025	3		—
October 2025 to September 2026	2		—
Total future undiscounted lease payments	520		1
Less imputed interest	(15)		—
Total lease obligations	$	505	$	1

Supplemental Cash Flow Information Related to Leases

Supplemental cash flow information related to leases for the three and nine months ended September 30, 2021 and 2020, was as follows (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Supplemental cash flow information
Cash paid, net, for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	161	$	134	$	421	$	401
Operating cash flows from restructured leases	$	—	$	17	$	35	$	52
Financing cash flows from finance leases	$	1	$	1	$	3	$	3

XML

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2021

Stockholders' Equity Note [Abstract]

Schedule of Stockholders' Equity Note, Warrants or Rights

As of September 30, 2021, we had the following outstanding warrants to purchase shares of common stock:

	Number of Underlying Shares	Exercise Price	Expiration
Investor Warrants	269,180	$3.3700	January 13, 2025
Placement Agent Warrants	41,680	$4.9940	January 13, 2025
	310,860

As of September 30, 2020, we had the following outstanding warrants to purchase shares of common stock:

	Number of Underlying Shares	Exercise Price	Expiration
Investor Warrants	497,472	$3.3700	January 13, 2025
Placement Agent Warrants	41,680	$4.9940	January 13, 2025
	539,152

Summary of stock-based compensation expense

The following table summarizes stock-based compensation expense and the impact it had on operations for the periods presented (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Cost of sales	$	2	$	1	$	7	$	2
Product development	2		3		10		5
Selling, general, and administrative	35		31		370		89
Total stock-based compensation	$	39	$	35	$	387	$	96

Schedule of valuation assumptions

Estimates utilized in the calculation include the expected life of the option, risk-free interest rate, and expected volatility, and are further detailed below.

	Nine months ended September 30,
	2021			2020
Fair value of options issued	$	4.18		$	2.00
Exercise price	$	5.39		$	2.61
Expected life of options (in years)	6.2			6.2
Risk-free interest rate	0.8		%	0.7		%
Expected volatility	96.5		%	93.5		%
Dividend yield	0.0		%	0.0		%

Summary of option activity

A summary of option activity under all outstanding stock incentive plans for the nine months ended September 30, 2021 is presented as follows:

	Number of Options	Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in years)
Balance at December 31, 2020	221,450	$	3.45
Granted	76,900	5.39
Canceled/forfeited	(35,287)	5.43
Expired	(1,500)	53.50
Balance at September 30, 2021	257,338	$	3.49	8.4
Vested and expected to vest at September 30, 2021	218,795	$	3.43	8.3
Exercisable at September 30, 2021	78,156	$	3.48	7.8

Summary of restricted stock activity

A summary of restricted stock unit activity under all outstanding stock incentive plans for the nine months ended September 30, 2021 is presented as follows:

	Restricted Stock Units	Weighted Average Grant Date Fair Value		Weighted Average Remaining Contractual Life (in years)
Balance at December 31, 2020	4,480	$	8.64
Granted	50,000	5.26
Vested	(52,080)	5.46
Balance at September 30, 2021	2,400	$	7.14	9.0

XML

Nature of Operations (Details)	Jun. 11, 2020 $ / shares shares	Sep. 30, 2021 $ / shares shares	Dec. 31, 2020 $ / shares shares
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Common stock, par value (USD per share) | $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, authorized (in shares) | shares	50,000,000	50,000,000	50,000,000
Reverse stock split ratio	0.2

XML

Basis of Presentation and Summary of Significant Accounting Policies - Certain Risks and Concentrations (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Customer concentration risk | Distributor To The U.S. Navy | Revenue
Concentration Risk [Line Items]
Concentration risk (less than for geographic concentration risk)	19.00%	67.00%	33.00%	52.00%
Customer concentration risk | Distributor To The U.S. Navy | Accounts receivable
Concentration Risk [Line Items]
Concentration risk (less than for geographic concentration risk)			12.00%		28.00%
Customer concentration risk | Shipbuilder For U.S. Navy | Revenue
Concentration Risk [Line Items]
Concentration risk (less than for geographic concentration risk)	17.00%		10.00%
Customer concentration risk | Shipbuilder For U.S. Navy | Accounts receivable
Concentration Risk [Line Items]
Concentration risk (less than for geographic concentration risk)			27.00%		21.00%
Customer concentration risk | Regional Commercial Lighting Retrofit Company | Revenue
Concentration Risk [Line Items]
Concentration risk (less than for geographic concentration risk)	27.00%	12.00%	17.00%	14.00%
Customer concentration risk | Regional Commercial Lighting Retrofit Company | Accounts receivable
Concentration Risk [Line Items]
Concentration risk (less than for geographic concentration risk)			34.00%
Customer concentration risk | Distributor To The U.S. Navy Combined With Sales To Shipbuilders | Revenue
Concentration Risk [Line Items]
Concentration risk (less than for geographic concentration risk)	36.00%	68.00%	43.00%	58.00%
Supplier concentration risk | Offshore Supplier | Accounts Payable
Concentration Risk [Line Items]
Concentration risk (less than for geographic concentration risk)			63.00%		44.00%
Supplier concentration risk | Offshore Supplier | Total Expenditures
Concentration Risk [Line Items]
Concentration risk (less than for geographic concentration risk)	19.00%	25.00%	30.00%	19.00%
Supplier concentration risk | Domestic Supplier | Total Expenditures
Concentration Risk [Line Items]
Concentration risk (less than for geographic concentration risk)		20.00%		14.00%
Geographic concentration risk | Revenue | Countries outside of the United States
Concentration Risk [Line Items]
Concentration risk (less than for geographic concentration risk)	1.00%	0.00%	1.00%	0.00%

XML

Basis of Presentation and Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenue from External Customer [Line Items]
Net sales	$ 2,749	$ 5,964	$ 7,460	$ 13,082
Commercial
Revenue from External Customer [Line Items]
Net sales	1,522	1,456	3,513	4,250
MMM products
Revenue from External Customer [Line Items]
Net sales	$ 1,227	$ 4,508	$ 3,947	$ 8,832

XML

Basis of Presentation and Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Loss per Share (Details) shares in Thousands, $ in Thousands			3 Months Ended		9 Months Ended
		Jun. 11, 2020	Sep. 30, 2021 USD ($) shares	Sep. 30, 2020 USD ($) shares	Sep. 30, 2021 USD ($) shares	Sep. 30, 2020 USD ($) shares
Numerator:
Net loss | $			$ (1,140)	$ (1,165)	$ (5,255)	$ (6,046)
Denominator:
Basic weighted average common shares outstanding (in shares)	[1]		5,086	3,308	4,309	3,196
Diluted weighted average common shares outstanding (in shares)	[1]		5,086	3,308	4,309	3,196
Reverse stock split ratio		0.2

[1] * Shares outstanding for the nine months ended September 30, 2020 have been restated for the 1-for-5 reverse stock split effective June 11, 2020.

XML

Basis of Presentation and Summary of Significant Accounting Policies - Net Loss per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Options
Impairment Effects on Earnings Per Share [Line Items]
Securities excluded from net loss per share calculation (less than for options in the three months ended June 30, 2020) (in shares)	41	117	60	57
Warrants
Impairment Effects on Earnings Per Share [Line Items]
Securities excluded from net loss per share calculation (less than for options in the three months ended June 30, 2020) (in shares)	11	321	56	152
Restricted share units
Impairment Effects on Earnings Per Share [Line Items]
Securities excluded from net loss per share calculation (less than for options in the three months ended June 30, 2020) (in shares)		13		7
Convertible securities
Impairment Effects on Earnings Per Share [Line Items]
Securities excluded from net loss per share calculation (less than for options in the three months ended June 30, 2020) (in shares)	175	519	289	531

XML

Basis of Presentation and Summary of Significant Accounting Policies - Product Warranties (Details)	9 Months Ended
	Sep. 30, 2021
Minimum | Commercial
Product Warranty Liability [Line Items]
Warranty service periods	5 years
Minimum | MMM LED Products
Product Warranty Liability [Line Items]
Warranty service periods	5 years
Maximum | Commercial
Product Warranty Liability [Line Items]
Warranty service periods	10 years
Maximum | MMM LED Products
Product Warranty Liability [Line Items]
Warranty service periods	10 years

XML

Basis of Presentation and Summary of Significant Accounting Policies - Warranty Activity (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]
Balance at beginning of period	$ 239	$ 215	$ 227	$ 195
Warranty accruals for current period sales	10	22	49	29
Adjustments to existing warranties	4	4	16	23
In kind settlements made during the period	(13)	(11)	(52)	(17)
Accrued warranty reserve at end of period	$ 240	$ 230	$ 240	$ 230

XML

Basis of Presentation and Summary of Significant Accounting Policies - Financial Instruments (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
	Nov. 25, 2019	Jun. 30, 2021	Jan. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Class of Stock [Line Items]
Amount paid for clearing fees		$ 19	$ 231
Offering costs paid on the issuance of common stock and warrants				$ 1	$ 0	$ 470	$ 474	$ 510
Proceeds from sale of common stock and warrants		$ 4,500	$ 2,300
Warrants issued (in shares)						310,860	539,152
Exercise price of common stock (USD per share)				$ 3.59		$ 3.59
Percentage of gross proceeds used to make payments on note			10.00%
Gross proceeds			$ 275
Payments on the Iliad Note				$ 0	450	$ 0	$ 976
Proceeds from issuance of warrants						$ 1,100
Warrants exercised (in shares)						156,446
Proceeds from the exercise of warrants				$ 0	$ 625	$ 527	$ 676
Iliad Note
Class of Stock [Line Items]
Percentage of gross proceeds used to make payments on note	10.00%
Payments on the Iliad Note			$ 226
Institutional investors
Class of Stock [Line Items]
Sale of common stock (in shares)		990,100	688,360
Sale of common stock (USD per share)		$ 5.05	$ 3.37
Warrants issued (in shares)			688,360			269,180	497,472
Exercise price of common stock (USD per share)			$ 3.37	$ 3.3700	$ 3.3700	$ 3.3700	$ 3.3700
Purchase price (USD per share)			$ 0.625
Placement agent
Class of Stock [Line Items]
Amount paid for placement agent commissions		$ 400	$ 193
Amount paid related to expenses for registered direct offering and concurrent private placement		$ 51	$ 50
Warrants issued (in shares)			48,185			41,680	41,680
Exercise price of common stock (USD per share)			$ 4.99	$ 4.9940	$ 4.9940	$ 4.9940	$ 4.9940

XML

Basis of Presentation and Summary of Significant Accounting Policies - Financial Assets and Liabilities Measured at Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Warrant liabilities	$ 2,928	$ 0
Fair Value, Recurring
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Warrant liabilities	2,928
Fair Value, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Warrant liabilities	0
Fair Value, Recurring | Significant Other Observable Inputs (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Warrant liabilities	0
Fair Value, Recurring | Significant Unobservable Inputs (Level 3)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Warrant liabilities	$ 2,928

XML

Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Inputs (Details)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Expected life of options (in years)	6 years 2 months 12 days	6 years 2 months 12 days
Warrants
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Expected Volatility, minimum		103.18%
Expected Volatility, maximum		99.38%
Risk free interest rate, minimum		0.21%
Risk free interest rate, maximum		0.24%
Warrants | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Expected life of options (in years)		3 years 9 months 14 days
Warrants | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Expected life of options (in years)		4 years 3 months 14 days

XML

Basis of Presentation and Summary of Significant Accounting Policies - Rollforward of Fair Value Measurements (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance January 1, 2020				$ 0
Issuance of warrants, January 2020				1,636
Settlements from exercise				(982)
(Gain) loss from change in fair value of warrants	$ 0	$ (153)	$ 0	2,274
Balance September 30, 2020		$ 2,928		$ 2,928

XML

Restructuring - Narrative (Details) $ in Thousands	1 Months Ended			3 Months Ended				9 Months Ended
	Jun. 30, 2021 USD ($)	Apr. 30, 2021 USD ($)	Jan. 31, 2020 USD ($)	Mar. 31, 2022 product	Dec. 31, 2021 product	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Mar. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Aug. 31, 2020 creditFacility	Aug. 11, 2020 creditFacility	Jun. 30, 2020 USD ($)	Mar. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring						$ 1	$ (16)	$ (21)	$ (44)
Proceeds from sale of common stock and warrants	$ 4,500		$ 2,300
Bridge financing obtained		$ 1,500
Number of new credit facilities | creditFacility												2	2
Stockholders' equity	$ 5,603					$ 4,502	$ 2,139	$ 4,502	$ 2,139	$ 3,278	$ 4,255			$ 1,714	$ 5,883	$ 3,996
Scenario, Forecast
Restructuring Cost and Reserve [Line Items]
Number of new products available | product				2	2

XML

Restructuring - Reconciliation of Restructuring Liability (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Restructuring Reserve [Roll Forward]
Less, short-term restructuring liability	$ 0		$ 11
Restructuring liability
Restructuring Reserve [Roll Forward]
Balance at December 31, 2020 and 2019	11	$ 38
Accretion of lease obligations	0	2
Payments	(11)	(22)
Balance at September 30, 2021 and 2020	0	18
Balance at September 30, 2021 and 2020	0	18	$ 11
Less, short-term restructuring liability	0	18
Long-term restructuring liability, included in other liabilities	$ 0	$ 0

XML

Inventories - Inventories, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 4,232		$ 2,695
Finished goods	6,409		5,840
Reserves for excess, obsolete, and slow-moving inventories	(2,886)	$ (2,956)	(2,894)	$ (3,415)	$ (3,326)	$ (3,645)
Inventories, net	$ 7,755		$ 5,641

XML

Inventories - Reserve Rollforward (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Jun. 30, 2021	Sep. 30, 2021	Sep. 30, 2020
Inventory, Reserve [Roll Forward]
Beginning balance	$ (2,956)	$ (3,326)	$ (2,894)	$ (2,894)	$ (3,645)
Accrual	34	(187)		(64)	(75)
Reduction due to sold inventory	36	121		72	288
Write-off for disposed inventory	0	(23)	17	0
Reserves for excess, obsolete, and slow-moving inventories	$ (2,886)	$ (3,415)	$ (2,956)	$ (2,886)	$ (3,415)

XML

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Finance lease right-of-use asset	$ 13		$ 13		$ 13
Property and equipment at cost	3,345		3,345		3,084
Less: accumulated depreciation	(2,757)		(2,757)		(2,664)
Property and equipment, net	588		588		420
Depreciation	43	$ 48	143	$ 140
Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,308		$ 1,308		1,281
Equipment | Minimum
Property, Plant and Equipment [Line Items]
Useful life (in years)			3 years
Equipment | Maximum
Property, Plant and Equipment [Line Items]
Useful life (in years)			15 years
Tooling
Property, Plant and Equipment [Line Items]
Property and equipment, gross	324		$ 324		240
Tooling | Minimum
Property, Plant and Equipment [Line Items]
Useful life (in years)			2 years
Tooling | Maximum
Property, Plant and Equipment [Line Items]
Useful life (in years)			5 years
Vehicles
Property, Plant and Equipment [Line Items]
Property and equipment, gross	83		$ 83		47
Useful life (in years)			5 years
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	86		$ 86		137
Useful life (in years)			5 years
Computer software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,189		$ 1,189		1,057
Useful life (in years)			3 years
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	169		$ 169		169
UV - Robots
Property, Plant and Equipment [Line Items]
Property and equipment, gross	105		$ 105		0
Useful life (in years)			5 years
Projects in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 68		$ 68		$ 140

XML

Leases - Narrative (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Jan. 21, 2021	Dec. 31, 2020	Sep. 30, 2020
Leases [Abstract]
Operating lease, borrowing rate		15.93%
Operating lease, discount rate	7.25%
Operating lease, weighted average remaining lease term	1 year 4 months 24 days
Finance lease, weighted average remaining lease term	7 months 6 days
Restricted cash held in other assets	$ 0		$ 300	$ 342

XML

Leases - Components of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Leases [Abstract]
Sub-lease income	$ (25)	$ (26)	$ (87)	$ (80)
Lease cost	139	148	423	451
Operating lease cost, net	114	122	336	371
Sub-lease income	0	(68)	(136)	(204)
Lease cost	0	59	109	180
Restructured lease income, net	0	(9)	(27)	(24)
Total lease cost, net	$ 114	$ 113	$ 309	$ 347

XML

Leases - Schedule of Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Operating Leases
Operating lease right-of-use assets	$ 419	$ 794
Restructured lease right-of-use assets	0	107
Operating lease right-of-use assets, total	419	901
Operating lease liabilities	505	916
Restructured lease liabilities	0	168
Operating lease liabilities, total	505	1,084
Finance Leases
Property and equipment	13	13
Allowances for depreciation	(11)	(9)
Finance lease assets, net	2	4
Finance lease liabilities	$ 1	$ 4

XML

Leases - Schedule of Future Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Operating Leases
October 2021 to September 2022	$ 488
October 2022 to September 2023	19
October 2023 to September 2024	8
October 2024 to September 2025	3
October 2025 to September 2026	2
Total future undiscounted lease payments	520
Less imputed interest	(15)
Total lease obligations	505	$ 916
Finance Lease
October 2021 to September 2022	1
October 2022 to September 2023	0
October 2023 to September 2024	0
October 2024 to September 2025	0
October 2025 to September 2026	0
Total future undiscounted lease payments	1
Less imputed interest	0
Total lease obligations	$ 1	$ 4

XML

Leases - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Leases [Abstract]
Operating cash flows from operating leases	$ 161	$ 134	$ 421	$ 401
Operating cash flows from restructured leases	0	17	35	52
Financing cash flows from finance leases	$ 1	$ 1	$ 3	$ 3

XML

Debt - Credit Facilities (Details)	Aug. 11, 2020 USD ($) creditFacility	Dec. 11, 2018 USD ($)	Sep. 30, 2021 USD ($)	Apr. 20, 2021 USD ($)	Dec. 31, 2020 USD ($)	Aug. 31, 2020 creditFacility
Line of Credit Facility [Line Items]
Number of debt financing facilities | creditFacility	2					2
Credit line borrowings, net of loan origination fees			$ 2,666,000		$ 2,298,000
Revolving Credit Facility | Inventory Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity on line of credit	$ 3,000,000			$ 3,500,000
Inventory costs	75.00%
Inventory, net orderly liquidation value	85.00%
Interest rate	5.75%		22.40%		23.60%
Monthly service fee	1.00%
Minimum monthly fee	$ 18,000
Credit line borrowings, net of loan origination fees			$ 1,400,000		$ 1,300,000
Amortized net issuance costs			$ 100,000		$ 100,000
Revolving Credit Facility | Inventory Facility | London Interbank Offered Rate (LIBOR)
Line of Credit Facility [Line Items]
Interest rate	4.00%
Revolving Credit Facility | Receivables Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity on line of credit	$ 2,500,000
Interest rate			8.00%		7.90%
Monthly service fee	1.00%
Minimum monthly fee	$ 25,000
Percent of accounts receivable used as borrowing capacity	90.00%
Stated interest rate on collateral management fee			6.00%		6.00%
Credit line borrowings, net of loan origination fees			$ 1,300,000		$ 1,000,000
Amortized net issuance costs			$ 14,000		$ 40,000
Revolving Credit Facility | Receivables Facility | Prime Rate
Line of Credit Facility [Line Items]
Interest rate	2.00%
Revolving Credit Facility | Austin Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity on line of credit		$ 5,000,000
Line of credit term (in years)		3 years
Annual facility fee		1.00%
Annual facility fee, payment period		3 years
Collateral management fee		0.50%
Payment to close Austin credit facility	$ 1,400,000
Termination fee	100,000
Write off of remaining issuance costs	$ 59,000
Revolving Credit Facility | Austin Facility | Prime Rate
Line of Credit Facility [Line Items]
Margin added to borrowing rate		2.00%

XML

Debt - Streeterville Note (Details) $ in Thousands		1 Months Ended
	Apr. 27, 2021 USD ($) creditFacility	Apr. 30, 2021 USD ($)	Sep. 30, 2021 USD ($)
Debt Instrument [Line Items]
Purchase price		$ 1,500
Streeterville Note
Debt Instrument [Line Items]
Principal amount	$ 1,700
Issue discount	194
Purchase price	1,500
Unamortized debt issuance costs	$ 15
Interest rate	8.00%
Maximum redemption amount	$ 205
Right to defer mandatory redemption, number of deferrals | creditFacility	3
Percentage increase due to deferral of redemption option	1.50%
Total liability, net of discount and financing fees			$ 1,600
Unamortized issuance costs at date of issuance			$ 100
Percentage increase if delisted from Nasdaq	15.00%
Streeterville Note | Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Prepayment premium	5.00%
Debt prepayment limit, percent	50.00%
Streeterville Note | Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Prepayment premium	10.00%

XML

Debt - PPP Loan (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Apr. 17, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Debt Instrument [Line Items]
Proceeds from PPP loan		$ 0	$ 0	$ 0	$ 795
PPP loan		0		0		$ 529
PPP loan, net of current maturities		0		0		$ 266
Gain on forgiveness of PPP loan		$ 0	$ 0	801	$ 0
Paycheck Protection Program
Debt Instrument [Line Items]
Proceeds from PPP loan	$ 795
Interest rate	1.00%
Gain on forgiveness of PPP loan				$ 801

XML

Debt - Iliad Note (Details) - USD ($)		1 Months Ended			3 Months Ended		9 Months Ended
	Nov. 25, 2019	Apr. 30, 2021	Dec. 31, 2020	Jan. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Debt Instrument [Line Items]
Purchase price		$ 1,500,000
Percentage of gross proceeds used to make payments on note				10.00%
Gross proceeds				$ 275,000
Payments on the Iliad Note					$ 0	$ 450,000	$ 0	$ 976,000
Iliad Note
Debt Instrument [Line Items]
Principal amount	$ 1,300,000
Issue discount	142,000
Purchase price	1,100,000
Unamortized debt issuance costs	$ 15,000
Write off of remaining issuance costs			$ 117,000
Interest rate	8.00%
Percentage of gross proceeds used to make payments on note	10.00%
Payments on the Iliad Note				$ 226,000
Total liability, net of discount and financing fees						200,000		200,000
Unamortized issuance costs at date of issuance						$ 100,000		$ 100,000

XML

Debt - Convertible Notes (Details) - USD ($) $ / shares in Units, $ in Millions				3 Months Ended	7 Months Ended	12 Months Ended
	Apr. 01, 2021	Jan. 16, 2020	Mar. 29, 2019	Jun. 30, 2019	Jan. 16, 2020	Dec. 31, 2020	Sep. 30, 2021	Jun. 11, 2020
Line of Credit Facility [Line Items]
Common stock, par value (USD per share)						$ 0.0001	$ 0.0001	$ 0.0001
Convertible Debt
Line of Credit Facility [Line Items]
Proceeds from issuance of subordinated convertible promissory notes			$ 1.7
Interest rate on convertible notes				5.00%	10.00%
Accumulated interest on subordinated debt		$ 0.1			$ 0.1
Net proceeds from the conversion of convertible debt to preferred stock		$ 1.8
Conversion rate (USD per share)		$ 0.67			$ 0.67
Conversion of notes to stock (in shares)		2,709,018
Common stock, par value (USD per share)		$ 0.0001	$ 0.0001		$ 0.0001
Convertible Debt | Preferred Stock
Line of Credit Facility [Line Items]
Preferred stock converted to common stock (in shares)	1,721,023					111,548
Convertible Debt | Common Stock
Line of Credit Facility [Line Items]
Common stock issued upon preferred stock conversion (in shares)	344,205					22,310

XML

Income Taxes - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2017
Operating Loss Carryforwards [Line Items]
Operating loss carry-forwards	$ 7.1	$ 8.3
Operating loss, subject to expiration			$ 37.3
U.S. Federal, State and Local tax authorities
Operating Loss Carryforwards [Line Items]
Deferred tax assets, operating loss carry-forwards	115.9
Deferred tax assets, operating loss carryforwards, portion available after application of IRC Section 382 limitations	61.5
State and Local Jurisdiction
Operating Loss Carryforwards [Line Items]
Deferred tax assets, operating loss carry-forwards	$ 72.3

XML

Stockholders' Equity - June 2021 Equity Offering (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2021	Jan. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Amount paid for clearing fees	$ 19	$ 231
Payments of Stock Issuance Costs			$ (1)	$ 0	$ (470)	$ (474)	$ (510)
Proceeds from sale of common stock and warrants	$ 4,500	$ 2,300
Institutional investors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of common stock (in shares)	990,100	688,360
Sale of common stock (USD per share)	$ 5.05	$ 3.37
Placement agent
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Amount paid for placement agent commissions	$ 400	$ 193
Amount paid related to expenses for registered direct offering and concurrent private placement	$ 51	$ 50

XML

Stockholders' Equity - Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Millions			12 Months Ended
	Apr. 01, 2021	Jan. 16, 2020	Dec. 31, 2020	Sep. 30, 2021	Jun. 11, 2020	Jan. 15, 2020	Mar. 29, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, authorized (in shares)			5,000,000	5,000,000		5,000,000	2,000,000
Common stock, par value (USD per share)			$ 0.0001	$ 0.0001	$ 0.0001
Votes equal to the number of shares of common stock convertible		11.07%
Series A Convertible Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, authorized (in shares)			3,300,000	3,300,000		3,300,000
Convertible Debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Net proceeds from the conversion of convertible debt to preferred stock		$ 1.8
Conversion rate (USD per share)		$ 0.67
Conversion of notes to stock (in shares)		2,709,018
Common stock, par value (USD per share)		$ 0.0001					$ 0.0001
Convertible Debt | Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock converted to common stock (in shares)	1,721,023		111,548
Convertible Debt | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issued upon preferred stock conversion (in shares)	344,205		22,310
Convertible Debt | Common Stock | Fusion Park
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issued upon preferred stock conversion (in shares)	184,851
Convertible Debt | Common Stock | Brilliant Start
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issued upon preferred stock conversion (in shares)	159,354

XML

Stockholders' Equity - Stock Split (Details)	Jun. 11, 2020 $ / shares shares	Sep. 30, 2021 $ / shares shares	Dec. 31, 2020 $ / shares shares
Stockholders' Equity Note [Abstract]
Reverse stock split ratio	0.2
Common stock, par value (USD per share) | $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, authorized (in shares) | shares	50,000,000	50,000,000	50,000,000

XML

Stockholders' Equity - Issuance of Common Stock and Warrants (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
	Nov. 25, 2019	Jun. 30, 2021	Jan. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants issued (in shares)						310,860	539,152
Exercise price of common stock (USD per share)				$ 3.59		$ 3.59
Amount paid for clearing fees		$ 19	$ 231
Offering costs paid on the issuance of common stock and warrants				$ 1	$ 0	$ 470	$ 474	$ 510
Proceeds from sale of common stock and warrants		$ 4,500	$ 2,300
Percentage of gross proceeds used to make payments on note			10.00%
Gross proceeds			$ 275
Payments on the Iliad Note				0	450	0	976
Proceeds from issuance of warrants						$ 1,100
Warrants exercised (in shares)						156,446
Proceeds from the exercise of warrants				$ 0	$ 625	$ 527	$ 676
Iliad Note
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of gross proceeds used to make payments on note	10.00%
Payments on the Iliad Note			$ 226
Institutional investors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of common stock (in shares)		990,100	688,360
Sale of common stock (USD per share)		$ 5.05	$ 3.37
Warrants issued (in shares)			688,360			269,180	497,472
Exercise price of common stock (USD per share)			$ 3.37	$ 3.3700	$ 3.3700	$ 3.3700	$ 3.3700
Purchase price (USD per share)			$ 0.625
Placement agent
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants issued (in shares)			48,185			41,680	41,680
Exercise price of common stock (USD per share)			$ 4.99	$ 4.9940	$ 4.9940	$ 4.9940	$ 4.9940
Amount paid for placement agent commissions		$ 400	$ 193
Amount paid related to expenses for registered direct offering and concurrent private placement		$ 51	$ 50

XML

Stockholders' Equity - Schedule of Warrants Outstanding (Details) - $ / shares	1 Months Ended	9 Months Ended
	Jan. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Underlying Shares (in shares)		310,860	539,152
Exercise Price (in dollars per share)		$ 3.59
Investor Warrants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Underlying Shares (in shares)	688,360	269,180	497,472
Exercise Price (in dollars per share)	$ 3.37	$ 3.3700	$ 3.3700
Placement Agent Warrants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Underlying Shares (in shares)	48,185	41,680	41,680
Exercise Price (in dollars per share)	$ 4.99	$ 4.9940	$ 4.9940

XML

Stockholders' Equity - Stock-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 39	$ 35	$ 387	$ 96
Unearned stock-based compensation	300	200	$ 300	200
Unearned compensation expected to be recognized, period			2 years 10 months 24 days
Cost of sales
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	2	1	$ 7	2
Product development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	2	3	10	5
Selling, general, and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 35	$ 31	$ 370	$ 89

XML

Stockholders' Equity - Estimates Utilized (Details) - $ / shares	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Stockholders' Equity Note [Abstract]
Fair value of options issued (USD per share)	$ 4.18	$ 2.00
Exercise price (USD per share)	$ 5.39	$ 2.61
Expected life of options (in years)	6 years 2 months 12 days	6 years 2 months 12 days
Risk-free interest rate	0.80%	0.70%
Expected volatility	96.50%	93.50%
Dividend yield	0.00%	0.00%

XML

Stockholders' Equity - Stock Options and a Summary of Activity (Details)	9 Months Ended
	Sep. 30, 2021 $ / shares shares
Number of Options
Outstanding at beginning of period (in shares) | shares	221,450
Granted (in shares) | shares	76,900
Canceled/forfeited (in shares) | shares	(35,287)
Expired (in shares) | shares	(1,500)
Outstanding at end of period (in shares) | shares	257,338
Vested and expected to vest at period end (in shares) | shares	218,795
Exercisable at period end (in shares) | shares	78,156
Weighted Average Exercise Price Per Share
Outstanding at beginning of period (USD per share) | $ / shares	$ 3.45
Granted (USD per share) | $ / shares	5.39
Canceled/forfeited (USD per share) | $ / shares	5.43
Expired (USD per share) | $ / shares	53.50
Outstanding at end of period (USD per share) | $ / shares	3.49
Vested and expected to vest at period end (USD per share) | $ / shares	3.43
Exercisable at period end (USD per share) | $ / shares	$ 3.48
Weighted Average Remaining Contractual Life (in years)
Outstanding at end of period	8 years 4 months 24 days
Vested and expected to vest at period end	8 years 3 months 18 days
Exercisable at period end	7 years 9 months 18 days

XML

Stockholders' Equity - Restricted Stock Units (Details)	9 Months Ended
	Sep. 30, 2021 $ / shares shares
Weighted Average Remaining Contractual Life (in years)
Outstanding at end of period	8 years 4 months 24 days
Restricted Stock Units
Restricted Stock Units
Outstanding at beginning of period (in shares) | shares	4,480
Granted (in shares) | shares	50,000
Vested (in shares) | shares	(52,080)
Outstanding at end of period (in shares) | shares	2,400
Weighted Average Grant Date Fair Value
Outstanding at beginning of period (USD per share) | $ / shares	$ 8.64
Granted (USD per share) | $ / shares	5.26
Released (USD per share) | $ / shares	5.46
Outstanding at end of period (USD per share) | $ / shares	$ 7.14
Weighted Average Remaining Contractual Life (in years)
Outstanding at end of period	9 years

XML

Commitments and Contingencies (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Sep. 30, 2021
Long-term Purchase Commitment [Line Items]
Outstanding purchase commitments		$ 2.9
Scenario, Forecast
Long-term Purchase Commitment [Line Items]
Purchase commitment	$ 2.6

XML

Other Income (Details) - USD ($) $ in Thousands		3 Months Ended			9 Months Ended
	Apr. 17, 2020	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Debt Instrument [Line Items]
ERTC refund		$ 431	$ 431
Proceeds from PPP loan		0		$ 0	$ 0	$ 795
PPP loan		0			0		$ 529
PPP loan, net of current maturities		0			0		$ 266
Gain on forgiveness of PPP loan		$ 0		$ 0	801	$ 0
Paycheck Protection Program
Debt Instrument [Line Items]
Proceeds from PPP loan	$ 795
Interest rate	1.00%
Gain on forgiveness of PPP loan					$ 801